syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.00440529	75.1975699889106
PUDENDAL NEURALGIA	1.75634923	65.89146157556502
ERYTHERMALGIA, PRIMARY	1.56988441	58.89601937514076
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516074
PAROXYSMAL EXTREME PAIN DISORDER	1.3983517	52.460772456783
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	1.3403752500000001	50.28571924856503
EHLERS-DANLOS SYNDROME, TYPE I	1.30671066	49.02275343256831
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.7205421218767
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.78280343709463
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1561323200000002	43.37363380718358
MENINGIOMA	1.0670669099999999	40.03224250499537
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.04	39.01679624307269
DUPLICATION OF THE PITUITARY GLAND	1.0357143	38.85601327801602
ULNA METAPHYSEAL DYSPLASIA SYNDROME	1.0344828	38.80981213900319
MONOSOMY 22Q13.3	1.023001039	38.37906066837948
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.0120527289999999	37.968322225614095
PAROXYSMAL KINESIGENIC DYSKINESIA	1.00980392	37.88395556932315
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.00943396	37.87007609438268
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.006676389	37.766622646466516
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	1.00662252	37.764601688969584
DEHYDRATED HEREDITARY STOMATOCYTOSIS	1.00413223	37.67117559520404
PROLIDASE DEFICIENCY	1.00359712	37.65110032805248
JERVELL AND LANGE-NIELSEN SYNDROME	1.000541419	37.53646219026713
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	1.0	37.51615023372374
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	1.0	37.51615023372374
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	1.0	37.51615023372374
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0	37.51615023372374
BNAR SYNDROME	1.0	37.51615023372374
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	1.0	37.51615023372374
118610 CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION;;FAMILIAL APATITE DISEASE	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.9048924150000001	33.94807978649709
LAFORA DISEASE	0.8983339	33.70202955244696
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.834328025	31.300775530106016
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.834328025	31.300775530106016
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7480334099999999	28.063333789404666
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.743468335	27.892069749876452
EARLY MYOCLONIC ENCEPHALOPATHY	0.73261378	27.48484863377623
PAROXYSMAL HEMICRANIA	0.7123674899999999	26.725285776460694
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.69003881	25.88759966305995
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.67478951	25.31550463330083
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.642857	24.117519790800944
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.636030625	23.861420480749207
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.6263889000000001	23.499700077136964
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6103603000000001	22.898368711500698
ROLANDIC EPILEPSY	0.60042522	22.52564275763663
RESTRICTIVE DERMOPATHY	0.6	22.509690140234245
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.5858771240000001	21.979854202486
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.556988269	20.896055578225734
AMYLOIDOSIS	0.5521391	20.71413342551302
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.543641259	20.395327145894722
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5415977799999999	20.31866368073126
SOLITARY BONE CYST	0.5387668	20.212456209742594
MOSAIC TRISOMY 1	0.5357143	20.09793816115415
PANNER DISEASE	0.5344828	20.05173702214132
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.5336554899999999	20.020699535891453
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
POEMS SYNDROME	0.5313239	19.93322725516801
TRIGEMINAL NEURALGIA	0.5290923000000001	19.849506214306437
FIBULAR HEMIMELIA	0.5277778	19.8001912348242
GANGLIONEUROMA	0.525	19.695978872704966
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 25	0.5249997	19.695967617859893
EHLERS-DANLOS SYNDROME, TYPE VI	0.52317616	19.62755541726269
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.51630151	19.369645015058424
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.51330784	19.25733404158823
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.51123841	19.179696994810055
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	0.5103093	19.144840364466397
INHALATIONAL ANTHRAX	0.50756216	19.041778247513328
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
CREST SYNDROME	0.50613497	18.988235573061257
NATIVE AMERICAN MYOPATHY	0.50601535	18.9837478911703
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.5037056440000001	18.89709661387857
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.50357143	18.8920614212911
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.500995025	18.79540462424818
ULNAR HEMIMELIA	0.500995025	18.79540462424818
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.5	18.75807511686187
CALCIPHYLAXIS	0.5	18.75807511686187
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.5	18.75807511686187
THUMB, DISTAL HYPEREXTENSIBILITY OF	0.5	18.75807511686187
ACQUIRED GENERALIZED LIPODYSTROPHY	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
TALONAVICULAR COALITION	0.5	18.75807511686187
RING CHROMOSOME 7 SYNDROME	0.5	18.75807511686187
FAMILIAL AVASCULAR NECROSIS OF FEMORAL HEAD	0.458333	17.194889685073303
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.42464282999999997	15.93096420595361
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.421596125	15.816663563455775
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064628
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.41834795	15.694804542170349
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.412869429	15.489271525275738
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
MARFAN SYNDROME	0.40310968499999994	15.123123503129051
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39840122	14.946480022818825
HELLP SYNDROME	0.38770552999999996	14.545218909925486
WILD TYPE ABETA2M AMYLOIDOSIS	0.3838235	14.399580089233666
DISTAL MONOSOMY 12Q	0.38034729	14.269166072629694
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.37438610999999994	14.045525548179421
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.37368563999999993	14.019246610425204
RARE CIRCULATORY SYSTEM DISEASE	0.366667	13.755934257748784
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.3609205	13.540347700430688
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
KAPOSI SARCOMA	0.35731968000000003	13.405258796346095
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.35463121999999997	13.304398127088735
CONGENITAL TRACHEAL STENOSIS	0.3505744	13.15220185849756
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.34946204	13.110470393623574
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.34884336	13.087259901796974
BIOTINIDASE DEFICIENCY	0.34506139999999996	12.94537532225904
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.344322	12.917635880776226
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.344183719	12.912448110005755
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34371795000000005	12.894974250227548
COMPLEX REGIONAL PAIN SYNDROME	0.34285699999999997	12.86267472068382
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.34173636	12.8206326220859
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.340009389	12.755843318600618
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.33868059	12.705991895686195
PIGMENTED VILLONODULAR SYNOVITIS	0.33773829	12.670640427320956
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III; CDG3	0.33710658	12.64694110005681
COG4-CDG	0.3355022	12.58675093894483
OSTEOGENESIS IMPERFECTA, TYPE V	0.33505008999999997	12.56978951226266
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	12.505370905857834
CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE	0.333333	12.505370905857834
ALCOHOL SENSITIVITY, ACUTE	0.333333	12.505370905857834
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF	0.333333	12.505370905857834
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.333333	12.505370905857834
CHRONIC ACTINIC DERMATITIS	0.333333	12.505370905857834
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.333333	12.505370905857834
ALDEHYDE DEHYDROGENASE 2 FAMILY	0.333333	12.505370905857834
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.333333	12.505370905857834
WIDOW'S PEAK SYNDROME	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
INSULIN AUTOIMMUNE SYNDROME	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
UVEAL MELANOMA	0.3269231	12.264896134474691
CRYPTOSPORIDIOSIS	0.31988906	12.001006033084668
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31971449	11.994456838738369
TUBEROUS SCLEROSIS COMPLEX	0.31438720000000003	11.794597426759754
HYPEREKPLEXIA 1; HKPX1	0.3125	11.72379694803867
CLEFT VELUM	0.31174240000000003	11.695374712621602
WILLIAMS-BEUREN SYNDROME; WBS	0.31161015000000003	11.690413201753191
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.30841260499999995	11.570453623154096
PARATHYROID CARCINOMA	0.30461784000000003	11.428088649312423
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.30461784000000003	11.428088649312423
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30073585999999997	11.282451704428109
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.29701459	11.142843980047862
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.291667	10.942222990219504
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.28644347000000003	10.746256253989142
WEST SYNDROME	0.2822581	10.58923728428542
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.2819398	10.577295893666026
CONGENITAL MYASTHENIC SYNDROME	0.27764387900000004	10.416129476037819
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.27764387900000004	10.416129476037819
DOORS SYNDROME	0.27712694	10.396735914852146
NASU-HAKOLA DISEASE	0.274759209	10.3079077629431
CONGENITAL ENTEROVIRUS INFECTION	0.27310926	10.24600802838112
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.26959418999999996	10.114136134179061
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.267489784	10.035186922530313
CASTLEMAN DISEASE	0.26381330000000003	9.897259396454434
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.2632534	9.876254103938571
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.2611111	9.795883255292862
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.25781673	9.672291175447391
WIEDEMANN-STEINER SYNDROME	0.25655676899999996	9.625022289282757
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.256282049	9.61471585249055
HYPERTRICHOSIS CUBITI	0.25621118	9.612057120439635
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25508440000000004	9.569784672679283
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.25498694	9.566128348677502
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.2535844	9.513510447328695
NON-FUNCTIONING PARAGANGLIOMA	0.2535844	9.513510447328695
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.2535844	9.513510447328695
TUBERCULOSIS	0.2535461	9.512073578774743
PRIMARY MYELOFIBROSIS	0.2535461	9.512073578774743
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.251925075	9.451258961342122
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.2511215	9.421111920918058
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	9.379037558430936
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.25	9.379037558430936
PALLISTER-HALL SYNDROME	0.25	9.379037558430936
PLACENTAL INSUFFICIENCY	0.25	9.379037558430936
TRICHOTHIODYSTROPHY	0.2489401	9.339274190798212
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.24380909000000003	9.146778448787474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.2424996	9.097651425217915
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.24138835999999994	9.055961978432189
GABRIELE-DE VRIES SYNDROME	0.24119421000000002	9.048678217864314
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23944559	8.98307672724262
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.2347064	8.805280563216458
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.23370397999999995	8.767673623899167
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.22166151400000003	8.315886660258661
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.22027639999999998	8.263922515343825
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.22027639999999998	8.263922515343825
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.22027639999999998	8.263922515343825
AUTOIMMUNE HYPOPARATHYROIDISM	0.22027639999999998	8.263922515343825
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.22024571	8.262771144693152
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.21978009999999998	8.245303249982827
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21976567500000002	8.244762079515706
UNILATERAL POLYMICROGYRIA	0.2180017	8.178584528407173
CARDIOFACIOCUTANEOUS SYNDROME	0.21591610500000002	8.10034103306047
CAMURATI-ENGELMANN DISEASE	0.215895065	8.099551693259553
19P13.13 MICRODELETION SYNDROME	0.214632489	8.052184702362059
MULTIPLE MYELOMA	0.2145351	8.048531042006948
ADIPOSIS DOLOROSA	0.21152282	7.935521892980906
CRI-DU-CHAT SYNDROME	0.21135889500000002	7.9293720580538425
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.20952369999999998	7.860522606725663
DYSTONIA 16; DYT16	0.20952369999999998	7.860522606725663
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.20840336	7.818491762972814
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.20806830000000004	7.805921601675503
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.20778964	7.795467351251373
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.206708405	7.754903576553413
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20618526	7.73527719013939
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20618526	7.73527719013939
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.20534759000000002	7.703851036573109
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424821999999998	7.662606906490657
PORPHYRIA, ACUTE HEPATIC	0.20401606	7.6538971570523975
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.201536444	7.560871510674453
ROMANO-WARD SYNDROME	0.200541419	7.523542003288142
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.200541419	7.523542003288142
BENIGN SCHWANNOMA	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.2	7.50323004674475
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.2	7.50323004674475
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.2	7.50323004674475
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.50323004674475
NEUROTROPHIC KERATOPATHY	0.2	7.50323004674475
TRANSALDOLASE DEFICIENCY	0.2	7.50323004674475
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.2	7.50323004674475
MACHADO-JOSEPH DISEASE; MJD	0.2	7.50323004674475
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.50323004674475
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.50323004674475
600736 VELOFACIOSKELETAL SYNDROME	0.2	7.50323004674475
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.2	7.50323004674475
MEDIAL CONDENSING OSTEITIS OF THE CLAVICLE	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19846036	7.445468681198898
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19846036	7.445468681198898
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19846036	7.445468681198898
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19846036	7.445468681198898
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19846036	7.445468681198898
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19846036	7.445468681198898
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19846036	7.445468681198898
SANDIFER SYNDROME	0.19432685	7.290395299046298
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.192208119	7.210908668545452
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.18685110000000005	7.009933938936539
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.1862434	6.987135374439505
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.18523452999999998	6.9492864559532075
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.864528843860672
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.780678747442289
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.780678747442289
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.18068328	6.778541077201973
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.17948699999999998	6.733661257000373
BUERGER DISEASE	0.17832710999999998	6.690146649505779
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.17736728400000001	6.6541376730915465
PRADER-WILLI SYNDROME	0.176025324	6.603792500123898
SARCOIDOSIS	0.1731223	6.494882215607792
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.171358745	6.428720421282358
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.168867875	6.335272568149682
SLC35A2-CDG	0.16832270500000004	6.314819888526764
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.166667	6.252704211004036
SINDING-LARSEN-JOHANSSON DISEASE	0.166667	6.252704211004036
OSGOOD-SCHLATTER DISEASE	0.166667	6.252704211004036
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.16546035500000003	6.207435535905264
HEPATOCELLULAR CARCINOMA	0.16529790999999996	6.2013412248805455
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.16310782499999996	6.1191776669959195
SMITH-FINEMAN-MYERS SYNDROME	0.161255719	6.04969378005114
KAPOSIFORM LYMPHANGIOMATOSIS	0.16023221999999998	6.011296037803073
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.15993287	6.000065578230609
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
HEREDITARY FRUCTOSE INTOLERANCE	0.15889171899999996	5.961005600898616
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.1568604	5.884798332122
NEUROLEPTIC MALIGNANT SYNDROME	0.15616357	5.858655953154635
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1559114	5.849195505550196
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.15455138999999998	5.798173166070828
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15435129999999997	5.790666559570563
ENCEPHALITIS LETHARGICA	0.154122349	5.782077199458402
PAGET DISEASE OF BONE 3; PDB3	0.15384599999999998	5.771709648857462
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15328598499999999	5.750700041984324
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.153202339	5.747561966081874
SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25	0.1527778	5.731634897177798
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.1527778	5.731634897177798
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.7068164631521805
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6871294881555325
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.15112145999999999	5.669495396899673
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.15054931	5.648030531543448
ADNP SYNDROME	0.15018282900000002	5.634281575289644
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.14947951999999998	5.607896129184912
PACHYDERMOPERIOSTOSIS	0.148623725	5.575789995395644
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.14803852399999998	5.553835506762717
ALPHA-MANNOSIDOSIS	0.147449145	5.531724275654116
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.14687305999999997	5.51011178424672
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.14687305999999997	5.51011178424672
CAROLI DISEASE, ISOLATED	0.14687305999999997	5.51011178424672
YELLOW NAIL SYNDROME	0.14645412	5.494394768267805
PEROXISOME BIOGENESIS DISORDER 11B	0.1456475	5.4641334911662796
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.440824707026066
BRANCHIOSKELETOGENITAL SYNDROME	0.14339841899999997	5.379756630482464
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.14339841899999997	5.379756630482464
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.14285699999999998	5.3594446739390715
GLOMUVENOUS MALFORMATION	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.14285699999999998	5.3594446739390715
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	5.3594446739390715
ANAUXETIC DYSPLASIA 2; ANXD2	0.14285699999999998	5.3594446739390715
SPINOCEREBELLAR ATAXIA 43; SCA43	0.14285699999999998	5.3594446739390715
ATELOSTEOGENESIS TYPE II	0.14285699999999998	5.3594446739390715
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.14285699999999998	5.3594446739390715
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.3594446739390715
TURNPENNY-FRY SYNDROME; TPFS	0.14090365	5.286162501880028
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356098
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.13959275	5.23698258053864
WYBURN-MASON SYNDROME	0.13705272899999998	5.141690771105827
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13702114999999998	5.1405060485975955
PROTEUS SYNDROME	0.135716994	5.091579136173384
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.13527862000000002	5.075133031330826
POLYARTERITIS NODOSA	0.13471841	5.054116108808391
MYXOPAPILLARY EPENDYMOMA	0.1343924	5.041885468670695
FUCOSIDOSIS	0.133233729	4.998416593363236
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.132997619	4.989558655131552
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.13211753	4.956541103988505
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13198487500000003	4.95156439907925
VIRAL HEMORRHAGIC FEVER	0.131771099	4.943544346546885
CHIARI MALFORMATION TYPE I	0.13137136500000002	4.928547865749358
CODAS SYNDROME	0.130382594	4.891452984366607
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.13034759	4.890139769043826
ASPARTYLGLUCOSAMINURIA	0.130133564	4.882110337473904
AICARDI SYNDROME; AIC	0.12987732500000002	4.872497236654165
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.1285461	4.822554799559276
MIRAGE SYNDROME; MIRAGE	0.127549294	4.785158475909398
SIALIDOSIS TYPE 1	0.126536444	4.747160243145171
SPONDYLOCOSTAL DYSOSTOSIS 5	0.125995025	4.726848286601779
SYRINGOMYELIA, ISOLATED	0.125995025	4.726848286601779
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.125995025	4.726848286601779
ARNOLD-CHIARI MALFORMATION TYPE I	0.125995025	4.726848286601779
SECKEL SYNDROME 7; SCKL7	0.125541419	4.709830735758859
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.125541419	4.709830735758859
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.125509274	4.708624779109597
SCHINZEL-GIEDION SYNDROME	0.12534349	4.70240520165925
OSTEOMESOPYKNOSIS	0.125	4.689518779215468
PROTRUSIO ACETABULI	0.125	4.689518779215468
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.125	4.689518779215468
ANGIOMA, TUFTED	0.125	4.689518779215468
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.125	4.689518779215468
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.125	4.689518779215468
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.125	4.689518779215468
RHEUMATOID ARTHRITIS	0.12461430000000001	4.6750488000703205
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.124515139	4.671328661096994
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.124153405	4.657757794008348
ILEAL NEUROENDOCRINE TUMOR	0.1230861	4.6177166192831445
JEJUNAL NEUROENDOCRINE TUMOR	0.1230861	4.6177166192831445
GRFOMA	0.12181328000000001	4.569965312942656
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.1204837	4.520084589914902
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12037025999999999	4.515828757832387
NOONAN SYNDROME 7; NS7	0.119367064	4.478192705982517
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.11928056000000002	4.4749474089226995
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.11835751900000002	4.440318464094814
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.117091519	4.392823017898919
8Q24.3 MICRODELETION SYNDROME	0.117024969	4.390326318100865
HEREDITARY ACROKERATOTIC POIKILODERMA	0.11564514000000001	4.338560446040015
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.1152645	4.324280298615051
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11512705999999999	4.319124078926927
NOCARDIOSIS	0.11504461900000001	4.31603120998551
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.1149069	4.310864523291471
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.11414429499999999	4.282254519542482
KIKUCHI-FUJIMOTO DISEASE	0.11329898000000001	4.250541555007662
INFANTILE MYOFIBROMATOSIS	0.1119149	4.198616201792169
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.110752575	4.155010242471756
SAY-BARBER-MILLER SYNDROME	0.10943396000000001	4.105540884031315
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.109025909	4.090232381412294
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.108600415	4.074269484584746
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.108277285	4.062146890959722
CADASIL	0.10776313900000001	4.042858112381655
MICROSCOPIC POLYANGIITIS	0.10712696000000002	4.018991125442114
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.1068806	4.009748646670534
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.10672411000000001	4.003877744320459
AGEL AMYLOIDOSIS	0.10662252	4.000066478618215
BILATERAL POLYMICROGYRIA	0.10628441000000001	3.9873818930626905
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10625166	3.9861532391425354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331	3.984714494781073
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.10576632	3.9679451507881
PMM2-CDG	0.105452509	3.956172170167105
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.1051282	3.944005345000957
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.1041667	3.907933566551231
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.1036867	3.8899258144390436
MANTLE CELL LYMPHOMA	0.1035461	3.884651043716182
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.10329669999999999	3.875294515847891
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.102534265	3.8466908898444423
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.10246914	3.8442476505604706
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.102381	3.84094097707887
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.10226438	3.836565843638614
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.101500229	3.807897839921363
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.10133491	3.801695707480875
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.100995025	3.7889445307586853
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.10066607000000001	3.7766034055585513
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.100541419	3.771926979915767
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10001750000000001	3.7522715560014652
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.10001168999999999	3.752053587168606
DESMINOPATHY	0.1	3.751615023372375
IMMUNODEFICIENCY 15A; IMD15A	0.1	3.751615023372375
MONOSOMY 13Q14	0.1	3.751615023372375
RUIJS-AALFS SYNDROME; RJALS	0.1	3.751615023372375
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.1	3.751615023372375
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.1	3.751615023372375
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.1	3.751615023372375
JUVENILE HYALINE FIBROMATOSIS	0.1	3.751615023372375
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0989248	3.711277658641074
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755000000001	3.6918724299326815
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
PSEUDOAMINOPTERIN SYNDROME	0.09775640000000001	3.6674437887079923
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.09773582900000001	3.6666720439815346
PEDIATRIC-ONSET GRAVES DISEASE	0.09743282	3.6553043128153635
SLC35A1-CDG	0.09722220000000001	3.6474026612531367
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.09703126	3.6402393275275093
GITELMAN SYNDROME	0.09598934	3.6011505002759883
CLASSIC HOMOCYSTINURIA	0.095603344	3.5866694163503716
CHOPS SYNDROME; CHOPS	0.09475525000000001	3.5548521944340523
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.09401411	3.5270474748498293
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.093008645	3.4893262988550786
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.092975754	3.488092355157741
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.0925926	3.4737178921310887
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.09222981000000001	3.4601074079877967
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.09145051900000001	3.430871409756008
SOMATOSTATINOMA	0.09111158000000001	3.41815572331194
GLUCAGONOMA	0.09111158000000001	3.41815572331194
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.09108092400000001	3.417005628210375
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.09102561	3.414930459876347
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.09100760000000001	3.414254794010637
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.09100760000000001	3.414254794010637
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.09100760000000001	3.414254794010637
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.09100760000000001	3.414254794010637
X-LINKED DYSTONIA-PARKINSONISM	0.0909091	3.410559453212615
MOHR-TRANEBJAERG SYNDROME	0.0909091	3.410559453212615
FAMILIAL PANCREATIC CARCINOMA	0.09067660000000001	3.4018369482832744
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0906217	3.3997773116354426
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.090183085	3.383322165400678
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.08928668000000001	3.3496925007504172
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.088097	3.305060287140361
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.08782041000000002	3.294683695147216
GLUTAMATE MONOSODIUM SENSITIVITY	0.08755764000000002	3.2848255763503005
MAJEED SYNDROME	0.08682289000000001	3.2572605849660716
SAPHO SYNDROME	0.08667478	3.2517040679549547
MYCETOMA	0.0866013	3.2489473812357805
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0860805	3.2294089701940565
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.08592016	3.223393630665581
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.08591994	3.22338537711253
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.08584155000000002	3.220444486095709
DUBOWITZ SYNDROME	0.0853676	3.202663706692435
KABUKI SYNDROME 1	0.085346954	3.2018891482547094
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08387471900000001	3.146656558815364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.08387471900000001	3.146656558815364
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08387471900000001	3.146656558815364
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.08387471900000001	3.146656558815364
VIPOMA	0.08376657	3.142599224683736
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.08351021	3.132981584409819
KERATOLYTIC WINTER ERYTHEMA; KWE	0.08333330000000001	3.1263446022719714
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN	0.08333330000000001	3.1263446022719714
HYPERHIDROSIS PALMARIS ET PLANTARIS	0.08333330000000001	3.1263446022719714
BLEEDING DISORDER, PLATELET-TYPE, 22; BDPLT22	0.08333330000000001	3.1263446022719714
%164800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5;;ONYCHOLYSIS, PARTIAL, WITH SCLERONYCHIA;;ONYCHOLYSIS, HEREDITARY DISTAL	0.08333330000000001	3.1263446022719714
LATE-ONSET JUNCTIONAL EPIDERMOLYSIS BULLOSA	0.08333330000000001	3.1263446022719714
BOOK SYNDROME	0.08333330000000001	3.1263446022719714
PACHYONYCHIA CONGENITA 2	0.08333330000000001	3.1263446022719714
ACQUIRED HEMOPHILIA	0.08333330000000001	3.1263446022719714
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.08333330000000001	3.1263446022719714
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.083037599	3.1152510391317083
IDIOPATHIC PANUVEITIS	0.08229944	3.087558155191333
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0821018	3.08014346325914
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.08140518	3.054008962683323
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.08122642	3.0473025756675427
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.08093916000000001	3.036525686351404
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.08082667999999998	3.0323058697731136
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0807512	3.029474150753473
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.080736444	3.028920562440624
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.080651825	3.025745983323996
BRUNNER SYNDROME; BRNRS	0.08057852000000001	3.022995861931114
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.08050127	3.020097739325558
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.08003577	3.0026339713917602
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.079954269	2.999576367631561
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.07986474900000001	2.996217921862639
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.079768635	2.992612094599074
LICHTENSTEIN SYNDROME	0.07942783	2.9798264030186696
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.079340719	2.9765583336556602
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9653819348556816
ESOPHAGEAL ATRESIA	0.079002935	2.9638859783651115
FONTAINE PROGEROID SYNDROME; FPS	0.07843897500000001	2.942728370279301
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.07814001000000001	2.931512354424676
BAZEX SYNDROME; BZX	0.07807659	2.929133080176853
GALLBLADDER NEUROENDOCRINE TUMOR	0.0776316	2.912438768484348
HSD10 DISEASE	0.07746451900000001	2.9061705325871476
PHELAN-MCDERMID SYNDROME	0.077365309	2.9024485553224593
NEOVASCULAR GLAUCOMA	0.07692310000000001	2.885858576043755
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.885858576043755
AMOEBIC KERATITIS	0.07692310000000001	2.885858576043755
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.07692310000000001	2.885858576043755
ICHTHYOSIS VULGARIS	0.07692310000000001	2.885858576043755
MACULAR CORNEAL DYSTROPHY	0.07692310000000001	2.885858576043755
PAGET DISEASE, EXTRAMAMMARY	0.07692310000000001	2.885858576043755
NEUROMYELITIS OPTICA	0.07692310000000001	2.885858576043755
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.07692310000000001	2.885858576043755
IDIOPATHIC ANTERIOR UVEITIS	0.07692310000000001	2.885858576043755
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07692310000000001	2.885858576043755
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.07692310000000001	2.885858576043755
NELSON SYNDROME	0.07692310000000001	2.885858576043755
COSTELLO SYNDROME; CSTLO	0.07685565999999999	2.883328486871992
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.076569019	2.872574820052848
HYDROXYKYNURENINURIA	0.07573640000000001	2.841338160561395
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.07527475000000002	2.824018829805997
SCIMITAR SYNDROME	0.07511691999999999	2.8180976558146074
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.075086474	2.816955439104592
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.0746965	2.8023251159333453
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07461872	2.7994071097681665
SMITH-MAGENIS SYNDROME; SMS	0.074519674	2.795691285152117
19P13.3 MICRODUPLICATION SYNDROME	0.07438741	2.7907292490576037
BARE LYMPHOCYTE SYNDROME, TYPE II	0.0742081	2.784002228159195
GAUCHER DISEASE, TYPE II	0.074139219	2.781418078214946
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.07407673000000001	2.779073731502991
16P13.2 MICRODELETION SYNDROME	0.073969834	2.7750634051076064
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.07374328999999999	2.7665643463690572
GLYCINE ENCEPHALOPATHY	0.07357086	2.760095436584257
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07294859999999999	2.7367506369398193
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.07283844399999999	2.7326180078946734
ADENOCARCINOMA OF OVARY	0.0726237	2.724561639728883
MARSHALL-SMITH SYNDROME; MRSHSS	0.072423625	2.717055595970871
ALKAPTONURIA	0.07218309	2.7080316487744023
22Q11.2 DELETION SYNDROME	0.07218037399999999	2.7079297549103667
IMMUNODEFICIENCY 49; IMD49	0.07197001900000001	2.7000380451279526
FRYNS MICROPHTHALMIA SYNDROME	0.0715198	2.683147561485875
FLUSHING OF EARS AND SOMNOLENCE	0.07142860000000001	2.67972608858456
ULERYTHEMA OPHRYOGENESIS	0.07142860000000001	2.67972608858456
OROFACIODIGITAL SYNDROME IX; OFD9	0.07142860000000001	2.67972608858456
CENTRIFUGAL LIPODYSTROPHY	0.07142860000000001	2.67972608858456
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07142860000000001	2.67972608858456
VERRUCOUS HEMANGIOMA	0.07142860000000001	2.67972608858456
PERICARDIAL EFFUSION, CHRONIC	0.07142860000000001	2.67972608858456
DERMODISTORTIVE URTICARIA	0.07142860000000001	2.67972608858456
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1	0.07142860000000001	2.67972608858456
KERATOSIS PILARIS ATROPHICANS	0.07142860000000001	2.67972608858456
INTERSTITIAL GRANULOMATOUS DERMATITIS WITH ARTHRITIS	0.07142860000000001	2.67972608858456
MELKERSSON-ROSENTHAL SYNDROME	0.07142860000000001	2.67972608858456
IDIOPATHIC LOCALIZED LIPODYSTROPHY	0.07142860000000001	2.67972608858456
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07142860000000001	2.67972608858456
PANNICULITIS-INDUCED LOCALIZED LIPODYSTROPHY	0.07142860000000001	2.67972608858456
PRESSURE-INDUCED LOCALIZED LIPOATROPHY	0.07142860000000001	2.67972608858456
OCULOPHARYNGODISTAL MYOPATHY	0.07142860000000001	2.67972608858456
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.071374719	2.6777046808938163
MERCURY POISONING	0.070995919	2.6634935631852823
CONGENITAL ANALBUMINEMIA	0.07077296	2.655128999845321
DUODENAL NEUROENDOCRINE TUMOR	0.0704545	2.6431816066418894
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.07019710000000001	2.6335249495717297
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07019114000000001	2.6333013533163365
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.070053065	2.6281213108728148
300270 ADRENOMYODYSTROPHY	0.07002023	2.6268894680798907
IDIOPATHIC BRONCHIECTASIS	0.0695762	2.61023117189161
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.068693274	2.577107187430349
PGM3-CDG	0.068472069	2.568808427417898
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.06825746	2.5607571239323894
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0677465	2.5415878718089657
SPASTIC PARAPLEGIA TYPE 7	0.06766172499999999	2.5384074401729015
WHITE-SUTTON SYNDROME; WHSUS	0.06761152000000001	2.5365239418504175
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.06739382000000001	2.528356675944536
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
COPPER DEFICIENCY, FAMILIAL BENIGN	0.067028319	2.5146444855179597
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.06702221900000001	2.5144156370015343
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.0666667	2.5010779327865906
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.0666667	2.5010779327865906
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.0666667	2.5010779327865906
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0666667	2.5010779327865906
X-LINKED SPASTIC PARAPLEGIA TYPE 34	0.0666667	2.5010779327865906
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
DYSTONIA 16	0.0666667	2.5010779327865906
13Q12.3 MICRODELETION SYNDROME	0.0665322	2.496032010580155
LETTERER-SIWE DISEASE	0.0664869	2.4943325289745673
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.06634615	2.4890521308291707
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.06627786000000001	2.4864901529297097
EPIDERMAL NEVUS SYNDROME	0.0662393	2.4850435301766973
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0662393	2.4850435301766973
PONTINE TEGMENTAL CAP DYSPLASIA	0.066205644	2.4837808866244306
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.06609712	2.479709483936466
EVEN-PLUS SYNDROME	0.0653846	2.4529784765719334
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.4519137307121506
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.06483885	2.4325040375818787
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0648141	2.431575512863594
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.4127236473711475
MYELOPEROXIDASE DEFICIENCY	0.0638946	2.397079412723685
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.0638889	2.3968655706673525
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.0638889	2.3968655706673525
TEMPLE SYNDROME	0.06344696500000001	2.3802858708138124
KOOLEN-DE VRIES SYNDROME; KDVS	0.063352314	2.3767349296780402
TAY-SACHS DISEASE; TSD	0.063041419	2.3650713461511264
GM2-GANGLIOSIDOSIS, AB VARIANT	0.063041419	2.3650713461511264
BRITTLE CORNEA SYNDROME	0.06299911500000001	2.3634842629316393
CHERUBISM	0.06287208	2.3587183987866975
NAVAJO NEUROHEPATOPATHY	0.06284244	2.35760642009377
COWDEN SYNDROME	0.06282908400000001	2.357105354391249
FLYNN-AIRD SYNDROME	0.06282908400000001	2.357105354391249
COCAINE EMBRYOFETOPATHY	0.0627273	2.3532868105558595
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.0625	2.344759389607734
CLEFT LARYNX, POSTERIORSTRIDOR, CONGENITAL, INCLUDED	0.0625	2.344759389607734
SPINOCEREBELLAR ATAXIA TYPE 8	0.0625	2.344759389607734
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0625	2.344759389607734
SPERMATOGENIC FAILURE 15; SPGF15	0.0625	2.344759389607734
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.06230067	2.3372812953816458
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.061930450000000005	2.323392066242117
KAGAMI-OGATA SYNDROME	0.061424399	2.3044069809001906
GERODERMA OSTEODYSPLASTICUM; GO	0.06123105	2.2971532707686504
AUTOIMMUNE HEPATITIS	0.06116912	2.2948298955846758
NEUROFIBROMATOSIS TYPE 1	0.061124684000000006	2.2931628279328904
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.06103736	2.28988676762988
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.06074833	2.2790434747278274
SHEEHAN SYNDROME	0.06060832	2.2737908385336034
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.060359944	2.264472727203152
LOEYS-DIETZ SYNDROME 3; LDS3	0.060249145000000004	2.260315975273406
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.0600359	2.2523158438168154
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.059998639000000006	2.2509179545429565
RIN2 SYNDROME	0.059773675	2.242478171321777
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.2361193714379124
DERMATITIS, ATOPIC	0.05943396	2.2297333723451276
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.059364919	2.2271432198168415
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.059364919	2.2271432198168415
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.059364919	2.2271432198168415
CONGENITAL ISOLATED ACTH DEFICIENCY	0.05910170000000001	2.2172682562684707
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.05910170000000001	2.2172682562684707
SANDHOFF DISEASE	0.05887461	2.2087487137118944
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.0588235	2.2068312632734486
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.0588235	2.2068312632734486
TRISOMY 8Q	0.0588235	2.2068312632734486
FANCONI-LIKE SYNDROME	0.0588235	2.2068312632734486
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.058550829000000006	2.1966016970730693
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.058486880000000005	2.1942025767817728
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.058331059000000005	2.1883567727362037
NEONATAL LUPUS ERYTHEMATOSUS	0.058184200000000005	2.182847188429029
EOSINOPHILIC GASTROENTERITIS	0.058148290000000005	2.181499983474136
SCLERODERMA	0.058139629	2.1811750560969614
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.058024740000000005	2.1768648631127596
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.0579283	2.173246805584219
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
DESMOID TUMOR	0.05689591	2.134515507244425
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.05688296	2.1340296730988983
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.056830450000000005	2.1320597000501254
JUVENILE POLYPOSIS SYNDROME	0.05676383	2.1295603741215547
ADENOCARCINOMA OF THE ANAL CANAL	0.05676383	2.1295603741215547
DIGEORGE SYNDROME; DGS	0.05586685400000001	2.0959092877495107
PERIVENTRICULAR NODULAR HETEROTOPIA	0.055658205	2.088081580519394
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.055585024	2.0853361111291395
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
PALLISTER-KILLIAN SYNDROME	0.05531944900000001	2.075372759530819
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0553161	2.075247117943686
MONOSOMY 22	0.05531131	2.0750674155840665
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.055236545	2.072262520611842
CHROMOSOME 18Q DELETION SYNDROME	0.055133563999999996	2.068399069944623
IMMUNODEFICIENCY 58; IMD58	0.0549897	2.0630018465073987
AARSKOG-SCOTT SYNDROME	0.054825205	2.056830627374702
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.05471376	2.0526496400119045
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.05463484499999999	2.04968905301621
PRIMARY PARATHYROID HYPERPLASIA	0.05461784000000001	2.0490510908814863
HYPOPLASMINOGENEMIA	0.0545894	2.047984131568839
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	2.047984131568839
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.054345679	2.0388406579177256
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.05422606	2.0343530135429178
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.054087519	2.0291554885733873
OCCIPITAL HORN SYNDROME	0.05389277499999999	2.0218494434122705
SILVER-RUSSELL SYNDROME	0.053810065000000004	2.01874648262644
PELIZAEUS-MERZBACHER DISEASE	0.053536924	2.0084992838354503
VAN DEN BOSCH SYNDROME	0.0533507	2.0015128762743255
BLACKFAN-DIAMOND ANEMIA	0.05335002	2.0014873652921663
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.053315599000000005	2.0001960218849715
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0530914	1.9917849385187207
GAUCHER DISEASE TYPE 3	0.05303248	1.9895744869469496
AMISH INFANTILE EPILEPSY SYNDROME	0.05301935	1.9890818998943811
CLASSICAL EHLERS-DANLOS SYNDROME	0.052832795	1.9820830744875289
AICARDI-GOUTIERES SYNDROME 7	0.052710619	1.9774995013165733
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0526646	1.9757730455989675
LARYNGEAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412546
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROMEIMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR	0.0526316	1.9745350126412546
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.05242532	1.966796181171042
VISCERAL STEATOSIS, CONGENITAL	0.052284318999999996	1.9615063664719365
ARACHNOIDITIS	0.05223811	1.9597727826857865
WHITE FORELOCK WITH MALFORMATIONS	0.05215862000000001	1.956790623903708
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.051920209999999994	1.9478463985264858
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.051805449	1.9435410076095136
MAJEED SYNDROME	0.05175922	1.9418066735003587
ADENOMYOSIS	0.0517429	1.9411944099285445
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.051731849	1.9407798189523116
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0517242	1.9404928579191734
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0517242	1.9404928579191734
GAUCHER DISEASE	0.051687170000000004	1.9391036348760191
ZIMMERMANN-LABAND SYNDROME 1	0.051624584	1.936755649097491
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.051470619999999995	1.9309795125429057
ERYTHRODERMA DESQUAMATIVUM	0.05139258	1.9280517521786662
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
CHRISTIANSON SYNDROME	0.05114291	1.9186850949498124
COHEN SYNDROME	0.051106769	1.9173292237642154
MARFANOID HABITUS WITH SITUS INVERSUS	0.05108316500000001	1.9164436925540989
PAROXYSMAL COLD HEMOGLOBINURIA	0.05106510000000001	1.9157659633001267
COLD AGGLUTININ DISEASE	0.05101408	1.9138518893152017
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.050783285	1.9051933494220092
WILLIAMS SYNDROME	0.05074713499999999	1.90383714059106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05073566	1.9034066427671283
RAT-BITE FEVER	0.050696660000000004	1.9019435129080133
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.050645679	1.9000309020529478
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.050541419000000004	1.8961194682295797
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.050541419000000004	1.8961194682295797
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.050329619	1.888173547610077
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0502451	1.8850027201084727
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.05	1.8758075116861874
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.05	1.8758075116861874
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.05	1.8758075116861874
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.05	1.8758075116861874
IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	0.05	1.8758075116861874
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.05	1.8758075116861874
WISKOTT-ALDRICH SYNDROME	0.0498254	1.869257191855379
WILSON DISEASE	0.04979461	1.8681020695896826
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.049606125	1.8610308380128793
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.04921893000000001	1.846504772223133
ALG11-CDG	0.049160144	1.844299347815493
COFFIN-LOWRY SYNDROME; CLS	0.049155444000000006	1.8441230219093947
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.04890819	1.834847003699505
OSTEOGENESIS IMPERFECTA, TYPE I	0.048861310000000005	1.8330882465765486
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.048743764999999994	1.828678410697325
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.048614025000000005	1.823811065366002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.048568759	1.8221128593095222
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.820707541837917
BULLOUS PEMPHIGOID	0.04840347	1.81591185235354
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.048389220000000004	1.8153772472127097
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.048371700000000004	1.8147199642606149
XP21 MICRODELETION SYNDROME	0.04834308899999999	1.8136465896862772
THROMBOCYTOPENIA 1	0.048314579999999996	1.8125770417592644
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.048141029	1.8060660763700516
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.048104140000000004	1.8046821431040798
LEGIONELLOSIS	0.04789638	1.7968877877315215
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.047788225000000004	1.7928302285029931
CHROMOSOME 1P36 DELETION SYNDROME	0.047729844	1.7906399981361978
TRANSKETOLASE DEFICIENCY	0.047619	1.786481557979691
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.047619	1.786481557979691
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.047619	1.786481557979691
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.047619	1.786481557979691
CANDIDIASIS, FAMILIAL, 8; CANDF8	0.047619	1.786481557979691
EPIDERMODYSPLASIA VERRUCIFORMIS	0.047619	1.786481557979691
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.04761683900000001	1.786400485579036
HYPOTONIA-CYSTINURIA SYNDROME	0.04752688000000001	1.7830255702201605
NON-DISTAL TRISOMY 10Q	0.047206205	1.7709950787439608
DISTAL TRISOMY 17Q	0.046990944	1.7629193147284994
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.046506399999999996	1.7447410892296498
ROWLEY-ROSENBERG SYNDROME	0.0463426	1.7385959438213658
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.046277869	1.7361674859005867
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.046211180000000004	1.7336655713576503
GLYCEROL KINASE DEFICIENCY; GKD	0.045995919	1.7255898073421885
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.045995919	1.7255898073421885
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0458139	1.718761155192796
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.7187198874275393
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.045682759999999996	1.7138412872511455
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.04546564	1.7056957807123998
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.045446519000000005	1.7049784344037806
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0453712	1.7021527554843268
VARIANT ABETA2M AMYLOIDOSIS	0.0452848	1.6989113601041328
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.045172910000000004	1.6947136780544818
KAPUR-TORIELLO SYNDROME	0.045107874000000006	1.6922737777078816
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
CURRARINO SYNDROME	0.0447964	1.6805884723299822
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0447921	1.6804271528839774
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.0447921	1.6804271528839774
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.0447921	1.6804271528839774
AICARDI SYNDROME	0.044719285	1.6776954144047087
SYSTEMIC MASTOCYTOSIS	0.044649879999999996	1.6750916059977368
SYSTEMIC SCLEROSIS	0.044580569	1.6724913241088875
LEUKOCYTE ADHESION DEFICIENCY	0.044520819	1.6702497341324225
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.04447332500000001	1.6684679420932225
CRANIOPHARYNGIOMA	0.044405139	1.6659098658733853
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.044352574000000006	1.6639378294363498
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.044019719000000006	1.6514503912503038
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.044019719000000006	1.6514503912503038
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.044019719000000006	1.6514503912503038
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.044019719000000006	1.6514503912503038
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.6514503912503038
LASSA FEVER	0.044010218999999996	1.651093987823083
SCRUB TYPHUS	0.04393075899999999	1.6481129545255113
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.043861655	1.6455204384797602
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0438464	1.6449481296079447
GRANULOMATOSIS WITH POLYANGIITIS	0.04383375900000001	1.6444738879528404
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.04380909	1.6435484020427247
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.6414216114859745
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.043751575	1.6413906606620319
MELAS	0.043627070000000004	1.6367197123771822
PREPAPILLARY VASCULAR LOOPS	0.0435606	1.6342260138711464
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	1.6311384347069111
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.6311384347069111
JUVENILE XANTHOGRANULOMA	0.043478300000000004	1.6311384347069111
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	1.6311384347069111
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.6311384347069111
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.043478300000000004	1.6311384347069111
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.6311384347069111
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.6311384347069111
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.6311384347069111
MARBURG HEMORRHAGIC FEVER	0.043468799999999995	1.6307820312796903
CHROMOSOME 17Q12 DELETION SYNDROME	0.043406625000000004	1.6284494646389092
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.043406610000000005	1.6284489018966557
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.04333954500000001	1.625932881281231
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.043288679000000004	1.624024584783442
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.043094715000000006	1.616747802219508
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0430753	1.61601942616272
16P13.11 MICRODELETION SYNDROME	0.04305235	1.6151584305148565
SHORT SYNDROME	0.04299204	1.6128958314942605
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.04292928	1.610541317905592
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.042921095000000006	1.6102342482159293
YUNIS-VARON SYNDROME	0.04288616	1.6089236215075138
3MC SYNDROME 2	0.04281613	1.6062963655066462
CLASSIC HODGKIN LYMPHOMA	0.04278403	1.6050920970841438
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.042721209999999996	1.6027353325264608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0427032	1.6020596666607516
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0425674	1.5969649734590121
LIMB-MAMMARY SYNDROME	0.0425674	1.5969649734590121
SPINOCEREBELLAR ATAXIA TYPE 34	0.0425674	1.5969649734590121
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.042520075000000004	1.5951895216492011
RHEUMATIC FEVER	0.042346640000000005	1.5886829081334153
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.042336820000000004	1.5883144995381202
ACROOSTEOLYSIS DOMINANT TYPE	0.042307555	1.58721658940153
MENTAL RETARDATION, X-LINKED 98; MRX98	0.04223572899999999	1.5845219543948426
DUBOWITZ SYNDROME	0.04223513400000001	1.5844996322854539
FABRY DISEASE	0.042206538999999994	1.58342685796952
SUBEPENDYMOMA	0.042139199	1.5809005204127813
EPENDYMOMA	0.042139199	1.5809005204127813
TAKAYASU ARTERITIS	0.042089329	1.5790295900006257
GANGLIOCYTOMA	0.041841474999999996	1.5697310621005962
FAMILIAL DYSAUTONOMIA	0.04176350400000001	1.5668058903507225
MYCOSIS FUNGOIDES	0.041692059999999996	1.5641255865134243
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.041692059999999996	1.5641255865134243
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.041666699999999994	1.5631741769434968
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.041666699999999994	1.5631741769434968
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.041666699999999994	1.5631741769434968
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.041666699999999994	1.5631741769434968
GLYCOGEN STORAGE DISEASE V; GSD5	0.041666699999999994	1.5631741769434968
DISTAL MYOPATHY WITH ANTERIOR TIBIAL ONSET	0.041666699999999994	1.5631741769434968
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.041666699999999994	1.5631741769434968
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.041666699999999994	1.5631741769434968
RIPPLING MUSCLE DISEASE; RMD	0.041666699999999994	1.5631741769434968
ATYPICAL WERNER SYNDROME	0.041666699999999994	1.5631741769434968
MUSCLE GLYCOGENOSIS, X-LINKED	0.041666699999999994	1.5631741769434968
MIYOSHI MYOPATHY	0.041666699999999994	1.5631741769434968
COG2-CDG	0.041666699999999994	1.5631741769434968
ADENOSINE MONOPHOSPHATE DEAMINASE DEFICIENCY	0.041666699999999994	1.5631741769434968
RIPPLING MUSCLE DISEASE 1; RMD1	0.041666699999999994	1.5631741769434968
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.041666699999999994	1.5631741769434968
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.04152505	1.5578600142628902
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.5560348535540194
SCHWARTZ-JAMPEL SYNDROME	0.041431735	1.55435919470383
KEPPEN-LUBINSKY SYNDROME	0.04126194400000001	1.5479892900394965
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.04119421	1.5454481711195651
OVARIAN HYPERSTIMULATION SYNDROME	0.04116923	1.5445110176867265
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04105306	1.540152766514075
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.040995025000000004	1.537975516735261
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.040995025000000004	1.537975516735261
JUVENILE IDIOPATHIC ARTHRITIS	0.04079562	1.530494608797905
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.040693980000000005	1.5266814672881495
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.04060843	1.5234719606356542
CURRY-JONES SYNDROME	0.0405229	1.520263204306164
H SYNDROME	0.04052256	1.5202504488150843
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.5006460093489498
3Q13 MICRODELETION SYNDROME	0.04	1.5006460093489498
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04	1.5006460093489498
MECKEL SYNDROME, TYPE 5	0.04	1.5006460093489498
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.5006460093489498
TRISOMY 12P	0.04	1.5006460093489498
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.5006460093489498
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.5006460093489498
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	1.5006460093489498
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.5006460093489498
YELLOW FEVER	0.0399227	1.4977460109358829
NORRIE DISEASE	0.039911764	1.4973357343169271
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.03985914	1.4953614844270273
ISOLATED POLYCYSTIC LIVER DISEASE	0.03980476	1.4933213561773175
DISTAL 16P11.2 MICRODELETION SYNDROME	0.039757139	1.4915347995870374
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.039730360000000006	1.4905301545999288
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	1.489436183659113
EBOLA HEMORRHAGIC FEVER	0.039604929000000004	1.4858244663599625
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.039592869	1.4853720215881436
MARSHALL-SMITH SYNDROME	0.03946972500000001	1.4807521327837623
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.039353515000000006	1.4763923809651012
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.03932192	1.4752070581984664
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
MEDULLOBLASTOMA	0.03928911	1.473976153309298
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
CASPASE 8 DEFICIENCY	0.03919586	1.470477772300003
FAMILIAL THROMBOCYTOSIS	0.039068669	1.4657060556356256
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.03906351	1.46551250981657
NETHERTON SYNDROME; NETH	0.03896951	1.4619859916945996
CHRONIC GRAFT VERSUS HOST DISEASE	0.03896895	1.461964982650469
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.038788164	1.4551825879143148
FAMILIAL MEDITERRANEAN FEVER	0.038659209	1.450344692760925
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.03861503	1.4486872667597495
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03850173	1.4444366869382683
PPOMA	0.03847998	1.4436207106706849
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.0384615	1.4429274122143658
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.0384615	1.4429274122143658
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0384615	1.4429274122143658
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0384615	1.4429274122143658
CZEIZEL-LOSONCI SYNDROME	0.0384615	1.4429274122143658
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.0384615	1.4429274122143658
BRACHYDACTYLY, TYPE B1	0.0384615	1.4429274122143658
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0384615	1.4429274122143658
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0384615	1.4429274122143658
KENNERKNECHT SYNDROME	0.0384615	1.4429274122143658
KOSAKI OVERGROWTH SYNDROME; KOGS	0.0384615	1.4429274122143658
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.0384615	1.4429274122143658
SPINAL DYSPLASIA, ANHALT TYPE	0.0384615	1.4429274122143658
MICROSPORIDIOSIS	0.038451609000000005	1.4425563399724042
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.038443359999999996	1.4422468692491257
HODGKIN LYMPHOMA	0.03835645	1.4389863406323131
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.038310583999999995	1.437265624885693
7Q11.23 MICRODUPLICATION SYNDROME	0.038286549	1.4363639242148256
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.03807992	1.4286119996081816
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.4284161653039615
PURE AUTONOMIC FAILURE	0.03805423	1.4276482097086771
PEHO SYNDROME	0.038024419999999996	1.4265298532702098
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
CINCA SYNDROME	0.03764123	1.412154039662149
HYPERLYSINEMIA, TYPE I	0.037578419	1.4097976127498186
GALLOWAY-MOWAT SYNDROME	0.037516179	1.4074626075592716
CHARGE SYNDROME	0.037461155	1.4053983189088115
AMYOTROPHIC LATERAL SCLEROSIS	0.037458870000000005	1.4053125945055276
HYPOPHOSPHATASIA, INFANTILE	0.03736702900000001	1.4018670737519123
AL AMYLOIDOSIS	0.03736319	1.4017230492511645
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.037193419	1.395353894909835
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.3894856562064262
GENITOURINARY TRACT ANOMALIES	0.037037	1.3894856562064262
NATHALIE SYNDROME	0.037037	1.3894856562064262
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.3894856562064262
TESTICULAR TORSION	0.037037	1.3894856562064262
DK PHOCOMELIA SYNDROME	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
LISSENCEPHALY 2; LIS2	0.037037	1.3894856562064262
GALACTORRHEA	0.037037	1.3894856562064262
CANAVAN DISEASE	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3894856562064262
PEYRONIE DISEASE	0.037037	1.3894856562064262
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.3894856562064262
URINARY BLADDER, ATONY OF	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.3894856562064262
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.3894856562064262
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.3894856562064262
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.3894856562064262
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
IMMUNOGLOBULIN A VASCULITIS	0.036987939	1.3876450763598094
SCALP-EAR-NIPPLE SYNDROME	0.036805	1.3807819093522022
ANAL SPHINCTER DYSPLASIA; ASDP	0.03675681	1.3789740060724394
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.03672557	1.3778020015391377
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.03672251000000001	1.3776872021194229
QAZI-MARKOUIZOS SYNDROME	0.036664629	1.375515729827744
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.03666339	1.3754692473176047
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.03666339	1.3754692473176047
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.03666339	1.3754692473176047
FAMILIAL COLD URTICARIA	0.03663483	1.3743977860669296
MUSCULAR HYPERTONIA, LETHAL	0.0366162	1.3736988601880753
STICKLER SYNDROME	0.036561485000000005	1.3716461640280373
BENIGN OCCIPITAL EPILEPSY	0.0364194	1.3663156818220783
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.036255719000000006	1.3601750008356726
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03623845	1.3595271344372861
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.036160239999999996	1.3565929963275065
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346006
INTERMEDIATE OSTEOPETROSIS	0.03604226	1.352166840922932
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.036019244000000006	1.3513033692091527
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036019244000000006	1.3513033692091527
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.035996289	1.3504421859805373
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.03585522	1.3451498201832164
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.03585522	1.3451498201832164
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	1.3432357461982913
RIFT VALLEY FEVER	0.035747809	1.3411201729704618
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.035714300000000004	1.33986304429228
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.035714300000000004	1.33986304429228
HOLT-ORAM SYNDROME	0.035714300000000004	1.33986304429228
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.035714300000000004	1.33986304429228
JAWAD SYNDROME	0.035714300000000004	1.33986304429228
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.035714300000000004	1.33986304429228
CAP MYOPATHY	0.035714300000000004	1.33986304429228
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.035714300000000004	1.33986304429228
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.035714300000000004	1.33986304429228
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
TUFTED ANGIOMA	0.03547011	1.3307019755667069
CLUSTER HEADACHE, FAMILIAL	0.03547011	1.3307019755667069
HOLMES-GANG SYNDROME	0.03542715	1.329090281752666
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0354232	1.328942092959243
COCKAYNE SYNDROME A; CSA	0.035024219	1.3139738618228416
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.035024219	1.3139738618228416
COG5-CDG	0.035024219	1.3139738618228416
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.035024219	1.3139738618228416
WRINKLY SKIN SYNDROME	0.035023689999999996	1.3139540157793677
MALIGNANT ATROPHIC PAPULOSIS	0.034911339	1.3097390387844587
SEVERE COMBINED IMMUNODEFICIENCY	0.03485472	1.3076149118743756
CHOREOACANTHOCYTOSIS	0.034826938999999994	1.3065726757047325
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
ALPERS-HUTTENLOCHER SYNDROME	0.034820050000000005	1.3063142269457726
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
PITT-HOPKINS-LIKE SYNDROME	0.034794394000000006	1.3053517125953762
TETRASOMY X	0.03478258	1.3049084967965148
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.03475939	1.3040384972725947
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.03472724	1.3028323530425805
SICKLE CELL ANEMIA	0.03470551	1.3020171270980019
CRYPTOCOCCOSIS	0.034575419	1.2971366135979465
ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD	0.0344828	1.2936619052794491
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	1.2936619052794491
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0344828	1.2936619052794491
BRACHYDACTYLY, TYPE A6	0.0344828	1.2936619052794491
CHANARIN-DORFMAN SYNDROME	0.0344828	1.2936619052794491
MACROCYTOSIS, FAMILIAL	0.0344828	1.2936619052794491
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.0344828	1.2936619052794491
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0344828	1.2936619052794491
ELSAHY-WATERS SYNDROME; ESWS	0.0344828	1.2936619052794491
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0344828	1.2936619052794491
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	1.2936619052794491
MYELOMA, MULTIPLE	0.0344828	1.2936619052794491
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0344828	1.2936619052794491
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	1.2936619052794491
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.0344828	1.2936619052794491
TREACHER-COLLINS SYNDROME	0.0344828	1.2936619052794491
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0344828	1.2936619052794491
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	1.2936619052794491
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.0344828	1.2936619052794491
HEMOPOIETIC PROLIFERATION	0.0344828	1.2936619052794491
ACETOPHENETIDIN SENSITIVITY	0.0344828	1.2936619052794491
FLOOD FACTOR DEFICIENCY	0.0344828	1.2936619052794491
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.0344828	1.2936619052794491
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0344828	1.2936619052794491
ACROCRANIOFACIAL DYSOSTOSIS	0.0344828	1.2936619052794491
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.0344828	1.2936619052794491
SPINAL INTRADURAL ARACHNOID CYSTS	0.0344828	1.2936619052794491
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0344828	1.2936619052794491
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0344828	1.2936619052794491
OROFACIODIGITAL SYNDROME TYPE 14	0.0344828	1.2936619052794491
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0344828	1.2936619052794491
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0344828	1.2936619052794491
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0344828	1.2936619052794491
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.0344828	1.2936619052794491
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0344828	1.2936619052794491
CEREBROFACIOARTICULAR SYNDROME	0.0344828	1.2936619052794491
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.0344828	1.2936619052794491
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0344828	1.2936619052794491
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.0344828	1.2936619052794491
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	1.2936619052794491
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	1.2936619052794491
EOSINOPHILOPENIA	0.0344828	1.2936619052794491
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0344828	1.2936619052794491
CERVICAL VERTEBRAL BRIDGE	0.0344828	1.2936619052794491
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.0344828	1.2936619052794491
COUMARIN RESISTANCE	0.0344828	1.2936619052794491
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0344828	1.2936619052794491
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.0344828	1.2936619052794491
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	1.2936619052794491
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.034455404999999995	1.2926341503437961
PRIMARY HYPEROXALURIA TYPE 1	0.0342525	1.2850219358806223
SOTOS SYNDROME	0.034156424000000005	1.2814175342307674
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.034137679000000004	1.2807142939946363
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
HALLERMANN-STREIFF SYNDROME; HSS	0.034052225000000005	1.2775083888925638
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0340496	1.2774099089982
BEHÇET DISEASE	0.033911519	1.2722296414577772
SIALURIA	0.033874749	1.2708501726136832
FELTY SYNDROME	0.033874390000000004	1.2708367043157494
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0338384	1.2694864980688374
THROMBOCYTOPENIA 3	0.0335738	1.2595597247169943
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.033550339	1.2586795583163608
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.033524649	1.2577157684168563
X-LINKED AGAMMAGLOBULINEMIA	0.033503599999999994	1.2569260909705866
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.03346038	1.2553046429574852
RAMOS-ARROYO SYNDROME	0.03346038	1.2553046429574852
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.03345123	1.2549613701828466
MALAKOPLAKIA	0.03336441	1.2517042180195548
HEREDITARY FOLATE MALABSORPTION	0.033277839	1.248456407377671
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.033258545	1.2477325707750615
SPINOCEREBELLAR ATAXIA TYPE 42	0.033253124999999994	1.2475292332407946
NIJMEGEN BREAKAGE SYNDROME	0.03324268	1.2471373770516037
COFS SYNDROME	0.033161399	1.2440880268444563
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.033125390000000005	1.2427371077906904
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.033125390000000005	1.2427371077906904
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.033125390000000005	1.2427371077906904
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.033125390000000005	1.2427371077906904
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.033117443999999996	1.2424390044609328
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.032983229999999995	1.2374038118734636
TRACHEOPATHIA OSTEOPLASTICA	0.0329524	1.2362471889617583
APLASIA CUTIS-MYOPIA SYNDROME	0.0328877	1.2338198940416363
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.032799519	1.2305116823978763
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.2305116823978763
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.032799519	1.2305116823978763
C SYNDROME	0.032684249	1.226187195760435
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.03258478	1.222455501812837
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.032522180000000005	1.2201069908082058
BABESIOSIS	0.0325026	1.2193724245866293
WHIPPLE DISEASE	0.032498909	1.2192339524761167
ERDHEIM-CHESTER DISEASE	0.03249461	1.219072670546262
PORPHYRIA	0.032452429000000005	1.2174902018132534
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544839
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544839
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0322581	1.2101997258544839
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.0322581	1.2101997258544839
PSORIASIS 14, PUSTULAR	0.0322581	1.2101997258544839
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.2101997258544839
IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14	0.0322581	1.2101997258544839
ALG13-CDG	0.0322581	1.2101997258544839
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544839
PSORIASIS 2; PSORS2	0.0322581	1.2101997258544839
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544839
PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15	0.0322581	1.2101997258544839
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544839
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544839
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544839
LIG4 SYNDROME	0.0322581	1.2101997258544839
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2101997258544839
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544839
INTERMEDIATE UVEITIS	0.0322581	1.2101997258544839
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.0322581	1.2101997258544839
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544839
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	1.2101997258544839
PSORIASIS 1, SUSCEPTIBILITY TO	0.0322581	1.2101997258544839
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544839
PLAGUE	0.03222872	1.209097501360617
3P25.3 MICRODELETION SYNDROME	0.03222193499999999	1.208842954281281
POTOCKI-LUPSKI SYNDROME	0.032158474	1.2064621418712989
PROPIONIC ACIDEMIA	0.03214283	1.2058752392170424
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.031949039	1.198604946947099
ROIFMAN SYNDROME; RFMN	0.031921820000000004	1.1975837948538874
16P12.1P12.3 TRIPLICATION SYNDROME	0.031880939999999997	1.1960501346323325
ACUTE INTERMITTENT PORPHYRIA	0.031825239000000005	1.1939604475481642
GAUCHER DISEASE, TYPE I	0.0318223	1.193850187582627
COFFIN-SIRIS SYNDROME 8; CSS8	0.031803704	1.1931525372528808
KAWASAKI DISEASE	0.03179609	1.1928668892850012
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.03179386	1.19278322826998
RECURRENT ACUTE PANCREATITIS	0.031676389	1.188376168585874
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.031581	1.1847975405312294
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.031581	1.1847975405312294
HYPOADRENOCORTICISM, FAMILIAL	0.031333359000000005	1.1755070035712003
STÜVE-WIEDEMANN SYNDROME	0.031309674999999995	1.1746184710690644
CUTANEOUS MASTOCYTOSIS	0.031227679999999997	1.1715423343306501
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
NEUROENDOCRINE TUMOR OF STOMACH	0.03113497	1.1680642120424818
CARCINOID SYNDROME	0.03113497	1.1680642120424818
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.03113497	1.1680642120424818
FATCO SYNDROME	0.031130659999999998	1.1679025174349742
OCULOCEREBRORENAL SYNDROME OF LOWE	0.031075363999999998	1.1658280243916503
VASCULAR EHLERS-DANLOS SYNDROME	0.031040980000000003	1.1645380690820142
DOWN SYNDROME	0.03104054	1.164521561975911
COSTELLO SYNDROME	0.03089063	1.1588975158943737
THYMIC TUMOR	0.030834939999999998	1.1568082414878575
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.03081442	1.1560384100850616
RELAPSING FEVER	0.030597189999999996	1.1478887767697896
JACOBSEN SYNDROME	0.030590894	1.1476525750879183
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.030571639999999997	1.146930239131318
GIANT CELL ARTERITIS	0.03049986	1.1442373298675415
DENGUE FEVER	0.03044493	1.142176567735203
PYCNODYSOSTOSIS	0.03036456	1.1391613947409185
RETINAL CAPILLARY MALFORMATION	0.03024694	1.134748745150428
TYPHOID	0.030152560000000002	1.1312079708913692
22Q11.2 MICRODUPLICATION SYNDROME	0.030107844	1.129530398717518
SPINOCEREBELLAR ATAXIA TYPE 25	0.030011085000000003	1.1259003735370532
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	1.124696667856804
NIJMEGEN BREAKAGE SYNDROME	0.029957499999999998	1.123890070626779
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.029957499999999998	1.123890070626779
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029953219	1.1237294639876283
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.029953219	1.1237294639876283
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.029947	1.123496151049325
EMANUEL SYNDROME	0.029945409	1.123436462854303
LARSEN SYNDROME	0.029933505	1.1229898706019208
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.029860240000000003	1.1202412498550471
STORMORKEN SYNDROME; STRMK	0.02985741	1.1201350791498856
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.029834318999999998	1.1192687937248387
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.029778009999999997	1.1171562968213278
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.0297619	1.1165519116410627
OMENN SYNDROME	0.0297619	1.1165519116410627
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.0297619	1.1165519116410627
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.02970463	1.1144033617171774
HEMORRHAGIC FEVER-RENAL SYNDROME	0.029704269999999998	1.114389855903093
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.0296863	1.1137156906833932
NIEMANN-PICK DISEASE TYPE B	0.0296313	1.1116523024205385
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.029594785	1.1102824001947538
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.029566425	1.1092184421741254
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.029473099999999995	1.105717247453563
CONGENITAL ATRANSFERRINEMIA	0.02943871	1.1044270670470253
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.1034175074442358
TRICHOHEPATOENTERIC SYNDROME 1	0.0294118	1.1034175074442358
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	1.1034175074442358
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.1034175074442358
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.1034175074442358
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.1034175074442358
MYASTHENIA GRAVIS; MG	0.0294118	1.1034175074442358
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	1.1034175074442358
MONOMELIC AMYOTROPHY	0.0294118	1.1034175074442358
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.1034175074442358
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.1034175074442358
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.1034175074442358
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	1.1034175074442358
RAGWEED SENSITIVITY	0.0294118	1.1034175074442358
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.1034175074442358
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.1034175074442358
IMMUNE SUPPRESSION	0.0294118	1.1034175074442358
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.1034175074442358
CUTIS LAXA	0.029410705	1.10337642725973
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.029244179999999998	1.0971290503420592
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.029190454	1.0951134576546022
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.029187100000000004	1.0949876284867184
LEPTOSPIROSIS	0.029169999999999998	1.0943461023177214
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.094174240833501
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029112819	1.0922008913312071
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.029112819	1.0922008913312071
CONGENITAL DISORDER OF GLYCOSYLATION	0.029112819	1.0922008913312071
DISTAL MONOSOMY 7Q36	0.029112819	1.0922008913312071
ALG1-CDG	0.029112819	1.0922008913312071
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.029103484	1.0918506780687751
ANGIOEDEMA, HEREDITARY, TYPE III	0.029016060000000003	1.0885708661507423
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.029016060000000003	1.0885708661507423
HYPERLIPOPROTEINEMIA, TYPE I	0.029016060000000003	1.0885708661507423
BUSCHKE-OLLENDORFF SYNDROME	0.02900634	1.0882062091704703
EISENMENGER SYNDROME	0.0290047	1.088144682684087
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.02877358	1.079473950042069
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.02877358	1.079473950042069
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.028772825000000002	1.0794456253486424
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.028772825000000002	1.0794456253486424
SILLENCE SYNDROME	0.028772825000000002	1.0794456253486424
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.028772825000000002	1.0794456253486424
NAIL-PATELLA SYNDROME	0.028772825000000002	1.0794456253486424
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.028772825000000002	1.0794456253486424
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.028772825000000002	1.0794456253486424
MENKES DISEASE	0.028746709	1.0784658535691385
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.028728029999999998	1.0777650893989226
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.028708799	1.077043616313778
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02869331	1.0764625286628078
DERMATITIS HERPETIFORMIS	0.028687419999999998	1.0762415585379312
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.028685034	1.0761520450034736
NEONATAL MARFAN SYNDROME	0.028684329999999997	1.0761256336337088
MALT LYMPHOMA	0.02867416	1.075744094385832
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.028666789999999998	1.0754676003586094
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.0718889347878144
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0718889347878144
PENTASOMY X	0.0285714	1.0718889347878144
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0718889347878144
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0718889347878144
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0718889347878144
FETAL ALCOHOL SYNDROME	0.0285714	1.0718889347878144
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0718889347878144
ALG12-CDG	0.0285714	1.0718889347878144
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.0718889347878144
CHEILITIS GLANDULARIS	0.0285714	1.0718889347878144
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.0718889347878144
ACRODYSOSTOSIS	0.0285714	1.0718889347878144
ALPHA-THALASSEMIA	0.0285714	1.0718889347878144
COG7-CDG	0.0285714	1.0718889347878144
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.028520139	1.0699658194106836
MIXED CONNECTIVE TISSUE DISEASE	0.028439249	1.0669311380182778
PRADER-WILLI SYNDROME; PWS	0.028436003999999997	1.0668093981107691
IMMUNODEFICIENCY 50; IMD50	0.02841568	1.066046919873419
YAO SYNDROME	0.02841139	1.0658859755889165
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.0636766495016525
SECONDARY SYRINGOMYELIA	0.028319219000000003	1.062428074505724
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.028238720000000002	1.0594080619280595
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.028075939	1.0533011454768637
ACRORENAL-MANDIBULAR SYNDROME	0.028074889999999998	1.0532617910352684
PFAPA SYNDROME	0.02802251	1.0512966950860259
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.028004029	1.0506033591135566
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.027976519999999998	1.049571327336777
CUSHING DISEASE	0.02794165	1.048263139178127
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.027843675	1.044587494358978
ADIPOSIS DOLOROSA	0.027836679	1.0443250313719428
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.027795809999999997	1.0427917838280407
EPILEPSY, PYRIDOXINE-DEPENDENT	0.027795809999999997	1.0427917838280407
PRIMARY HYPEROXALURIA TYPE 3	0.027777800000000002	1.0421161179623315
ACATALASEMIA	0.027777800000000002	1.0421161179623315
VULVOVAGINAL GINGIVAL SYNDROME	0.027777800000000002	1.0421161179623315
ANAPLASTIC THYROID CARCINOMA	0.027777800000000002	1.0421161179623315
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.027777800000000002	1.0421161179623315
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.027777800000000002	1.0421161179623315
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.027777800000000002	1.0421161179623315
PELVIS-SHOULDER DYSPLASIA	0.027777800000000002	1.0421161179623315
INFANTILE DIGITAL FIBROMATOSIS	0.027777800000000002	1.0421161179623315
OROMANDIBULAR DYSTONIA	0.027777800000000002	1.0421161179623315
THYROID LYMPHOMA	0.027777800000000002	1.0421161179623315
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.027777800000000002	1.0421161179623315
O'SULLIVAN-MCLEOD SYNDROME	0.027777800000000002	1.0421161179623315
SPINOCEREBELLAR ATAXIA TYPE 43	0.027777800000000002	1.0421161179623315
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.027777800000000002	1.0421161179623315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623315
HEREDITARY PAINFUL CALLOSITIES	0.027777800000000002	1.0421161179623315
OSTEOSARCOMA	0.027777800000000002	1.0421161179623315
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.027777800000000002	1.0421161179623315
INTERSTITIAL CYSTITIS	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.027777800000000002	1.0421161179623315
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.027777800000000002	1.0421161179623315
LYNCH SYNDROME	0.027730069	1.0403254345955255
FAMILIAL COLORECTAL CANCER TYPE X	0.027730069	1.0403254345955255
REACTIVE ARTHRITIS	0.0276957	1.0390360420281428
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.02758137	1.034746820571921
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.02758137	1.034746820571921
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.02741233	1.0284050905364124
RIDDLE SYNDROME	0.02736665	1.0266913527937358
HENNEKAM-BEEMER SYNDROME	0.027119734000000003	1.0174280150426258
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.02709644	1.0165541138390812
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0269612	1.0114804296814726
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.02694784	1.01097921391435
COWDEN SYNDROME 6; CWS6	0.026732884	1.0029148923247098
COWDEN SYNDROME 5; CWS5	0.026732884	1.0029148923247098
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.026722309	1.002518159035988
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.026656609	1.0000533479656324
CLEIDOCRANIAL DYSPLASIA; CCD	0.026636025000000004	0.9992811155292216
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.026601189999999997	0.9979742404358295
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.026585159999999997	0.997372856547583
INFANTILE SYSTEMIC HYALINOSIS	0.026306659999999996	0.9869246087074908
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.026302539	0.9867700046523777
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026242985	0.9845357678413587
DYSOSTEOSCLEROSIS	0.026182419000000005	0.9822635646863032
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.02613268	0.9803975488898278
ACUTE ADRENAL INSUFFICIENCY	0.026105019	0.9793598146582128
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.026105019	0.9793598146582128
ADDISON DISEASE	0.026105019	0.9793598146582128
NOONAN SYNDROME	0.025960684999999997	0.9739449586303784
OSTEOPETROSIS AND RELATED DISORDERS	0.02587598	0.9707671531248309
GRAFT VERSUS HOST DISEASE	0.025810770000000004	0.9683207249680899
HUGHES-STOVIN SYNDROME	0.02581011	0.9682959643089356
GRANGE SYNDROME	0.025641000000000004	0.9619516081429106
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.025641000000000004	0.9619516081429106
BETA-THALASSEMIA INTERMEDIA	0.025641000000000004	0.9619516081429106
GNATHODIAPHYSEAL DYSPLASIA; GDD	0.025641000000000004	0.9619516081429106
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.025641000000000004	0.9619516081429106
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.025641000000000004	0.9619516081429106
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.025641000000000004	0.9619516081429106
BRUCK SYNDROME 2	0.025641000000000004	0.9619516081429106
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.025641000000000004	0.9619516081429106
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.025641000000000004	0.9619516081429106
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.02549206	0.9563639527270996
ACROMEGALY	0.02544762	0.9546967350107131
SOMATOMAMMOTROPINOMA	0.02544762	0.9546967350107131
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.025423299	0.9537843047208786
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.025306959999999996	0.9494197133188373
ACUTE PROMYELOCYTIC LEUKEMIA	0.02528985	0.9487778119883383
STICKLER SYNDROME, TYPE III	0.025238589999999998	0.9468547341273577
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.025000009	0.9379040934884456
TIGLIC ACIDEMIA	0.025	0.9379037558430937
ESTROGEN RESISTANCE SYNDROME	0.025	0.9379037558430937
ZOLLINGER-ELLISON SYNDROME	0.025	0.9379037558430937
ASHERMAN SYNDROME	0.025	0.9379037558430937
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.02488188	0.9334723481774861
HYPERCALCEMIA, INFANTILE, 1	0.02484936	0.9322523229718854
POLYMYOSITIS	0.02484879	0.9322309387662521
PULMONARY BLASTOMA	0.0248372	0.9317961265850433
LYME DISEASE	0.02481029	0.9307865669822538
ISOLATED AGAMMAGLOBULINEMIA	0.0248057	0.930614367852681
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0248023	0.9304868129418864
ADENOCARCINOMA OF THE ESOPHAGUS	0.0247824	0.9297402415522352
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.024762754999999997	0.9290032367808936
SALT-AND-PEPPER SYNDROME	0.024721809999999997	0.9274671380095738
LUJO HEMORRHAGIC FEVER	0.024719999000000003	0.9273991962615007
LYSINURIC PROTEIN INTOLERANCE	0.024664739999999997	0.9253260913157353
BRONCHIAL NEUROENDOCRINE TUMOR	0.0246416	0.924457967599327
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.02445859	0.9175921369450531
BRITTLE CORNEA SYNDROME 2; BCS2	0.024414520000000002	0.915938800204253
611961 STEVENSON-CAREY SYNDROME	0.024338624	0.9130914744661143
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.02428798	0.9111915065536775
SCHNITZLER SYNDROME	0.02428798	0.9111915065536775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.9073153379115292
HEREDITARY COPROPORPHYRIA	0.024132929	0.9053745899437885
TETRASOMY 9P	0.024110459	0.9045316020480367
POLYCYTHEMIA VERA	0.02408248	0.9034819376806474
AA AMYLOIDOSIS	0.02402129	0.9011863244478459
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.02394634	0.8983744889878282
PRIMARY CILIARY DYSKINESIA	0.023857385000000002	0.8950372398437875
WALDENSTRÖM MACROGLOBULINEMIA	0.023835010000000004	0.8941978159823079
VESICOURETERAL REFLUX 8; VUR8	0.023717929999999998	0.8898054251129432
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.02365875	0.8875852193421117
VON HIPPEL-LINDAU DISEASE	0.0236312	0.8865516494031725
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.023571718999999998	0.8843201512711204
PRUNE BELLY SYNDROME	0.023548174999999998	0.8834368710300176
WOLFRAM SYNDROME	0.023546029	0.883356361371616
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.023529389999999997	0.882732130147877
DE BARSY SYNDROME	0.023529389999999997	0.882732130147877
ROIFMAN SYNDROME	0.023518459999999998	0.8823220786258225
DENT DISEASE	0.02338569	0.877341059359291
MILLER-DIEKER SYNDROME	0.023268719	0.8729527577503022
SITOSTEROLEMIA	0.02324342	0.8720036366655393
OSTEOGENESIS IMPERFECTA	0.023162975	0.8689856499599871
ROIFMAN-CHITAYAT SYNDROME	0.02314816	0.8684298481942746
CLASSIC GALACTOSEMIA	0.02301007	0.8632492430084997
CARNEY TRIAD	0.02296322	0.8614916113700497
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.02293205	0.8603222329672646
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.02292276	0.8599737079315932
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.02283361	0.8566291431382569
48,XXYY SYNDROME	0.022810904	0.8557773014310498
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.02277258	0.8543395324894928
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.0227553	0.853691253413454
GOOD SYNDROME	0.0227553	0.853691253413454
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069097
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069097
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069097
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.8526408012069097
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069097
SILVER-RUSSELL SYNDROME; SRS	0.0227273	0.8526408012069097
WATSON SYNDROME	0.0227273	0.8526408012069097
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069097
FETAL HYDANTOIN SYNDROME	0.0227273	0.8526408012069097
BETHLEM MYOPATHY 1	0.0227273	0.8526408012069097
THUMB DEFORMITY	0.0227273	0.8526408012069097
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069097
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8526408012069097
SIRENOMELIA	0.0227273	0.8526408012069097
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069097
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8526408012069097
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069097
EBSTEIN MALFORMATION	0.02270216	0.8516976451900338
LEISHMANIASIS	0.022657289999999997	0.8500142955290465
HURLER SYNDROME	0.022634344999999997	0.8491534874619338
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02258899	0.8474519424680834
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.02258441	0.8472801185000128
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.02258441	0.8472801185000128
LYMPHANGIOLEIOMYOMATOSIS	0.022569568999999998	0.846723341314394
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.022569369	0.8467158380843474
CUSHING SYNDROME	0.022565309999999998	0.8465635600305487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.02249554	0.8439460582287419
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.022487985000000002	0.843662623713726
CRANIOECTODERMAL DYSPLASIA 4	0.02241783	0.8410306781940791
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.022384229999999998	0.8397701355462259
RENPENNING SYNDROME 1; RENS1	0.022369744	0.8392266765939402
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.02220666	0.8331083927492237
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.022180738999999998	0.8321359366190153
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.02208844	0.828673233468593
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02206783	0.8279000256122758
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.02206686	0.8278636349465492
THYMIC CARCINOMA	0.02199111	0.8250217865663446
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8241416576818613
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818613
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818613
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818613
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.02187414	0.820633522473506
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.021828325	0.8189147200505478
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.021828325	0.8189147200505478
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.021828325	0.8189147200505478
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.021794710000000002	0.8176536146604413
VAN DEN BOSCH SYNDROME	0.021778919999999997	0.8170612346482506
GAUCHER DISEASE TYPE 1	0.02174375	0.8157417916445305
MASTOCYTOSIS	0.02171911	0.8148173937027717
CRISPONI SYNDROME	0.021707254	0.8143726022256006
HYPER-IGD SYNDROME	0.0217035	0.8142317665976232
SPONTANEOUS PERIODIC HYPOTHERMIA	0.021688379	0.8136644848899391
PROPIONIC ACIDEMIA	0.021611448999999998	0.8107783674524588
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.021408229	0.8031543354019615
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021374719	0.8018971692076293
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.021374719	0.8018971692076293
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.021374719	0.8018971692076293
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.021374719	0.8018971692076293
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.021374719	0.8018971692076293
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021374719	0.8018971692076293
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8018971692076293
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.021374719	0.8018971692076293
168830 PASSOVOY FACTOR DEFECT	0.02132842	0.8001602089679581
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.02132842	0.8001602089679581
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.02132842	0.8001602089679581
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.02129822	0.7990272212308996
MIDDLE EAR NEUROENDOCRINE TUMOR	0.02124934	0.7971934318074753
49,XXXXY SYNDROME	0.021231464000000002	0.7965227931058974
STEVENS-JOHNSON SYNDROME	0.021184	0.7947421265512039
TSH-SECRETING PITUITARY ADENOMA	0.021172229	0.7943005239468026
BOTULISM	0.02115831	0.7937783366516994
TIMOTHY SYNDROME; TS	0.021141729	0.7931562813646742
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02100569	0.7880526218030285
JUVENILE DERMATOMYOSITIS	0.02100264	0.7879381975448155
NIPAH VIRUS DISEASE	0.020946419	0.7858290020625256
DERMATOMYOSITIS	0.02094468	0.785763761477269
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.02093625	0.7854475003307987
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.020892419	0.7838031299499044
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7815852126642369
CRANDALL SYNDROME	0.0208333	0.7815852126642369
CHROMOSOME 16Q22 DELETION SYNDROME	0.0208333	0.7815852126642369
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642369
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642369
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642369
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642369
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642369
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642369
IMINOGLYCINURIA	0.0208333	0.7815852126642369
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642369
RIBOFLAVIN DEFICIENCY	0.0208333	0.7815852126642369
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7815852126642369
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642369
611426 TENTED EYEBROWS	0.0208333	0.7815852126642369
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.0208333	0.7815852126642369
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642369
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642369
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642369
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0208333	0.7815852126642369
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642369
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642369
TRANSALDOLASE DEFICIENCY	0.0208333	0.7815852126642369
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642369
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642369
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642369
CLEFT LIP/PALATE	0.0208333	0.7815852126642369
DERMOIDS OF CORNEA	0.0208333	0.7815852126642369
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642369
CORNELIA DE LANGE SYNDROME 1	0.020745609	0.7782953839340915
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.020735369	0.7779112185556981
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.020650244999999998	0.7747176937832024
GM1 GANGLIOSIDOSIS	0.020649954	0.7747067765834846
HAREL-YOON SYNDROME; HAYOS	0.020558764999999996	0.7712857163598213
DYSKERATOSIS CONGENITA	0.020548915	0.7709161822800193
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.02054506	0.7707715575208683
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.020510819	0.7694869670207154
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.02050558	0.7692904199096409
MARFANOID HYPERMOBILITY SYNDROME	0.020439455000000002	0.7668096644754361
LATERAL MENINGOCELE SYNDROME	0.020439455	0.7668096644754359
CITRULLINEMIA TYPE I	0.020376749	0.76445717675888
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.020356165	0.763684944322469
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020305849	0.7617972817073091
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.020305849	0.7617972817073091
LOEYS-DIETZ SYNDROME 5	0.02030344	0.761706905301396
DISTAL MONOSOMY 10Q	0.020294529	0.7613725988866633
RABIES	0.020253889	0.7598479425411647
MAFFUCCI SYNDROME	0.020248485	0.7596452052653018
MULTIPLE OSTEOCHONDROMAS	0.020248485	0.7596452052653018
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.02023252	0.7590462599268203
GITELMAN SYNDROME	0.020212529	0.7582962745674979
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.020169329	0.7566755768774011
POTASSIUM-AGGRAVATED MYOTONIA	0.02014887	0.7559080339597692
HYPERKALEMIC PERIODIC PARALYSIS	0.02014887	0.7559080339597692
MEIER-GORLIN SYNDROME 3; MGORS3	0.02009985	0.7540689922753121
PARKES WEBER SYNDROME	0.02008224	0.7534083328696963
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.020065124	0.752766206442296
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.020055879	0.7524193696333851
BENIGN FAMILIAL INFANTILE EPILEPSY	0.020026409000000002	0.7513137686859974
NODULAR NON-SUPPURATIVE PANNICULITIS	0.02002008	0.751076328971168
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.019929789	0.7476889582504148
IMMUNODEFICIENCY 55; IMD55	0.01991895	0.7472823206980316
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.019911440000000002	0.7470005744097763
TEMPLE SYNDROME	0.019900915	0.7466057169285665
CONGENITAL SHORT BOWEL SYNDROME	0.01988906	0.7461609629675455
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.01974326	0.7406911082634686
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.01974326	0.7406911082634686
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.01971685	0.739700306735796
ANTISYNTHETASE SYNDROME	0.01969741	0.7389709927752524
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.019692225	0.7387764715362906
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0196671	0.7378338782616682
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.019569469	0.7341711389981995
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.019569469	0.7341711389981995
CONGENITAL PRIMARY MEGAURETER	0.01951683	0.7321963263660465
SMALL CELL CARCINOMA OF THE BLADDER	0.01951683	0.7321963263660465
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.019470119999999997	0.7304439469886292
IMMUNODEFICIENCY 36; IMD36	0.019470119999999997	0.7304439469886292
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.019422699	0.7286648936283959
INDOLENT SYSTEMIC MASTOCYTOSIS	0.01941712	0.7284555910262419
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7281629275382687
HHHH SYNDROME	0.019409319	0.7281629275382687
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019409319	0.7281629275382687
BAND HETEROTOPIA; BH	0.019409319	0.7281629275382687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.019383984	0.7272124558720973
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.01936114	0.726355436936158
CORNELIA DE LANGE SYNDROME	0.019308649	0.7243861766942398
TENORIO SYNDROME; TNORS	0.019271494	0.7229922641323057
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.01926145	0.7226154519193582
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.01925346	0.7223156978789907
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.01925346	0.7223156978789907
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.01925346	0.7223156978789907
MCCUNE-ALBRIGHT SYNDROME	0.01925346	0.7223156978789907
MAZABRAUD SYNDROME	0.01925346	0.7223156978789907
PAGET DISEASE OF BONE 6	0.01925346	0.7223156978789907
PRIMARY HYPEROXALURIA	0.01925346	0.7223156978789907
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.01925346	0.7223156978789907
X-LINKED HYPOPHOSPHATEMIA	0.01925346	0.7223156978789907
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.01925346	0.7223156978789907
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.01925346	0.7223156978789907
FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA	0.01925346	0.7223156978789907
DENT DISEASE 1	0.01925346	0.7223156978789907
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.01925346	0.7223156978789907
HOLOPROSENCEPHALY	0.019213784	0.7208272071023175
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.019196320000000003	0.7201720250546358
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.019192373999999998	0.7200239863258134
WEILL-MARCHESANI SYNDROME 2; WMS2	0.019176824999999998	0.7194406477058293
WEILL-MARCHESANI SYNDROME 1; WMS1	0.019176824999999998	0.7194406477058293
SECKEL SYNDROME 9; SCKL9	0.01898172	0.7121210592144787
UROFACIAL SYNDROME 2	0.01895603	0.7111572693149742
OCHOA SYNDROME	0.01895603	0.7111572693149742
UROFACIAL SYNDROME	0.01895603	0.7111572693149742
HINMAN SYNDROME	0.01895603	0.7111572693149742
ALEXANDER DISEASE	0.018935154	0.710374082162695
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.018894809999999998	0.7088605305976656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.018883559	0.7084384363913862
PUBIC BONE DYSPLASIA	0.0188679	0.7078509709948763
TRACHEOBRONCHOMEGALY	0.0188679	0.7078509709948763
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7078509709948763
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7078509709948763
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7078509709948763
RAYNAUD DISEASE	0.0188679	0.7078509709948763
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7078509709948763
KNUCKLE PADS	0.0188679	0.7078509709948763
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.7078509709948763
CARPAL DISPLACEMENT	0.0188679	0.7078509709948763
VESICOURETERAL REFLUX 1	0.0188679	0.7078509709948763
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7078509709948763
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7078509709948763
NEPHROSIALIDOSIS	0.0188679	0.7078509709948763
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7078509709948763
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7078509709948763
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7078509709948763
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7078509709948763
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7078509709948763
TOE, MISSHAPEN	0.0188679	0.7078509709948763
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7078509709948763
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7078509709948763
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7078509709948763
SPINAL ARACHNOIDITIS	0.0188679	0.7078509709948763
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7078509709948763
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7078509709948763
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7078509709948763
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7078509709948763
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7078509709948763
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7078509709948763
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7078509709948763
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7078509709948763
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7078509709948763
MONOPHALANGY OF GREAT TOE	0.0188679	0.7078509709948763
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7078509709948763
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7078509709948763
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.018794655	0.7051031005710071
48,XXXY SYNDROME	0.018762324	0.7038901659178006
20Q11.2 MICRODUPLICATION SYNDROME	0.018723219	0.7024230968629108
KNOBLOCH SYNDROME 1; KNO1	0.018723219	0.7024230968629108
ACID PHOSPHATASE DEFICIENCY	0.01872196	0.7023758640297665
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.01871266	0.7020269638325929
CRYPTOGENIC ORGANIZING PNEUMONIA	0.01870409	0.7017054504250899
XQ12-Q13.3 DUPLICATION SYNDROME	0.01869322	0.7012976498720493
ROTHMUND-THOMSON SYNDROME	0.018688765	0.7011305154227581
FAMILIAL TUMORAL CALCINOSIS	0.01868131	0.7008508325227657
AMERICAN TRYPANOSOMIASIS	0.01862974	0.6989161246552125
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.018554378999999996	0.6960888700574488
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
CYCLIC VOMITING SYNDROME	0.018493628999999998	0.6938097639307501
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.018472069	0.6930009157317112
PERIPARTUM CARDIOMYOPATHY	0.01843103	0.6914612904422693
EPISODIC ATAXIA TYPE 1	0.01841624	0.6909064265803125
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.018409979	0.6906715379636992
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.018370245	0.6891808712503125
COMMON VARIABLE IMMUNODEFICIENCY	0.018294190000000002	0.6863275804442865
REFRACTORY ANEMIA	0.018251999999999997	0.6847447740659257
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.018236425	0.6841604600260356
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.018236425	0.6841604600260356
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.01821166	0.6832313725654974
CHROMOSOME 19P13.13 DELETION SYNDROME	0.018203919	0.682940960046538
HAMAMY SYNDROME; HMMS	0.018181799999999998	0.6821111403195182
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.018181799999999998	0.6821111403195182
MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26	0.018181799999999998	0.6821111403195182
MYOPIA 5	0.018181799999999998	0.6821111403195182
MYOPIA 17	0.018181799999999998	0.6821111403195182
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.018181799999999998	0.6821111403195182
WEILL-MARCHESANI SYNDROME	0.018181799999999998	0.6821111403195182
DEAFNESS AND MYOPIA; DFNMYP	0.018181799999999998	0.6821111403195182
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.018181799999999998	0.6821111403195182
STICKLER SYNDROME, TYPE V; STL5	0.018181799999999998	0.6821111403195182
APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	0.018181799999999998	0.6821111403195182
%613969 MYOPIA 19, AUTOSOMAL DOMINANT; MYP19	0.018181799999999998	0.6821111403195182
JUVENILE GLAUCOMA	0.018181799999999998	0.6821111403195182
MENTAL RETARDATION, X-LINKED 92	0.018181799999999998	0.6821111403195182
MYOPIA 25, AUTOSOMAL DOMINANT	0.018181799999999998	0.6821111403195182
CONGENITAL STATIONARY NIGHT BLINDNESS	0.018181799999999998	0.6821111403195182
CONE-ROD DYSTROPHY 18	0.018181799999999998	0.6821111403195182
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.018181799999999998	0.6821111403195182
RETINITIS PIGMENTOSA 51; RP51	0.018181799999999998	0.6821111403195182
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.018181799999999998	0.6821111403195182
MYOPIA 3	0.018181799999999998	0.6821111403195182
SINUS NODE DISEASE AND MYOPIA	0.018181799999999998	0.6821111403195182
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.018128299	0.680103988765864
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01801068	0.6756913766915236
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.017968249	0.6740995289209564
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.017945799999999998	0.6732573288643595
PULMONARY ARTERIAL HYPERTENSION	0.01789592	0.6713860232907013
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.01785808	0.6699664121658572
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.01785808	0.6699664121658572
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.01785808	0.6699664121658572
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.01785374	0.669803592073843
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.01785374	0.669803592073843
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.01766248	0.662628253180141
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.01766248	0.662628253180141
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.01766248	0.662628253180141
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.01766248	0.662628253180141
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.01766248	0.662628253180141
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.01766248	0.662628253180141
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.017629899	0.661405939489376
HIRSCHSPRUNG DISEASE	0.01761221	0.6607423163078916
FOODBORNE BOTULISM	0.01761221	0.6607423163078916
ACQUIRED METHEMOGLOBINEMIA	0.017612149	0.6607400278227273
CONGENITAL ALPHA2-ANTIPLASMIN DEFICIENCY	0.01761152	0.6607164301642303
MEVALONIC ACIDURIA; MEVA	0.01754252	0.6581278157981034
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.017509649999999998	0.6568946599399209
IMMUNODEFICIENCY 32B; IMD32B	0.01748602	0.6560081533098981
PRIMARY FAMILIAL POLYCYTHEMIA	0.01745996	0.6550304824348072
INSULIN-RESISTANCE SYNDROME TYPE B	0.017435	0.6540940793249734
ADULT-ONSET STILL DISEASE	0.01743121	0.6539518931155875
MYXEDEMA	0.017426829999999997	0.6537875723775639
RFT1-CDG	0.017416519	0.653400743352504
TOXIC EPIDERMAL NECROLYSIS	0.01741042	0.6531719323522286
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.017409444	0.6531353165896003
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.01737522	0.6518513638640014
POLYVALVULAR HEART DISEASE SYNDROME	0.017322280000000002	0.6498652588706282
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.017287354	0.6485549698075651
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
EMANUEL SYNDROME	0.017189484	0.6448832641841906
MARSHALL SYNDROME	0.017183729999999998	0.6446673962557457
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.01717504	0.6443413809102145
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.017156169	0.6436334136391539
SHWACHMAN-DIAMOND SYNDROME	0.017140395	0.6430416338853672
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.01712627	0.6425117182633159
TURCOT SYNDROME WITH POLYPOSIS	0.01709606	0.6413783553647552
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.017094599999999998	0.6413235817854138
ARTERIAL TORTUOSITY SYNDROME	0.017067595	0.6403104581483523
INHALATIONAL BOTULISM	0.01702608	0.6387529751713991
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.017020709999999998	0.638551513444644
BERNARD-SOULIER SYNDROME	0.016967859000000002	0.6365687473886416
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.016944194	0.6356809276933604
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.01687064	0.6329214647790692
MALARIA	0.0168589	0.6324810251753252
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.016815965	0.6308702692650403
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01680056	0.6302923329706898
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0167995	0.630252565851442
HERMANSKY-PUDLAK SYNDROME	0.01676999	0.6291454642580449
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.01670253	0.6266146247632778
MONOSOMY 18Q	0.016691479000000002	0.626200033787045
X-LINKED EHLERS-DANLOS SYNDROME	0.01667985	0.6257637584759769
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.01666782	0.6253124391886653
KABUKI SYNDROME	0.016628234	0.6238273248655131
POSTORGASMIC ILLNESS SYNDROME	0.01661475	0.6233214570957616
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.01659779	0.6226851831877976
TETRASOMY 12P	0.016520479999999997	0.6197848096132283
ATYPICAL TERATOID RHABDOID TUMOR	0.016480309	0.6182777483421895
EPISODIC ATAXIA TYPE 6	0.016480309	0.6182777483421895
PELGER-HUET ANOMALY; PHA	0.016476209999999998	0.6181239696423815
MUCOPOLYSACCHARIDOSIS TYPE 2	0.016414419	0.6158058092032894
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.016414419	0.6158058092032894
SEVERE HEMOPHILIA A	0.01640415	0.6154205558565393
MADELUNG DEFORMITY	0.016389315	0.6148640037678221
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.016387494000000002	0.6147956868582465
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.016379625000000002	0.6145004722720573
FANCONI ANEMIA	0.016379625000000002	0.6145004722720573
FG SYNDROME TYPE 1	0.016362359	0.6138527184221217
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
PERMANENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
PSEUDOXANTHOMA ELASTICUM	0.016297865	0.6114331518289481
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.016255093999999998	0.6098285485673013
2Q37 MICRODELETION SYNDROME	0.016186559	0.6072573792110332
MYOPATHIC EHLERS-DANLOS SYNDROME	0.01615006	0.6058880772436526
MARFAN SYNDROME; MFS	0.01615006	0.6058880772436526
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.01614537	0.6057121264990563
SMITH-LEMLI-OPITZ SYNDROME	0.016142584	0.6056076065045052
CLASSIC PHENYLKETONURIA	0.016110349	0.604398273401721
MYOTONIA FLUCTUANS	0.01610029	0.6040208984465201
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.01610029	0.6040208984465201
MYOTONIA PERMANENS	0.01610029	0.6040208984465201
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0160541	0.6022880274672243
CAMURATI-ENGELMANN DISEASE	0.016032605000000002	0.6014816178179505
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.016023369000000003	0.601135118654392
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.016023369000000003	0.601135118654392
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.016023369000000003	0.601135118654392
MACS SYNDROME	0.015950875	0.5984154228593482
FAMILIAL PAROXYSMAL ATAXIA	0.01593889	0.597965791798797
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.015935709	0.5978464529249036
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.015920425	0.5972730560847312
MYOCLONIC-ATONIC EPILEPSY	0.015920425	0.5972730560847312
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.015884469999999998	0.5959241629030777
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.015872999999999998	0.595493852659897
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.015872999999999998	0.595493852659897
ACRODERMATITIS ENTEROPATHICA	0.015872999999999998	0.595493852659897
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.015872999999999998	0.595493852659897
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.015872999999999998	0.595493852659897
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.015872999999999998	0.595493852659897
IMMUNODEFICIENCY 46; IMD46	0.015872999999999998	0.595493852659897
WILD TYPE ATTR AMYLOIDOSIS	0.015872999999999998	0.595493852659897
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	0.595493852659897
RADICULONEUROPATHY, FATAL NEONATAL	0.015872999999999998	0.595493852659897
PANCREATIC COLIPASE DEFICIENCY	0.015872999999999998	0.595493852659897
CENTRAL DIABETES INSIPIDUS	0.015826309	0.5937421860893342
MÉNÉTRIER DISEASE	0.01576802	0.5915554072083606
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.01576802	0.5915554072083606
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.01568564	0.5884648267521065
MARSILI SYNDROME; MARSIS	0.01568564	0.5884648267521065
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.01565689	0.587386237432887
RHABDOID TUMOR	0.01564354	0.5868853968272667
XQ28 (MECP2) DUPLICATION	0.015604699000000001	0.5854282320360388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.015586159	0.5847326826107054
VISCERAL MYOPATHY; VSCM	0.0154933	0.5812489704161521
SMITH-MAGENIS SYNDROME	0.015471744	0.5804402722817139
GERODERMA OSTEODYSPLASTICA	0.015470665	0.5803997923556117
COLE-CARPENTER SYNDROME	0.015470665	0.5803997923556117
MONOSOMY 5P	0.015470665	0.5803997923556117
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.015439934	0.5792468835427792
ALPORT SYNDROME	0.01540764	0.5780353369871313
KIENBOCK DISEASE	0.015394290000000001	0.5775344963815111
MELORHEOSTOSIS	0.015394290000000001	0.5775344963815111
COFFIN-SIRIS SYNDROME	0.015393324000000002	0.5774982557803854
MALAN OVERGROWTH SYNDROME	0.015388944000000002	0.5773339350423617
HARDIKAR SYNDROME	0.0153846	0.5771709648857464
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.0153846	0.5771709648857464
POLYCYSTIC KIDNEY DISEASE 2	0.0153846	0.5771709648857464
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0153846	0.5771709648857464
HAND-FOOT-GENITAL SYNDROME	0.0153846	0.5771709648857464
JOUBERT SYNDROME 35; JBTS35	0.0153846	0.5771709648857464
CONGENITAL MEGACALYCOSIS	0.0153846	0.5771709648857464
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0153846	0.5771709648857464
POSTERIOR URETHRAL VALVE	0.0153846	0.5771709648857464
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY	0.0153846	0.5771709648857464
PRIMARY HYPEROXALURIA TYPE 2	0.0153846	0.5771709648857464
109820 BLADDER DIVERTICULUM	0.0153846	0.5771709648857464
BLADDER EXSTROPHY	0.0153846	0.5771709648857464
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.01528489	0.5734302295459417
15Q OVERGROWTH SYNDROME	0.015246114	0.5719755033044788
NIEMANN-PICK DISEASE, TYPE A	0.01523319	0.5714906445788582
KERION CELSI	0.01515151	0.5684263254277676
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.015129219999999999	0.567590090439058
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.015079525	0.5657257253531931
ALSTROM SYNDROME; ALMS	0.015079525	0.5657257253531931
FOLATE MALABSORPTION, HEREDITARY	0.015074989	0.5655555520957329
BLOOM SYNDROME	0.01506301	0.5651061461320831
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.01503732	0.5641423562325787
KRABBE DISEASE	0.01502558	0.5637019166288347
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.01502558	0.5637019166288347
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.015018983999999999	0.563454460101893
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.015017059	0.5633822415126932
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.01495585	0.5610859154730372
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.014934369999999999	0.5602800685660169
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.014925399999999998	0.5599435486984203
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984203
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
RIGID SPINE SYNDROME	0.014883925000000001	0.5583875663674768
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.01485616	0.5573459304562373
CHROMOSOME 16P13.3 DELETION SYNDROME	0.014765574000000002	0.5539474924711653
FACTOR VIII DEFICIENCY	0.0147059	0.5517087537221179
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.0147059	0.5517087537221179
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF	0.0147059	0.5517087537221179
HEMOPHILIA B	0.0147059	0.5517087537221179
ACUTE MYELOMONOCYTIC LEUKEMIA	0.0147059	0.5517087537221179
HEMOCHROMATOSIS, NEONATAL	0.0147059	0.5517087537221179
THROMBOCYTOPENIA, CYCLIC	0.0147059	0.5517087537221179
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEINC AND PROTEIN C INHIBITOR	0.0147059	0.5517087537221179
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.0147059	0.5517087537221179
BROOKE-SPIEGLER SYNDROME	0.0147059	0.5517087537221179
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.0147059	0.5517087537221179
WOLFRAM SYNDROME 2; WFS2	0.0147059	0.5517087537221179
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.0147059	0.5517087537221179
DISORDER OF BILE ACID SYNTHESIS	0.0147059	0.5517087537221179
ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO	0.0147059	0.5517087537221179
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	0.0147059	0.5517087537221179
PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	0.0147059	0.5517087537221179
PECHET FACTOR DEFICIENCY	0.0147059	0.5517087537221179
CAR FACTOR DEFICIENCY	0.0147059	0.5517087537221179
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.0147059	0.5517087537221179
HYPERHEPARINEMIA	0.0147059	0.5517087537221179
ATHROMBIA, ESSENTIAL	0.0147059	0.5517087537221179
BODY SKIN HYPERLAXITY DUE TO VITAMIN K-DEPENDENT COAGULATION FACTOR DEFICIENCY	0.0147059	0.5517087537221179
PEROXISOME BIOGENESIS DISORDER 3B	0.0147059	0.5517087537221179
AFIBRINOGENEMIA, CONGENITALHYPOFIBRINOGENEMIA, CONGENITAL, INCLUDED	0.0147059	0.5517087537221179
TYROSINEMIA, TYPE I; TYRSN1	0.0147059	0.5517087537221179
PLATELET FACTOR 3 DEFICIENCY	0.0147059	0.5517087537221179
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0147059	0.5517087537221179
GLYCOGEN STORAGE DISEASE IA	0.0147059	0.5517087537221179
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.0147059	0.5517087537221179
AYMÉ-GRIPP SYNDROME	0.014693624999999998	0.5512482429779989
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.014693624999999998	0.5512482429779989
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014625919	0.5487081745102744
WHIM SYNDROME	0.014625919	0.5487081745102744
RENAL TUBULAR DYSGENESIS	0.01461454	0.548281278236765
EOSINOPHILIC ESOPHAGITIS	0.01459885	0.5476926498395979
CARCINOMA OF ESOPHAGUS	0.01459885	0.5476926498395979
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.01458862	0.5473088596227069
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.01458862	0.5473088596227069
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0145351	0.545300995262198
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.01447564	0.5430702849693008
ZLOTOGORA-OGUR SYNDROME	0.014447838999999999	0.542027298476653
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.014439249999999999	0.5417050722622955
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.014430319	0.5413700155245582
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.01438641	0.5397227188839456
PORPHYRIA VARIEGATA	0.014380048999999999	0.5394840786523089
RUBINSTEIN-TAYBI SYNDROME	0.014372609000000001	0.5392049584945701
EPISODIC ATAXIA, TYPE 6	0.014361399	0.5387844024504499
MEIER-GORLIN SYNDROME 2; MGORS2	0.014348679999999999	0.5383072345356271
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.014328955	0.537567228472267
LOCALIZED EPIDERMOLYSIS BULLOSA SIMPLEX	0.01431483	0.5370373128502156
THYMIC EPITHELIAL NEOPLASM	0.0142988	0.5364359289619691
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0142988	0.5364359289619691
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0142988	0.5364359289619691
THYMOMA	0.0142988	0.5364359289619691
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.014292369000000001	0.536194662599816
KAGAMI-OGATA SYNDROME	0.014292369000000001	0.536194662599816
PONTIAC FEVER	0.01427003	0.5353565893197447
COHEN SYNDROME	0.014265344000000001	0.5351807886397496
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.014222339	0.5335674065989483
CK SYNDROME	0.014222339	0.5335674065989483
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014204918999999998	0.5329138752618767
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.014153469	0.5309836693323517
LYSOSOMAL ACID LIPASE DEFICIENCY	0.014091069999999999	0.5286426990739176
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.0140845	0.5283962179668821
CYSTIC FIBROSIS	0.0140845	0.5283962179668821
LIGNEOUS CONJUNCTIVITIS	0.0140845	0.5283962179668821
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.0140845	0.5283962179668821
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.0140845	0.5283962179668821
CILIARY DYSKINESIA, PRIMARY, 33	0.0140845	0.5283962179668821
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0140845	0.5283962179668821
BRAIN-LUNG-THYROID SYNDROME	0.0140845	0.5283962179668821
TRIMETHYLAMINURIA	0.0140845	0.5283962179668821
MASP2 DEFICIENCY	0.0140845	0.5283962179668821
LEPTIN DEFICIENCY OR DYSFUNCTION	0.0140845	0.5283962179668821
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0140845	0.5283962179668821
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.01407396	0.5280007977434187
IMMUNODEFICIENCY 23; IMD23	0.014026105	0.5262054623739838
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.013963439999999999	0.5238545128195874
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.01390642	0.5217153419332604
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.01390642	0.5217153419332604
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.01390642	0.5217153419332604
ACHONDROPLASIA	0.013903490000000001	0.5216054196130758
IMMUNODEFICIENCY 13; IMD13	0.013888900000000001	0.5210580589811658
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.013888900000000001	0.5210580589811658
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.013888900000000001	0.5210580589811658
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.013888900000000001	0.5210580589811658
MOUNIER-KÜHN SYNDROME	0.013888900000000001	0.5210580589811658
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.013888900000000001	0.5210580589811658
MELIOIDOSIS	0.013888900000000001	0.5210580589811658
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.013888900000000001	0.5210580589811658
215030 CHOLESTEROL PNEUMONIA	0.013888900000000001	0.5210580589811658
CRYOGLOBULINEMIC VASCULITIS	0.013885109999999999	0.5209158727717799
MUCKLE-WELLS SYNDROME	0.013885109999999999	0.5209158727717799
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.013885109999999999	0.5209158727717799
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.013880729999999999	0.5207515520337561
LAMBERT-EATON MYASTHENIC SYNDROME	0.013880729999999999	0.5207515520337561
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.013851405	0.5196513909281523
CRANIO-OSTEOARTHROPATHY	0.01383925	0.5191953821220613
PSEUDOMYXOMA PERITONEI	0.013838630000000001	0.5191721221089164
PRIMARY PERITONEAL CARCINOMA	0.013838630000000001	0.5191721221089164
FLOATING-HARBOR SYNDROME	0.01383119	0.5188930019511775
LOEYS-DIETZ SYNDROME	0.013828725	0.5188005246408514
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.013823569	0.5186070913702464
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.01381998	0.5184724459070575
LIPOSARCOMA	0.0138133	0.5182218380234962
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.013773464999999999	0.5167273821789357
RESTRICTIVE DERMOPATHY, LETHAL	0.013750950000000001	0.5158827060564235
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
WARBURG MICRO SYNDROME 1	0.01368092	0.5132554500555558
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.01368092	0.5132554500555558
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.5126019187184843
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.013663499999999999	0.5126019187184843
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.013663499999999999	0.5126019187184843
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013663499999999999	0.5126019187184843
DESMOSTEROLOSIS	0.013663499999999999	0.5126019187184843
PEHO-LIKE SYNDROME; PEHOL	0.013663499999999999	0.5126019187184843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.013663499999999999	0.5126019187184843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013663499999999999	0.5126019187184843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.013663499999999999	0.5126019187184843
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.013658115	0.5123998942494757
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.01360284	0.5103261890453067
SCHAAF-YANG SYNDROME; SHFYNG	0.013592364	0.5099331698554582
PITT-HOPKINS SYNDROME	0.013592364	0.5099331698554582
NETHERTON SYNDROME	0.013572499	0.5091879115310654
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.013566189999999999	0.5089512221392406
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.01352646	0.5074607054904549
SHPRINTZEN-GOLDBERG SYNDROME	0.013521495	0.5072744378045444
NON-FUNCTIONING PITUITARY ADENOMA	0.013479919	0.5057146663424271
PROLACTINOMA	0.013479919	0.5057146663424271
LOWE OCULOCEREBRORENAL SYNDROME	0.013441204	0.5042622285861286
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.01335	0.500840605620212
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.01332773	0.5000051209545069
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.013306589	0.4992119920224158
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.013306589	0.4992119920224158
POSTPOLIOMYELITIS SYNDROME	0.013298979999999998	0.49892653163528733
EOSINOPHILIC FASCIITIS	0.013298979999999998	0.49892653163528733
MACROPHAGIC MYOFASCIITIS	0.013298979999999998	0.49892653163528733
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013268179	0.4977709966919384
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.013264844	0.497645880330909
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.013262769	0.497568034319174
GASTROINTESTINAL STROMAL TUMOR	0.0132525	0.4971827809724239
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.01320754	0.49549605485791576
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.01320754	0.49549605485791576
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.013195609	0.4950484496694771
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.013194109	0.4949921754441266
OKAMOTO SYNDROME	0.013174505	0.4942567088349446
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.013174505	0.4942567088349446
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.013139604	0.49294735767563735
STICKLER SYNDROME TYPE 1	0.01308561	0.4909217106599177
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.013057599999999999	0.4898708832918711
AUTOIMMUNE HEMOLYTIC ANEMIA	0.01305467	0.48976096097168637
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.01303108	0.4888759549876728
CHRONIC GRANULOMATOUS DISEASE	0.01303108	0.4888759549876728
1P36 DELETION SYNDROME	0.013002604000000001	0.48780764509361735
ZELLWEGER SYNDROME	0.012993359000000001	0.4874608082847065
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.012993359	0.4874608082847065
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.012977819	0.4868778073100744
ODONTOCHONDRODYSPLASIA; ODCD	0.012925475	0.4849140619422404
CLEIDOCRANIAL DYSPLASIA	0.012856605	0.48233032467564385
GAUCHER DISEASE TYPE 2	0.01285638	0.4823218835418413
HYPOPHOSPHATASIA	0.012854458999999999	0.4822498150172422
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.012814479	0.48074991933089795
COFFIN-SIRIS SYNDROME 6; CSS6	0.01276517	0.47890003547902327
REYNOLDS SYNDROME	0.01273984	0.47794975139360313
CONGENITAL TOXOPLASMOSIS	0.012718359	0.47714386697043254
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.012600419000000002	0.4727192122118672
KLEEFSTRA SYNDROME	0.012551144	0.4708706039091004
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.012540279	0.47046299093681093
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.012525444	0.4699064388480937
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.012518919	0.4696616459678186
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.012516209	0.46955997720068526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012489324999999999	0.46855139301780174
BETA-UREIDOPROPIONASE DEFICIENCY	0.012489324999999999	0.46855139301780174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012489324999999999	0.46855139301780174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012489324999999999	0.46855139301780174
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012489324999999999	0.46855139301780174
3C SYNDROME	0.012486875000000001	0.4684594784497292
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.012478499999999998	0.46814528069152167
GMS SYNDROME	0.012451940000000002	0.46714885174131404
BECKWITH-WIEDEMANN SYNDROME	0.012451940000000002	0.46714885174131404
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.012451940000000002	0.46714885174131404
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.01241859	0.4658976881310194
NEPHROGENIC DIABETES INSIPIDUS	0.012417019	0.4658387502590022
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.01238984	0.4648190988117997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.012379639	0.4644363965632656
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.012338914	0.46290855134499714
JABERI-ELAHI SYNDROME; JABELS	0.012338914	0.46290855134499714
WITTEVEEN-KOLK SYNDROME	0.012296434000000002	0.46131486528306864
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.01227306	0.46043796278750554
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.01224951	0.4595544574495013
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.012177489	0.4568525067935183
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.012177489	0.4568525067935183
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012144578999999999	0.45561785028932644
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.012106125	0.4541752042482389
BUERGER DISEASE	0.0120976	0.4538553790674964
NAKAJO-NISHIMURA SYNDROME	0.0120976	0.4538553790674964
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.012094004	0.4537204709912559
FAMILIAL HYPOALDOSTERONISM	0.01207775	0.45311068348535694
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.012074269	0.4529800897663933
L1 SYNDROME	0.012052729	0.4521719918903589
LHERMITTE-DUCLOS DISEASE	0.012052729	0.4521719918903589
ZTTK SYNDROME; ZTTKS	0.012038974	0.45165595724389407
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748833
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012018659000000001	0.450893816651896
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.012000749	0.45022190240120996
CRONKHITE-CANADA SYNDROME	0.011993329	0.4499435325664758
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.011984025	0.44959448230470117
HEREDITARY ANGIOEDEMA TYPE 1	0.01192187	0.44726266598692405
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.01192187	0.44726266598692405
PANCREATOBLASTOMA	0.01192187	0.44726266598692405
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.01192187	0.44726266598692405
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.01190476	0.4466207646564251
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.011845743999999998	0.4444067115342316
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.011845743999999998	0.4444067115342316
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.01183822	0.44412444001987306
ADRENOCORTICAL CARCINOMA	0.01182454	0.44361121908467577
KASABACH-MERRITT SYNDROME	0.01182454	0.44361121908467577
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.011797495	0.44259659480160474
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.011797495	0.44259659480160474
COFFIN-LOWRY SYNDROME	0.011796204000000001	0.442548161451653
KOOLEN-DE VRIES SYNDROME	0.011796204000000001	0.442548161451653
INSULINOMA	0.011779829	0.44193383449157575
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0117284	0.4400044164012055
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01171972	0.43967877621717677
PORPHYRIA VARIEGATA	0.01171972	0.43967877621717677
CAMOS SYNDROME	0.011652519	0.43715765340532037
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.011652519	0.43715765340532037
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.011652519	0.43715765340532037
COFFIN-SIRIS SYNDROME 1; CSS1	0.011651284	0.43711132095978167
ANGELMAN SYNDROME	0.011625594000000001	0.43614753106027737
PSEUDOACHONDROPLASIA	0.011611495	0.4356185908581321
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.01160316	0.4353058937459339
SSR4-CDG	0.011567853999999999	0.43398134854578213
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.01155877	0.4336405518370589
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.011556119	0.4335410965227894
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.011556119	0.4335410965227894
NK-CELL ENTEROPATHY	0.01154981	0.43330440713096485
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01153285	0.4326681332230009
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.011522374	0.4322751140331524
SUSAC SYNDROME	0.01151131	0.4318600353469665
CENTRAL NEUROCYTOMA	0.01151131	0.4318600353469665
PINEOCYTOMA	0.01151131	0.4318600353469665
PAPILLARY TUMOR OF THE PINEAL REGION	0.01151131	0.4318600353469665
HEMANGIOBLASTOMA	0.01151131	0.4318600353469665
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.011497555	0.43134400070050155
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.011497555	0.43134400070050155
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.011494299999999999	0.4312218856314908
PERLMAN SYNDROME	0.011494299999999999	0.4312218856314908
RING CHROMOSOME 14 SYNDROME	0.011494299999999999	0.4312218856314908
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.4312218856314908
PYRIDOXINE-DEPENDENT EPILEPSY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.011494299999999999	0.4312218856314908
FUMARASE DEFICIENCY; FMRD	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
MEDULLARY THYROID CARCINOMA	0.01146589	0.4301560518033507
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.011447539999999999	0.42946763044656183
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.01142846	0.42875182230010245
SECONDARY SHORT BOWEL SYNDROME	0.011361070000000001	0.4262236089358518
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.01134975	0.42579892611520603
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.011344744	0.42561112026713604
SAETHRE-CHOTZEN SYNDROME	0.011340364	0.42544679952911235
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.011304324999999999	0.42409475499083904
CYCLIC NEUTROPENIA	0.01127545	0.4230114761528404
THYROTOXIC PERIODIC PARALYSIS	0.01126374	0.4225721620336034
WEAVER SYNDROME	0.011254785	0.42223620490826047
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.01123841	0.4216218779481833
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.011123224	0.41730054266736155
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.011123224	0.41730054266736155
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011123224	0.41730054266736155
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0111167	0.4170557873032368
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0111167	0.4170557873032368
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.0111167	0.4170557873032368
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011113979	0.4169537058584507
PRENATAL BOWING	0.0111111	0.41684569686192785
ACROMIAL DIMPLES	0.0111111	0.41684569686192785
PILONIDAL SINUS	0.0111111	0.41684569686192785
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.41684569686192785
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.41684569686192785
DERMAL RIDGES, PATTERNLESS	0.0111111	0.41684569686192785
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.41684569686192785
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.41684569686192785
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.41684569686192785
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.41684569686192785
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.41684569686192785
131600 EPIDERMOID CYSTS	0.0111111	0.41684569686192785
TRIOPIA	0.0111111	0.41684569686192785
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.41684569686192785
PARANA HARD-SKIN SYNDROME	0.0111111	0.41684569686192785
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0111111	0.41684569686192785
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.41684569686192785
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.41684569686192785
PSEUDOATROPHODERMA COLLI	0.0111111	0.41684569686192785
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0111111	0.41684569686192785
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.41684569686192785
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.41684569686192785
SAY SYNDROME	0.0111111	0.41684569686192785
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.41684569686192785
KYRLE DISEASE	0.0111111	0.41684569686192785
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.41684569686192785
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.41684569686192785
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.41684569686192785
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.41684569686192785
KERATOSIS, FAMILIAL ACTINIC	0.0111111	0.41684569686192785
TRICHILEMMAL CYST 1	0.0111111	0.41684569686192785
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.41684569686192785
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0111111	0.41684569686192785
GLOMUVENOUS MALFORMATIONS	0.0111111	0.41684569686192785
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.41684569686192785
SYRINGOMAS, MULTIPLE	0.0111111	0.41684569686192785
FUTCHER LINE	0.0111111	0.41684569686192785
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.41684569686192785
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.41684569686192785
LENTIGINES	0.0111111	0.41684569686192785
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.41684569686192785
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.41684569686192785
LICHEN PLANUS, FAMILIAL	0.0111111	0.41684569686192785
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.41684569686192785
CAROTENEMIA, FAMILIAL	0.0111111	0.41684569686192785
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.41684569686192785
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.41684569686192785
PIGMENTED PURPURIC ERUPTION	0.0111111	0.41684569686192785
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.41684569686192785
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.41684569686192785
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.41684569686192785
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.41684569686192785
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.011098979	0.416390963604945
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.011098979	0.416390963604945
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.011052355	0.4146418106164478
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.011043948999999999	0.41432644985758305
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.011043948999999999	0.41432644985758305
DUPLICATION/INVERSION 15Q11	0.011043948999999999	0.41432644985758305
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.011043948999999999	0.41432644985758305
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.011026435	0.41366939200238967
AROMATASE DEFICIENCY	0.010989	0.41226497491839026
BLUE RUBBER BLEB NEVUS	0.010989	0.41226497491839026
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.010989	0.41226497491839026
PAGET DISEASE OF BONE 4; PDB4	0.010989	0.41226497491839026
OLLIER DISEASE	0.010989	0.41226497491839026
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010989	0.41226497491839026
PROGRESSIVE OSSEOUS HETEROPLASIA	0.010989	0.41226497491839026
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.010989	0.41226497491839026
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.010989	0.41226497491839026
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.010989	0.41226497491839026
BONE PAIN, PERIODIC	0.010989	0.41226497491839026
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.010989	0.41226497491839026
METACHONDROMATOSIS	0.010989	0.41226497491839026
ADAMANTINOMA	0.010989	0.41226497491839026
FAMILIAL EXPANSILE OSTEOLYSIS	0.010989	0.41226497491839026
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.010970404	0.4115673245886439
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0109168	0.4095563088715154
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.010905289	0.40912446046617496
CORNELIA DE LANGE SYNDROME 3	0.010905289	0.40912446046617496
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010858909	0.40738446141833484
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.010850718999999998	0.4070772041479206
DERMOTRICHIC SYNDROME	0.010850718999999998	0.4070772041479206
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.010850718999999998	0.4070772041479206
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.010850718999999998	0.4070772041479206
MELNICK-NEEDLES SYNDROME	0.010803325	0.40529916372374364
DIASTROPHIC DWARFISM	0.010803325	0.40529916372374364
STICKLER SYNDROME, TYPE II	0.01080247	0.4052670874152937
1P21.3 MICRODELETION SYNDROME	0.01080247	0.4052670874152937
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.010801179000000001	0.4052186540653421
CHÉDIAK-HIGASHI SYNDROME	0.010761059	0.40371350611796497
JOUBERT SYNDROME 10	0.01075999	0.40367340135336516
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.010758934000000001	0.4036337842987184
CONGENITAL FIBRINOGEN DEFICIENCY	0.01075475	0.40347681672614044
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.01075475	0.40347681672614044
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0107527	0.4033999086181613
ESSENTIAL THROMBOCYTHEMIA	0.0107527	0.4033999086181613
FAMILIAL ATRIAL MYXOMA	0.0107527	0.4033999086181613
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.0107527	0.4033999086181613
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	0.0107527	0.4033999086181613
THYMIC NEUROENDOCRINE TUMOR	0.0107527	0.4033999086181613
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.0107527	0.4033999086181613
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	0.0107527	0.4033999086181613
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	0.0107527	0.4033999086181613
ANEURYSM OF SINUS OF VALSALVA	0.0107527	0.4033999086181613
PLEURAL MESOTHELIOMA	0.0107527	0.4033999086181613
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.0107527	0.4033999086181613
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	0.0107527	0.4033999086181613
DPM3-CDG	0.0107527	0.4033999086181613
FAMILIAL AORTIC DISSECTION	0.0107527	0.4033999086181613
HALLERMANN-STREIFF SYNDROME	0.0107336	0.40268335014869716
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0107336	0.40268335014869716
GALACTOSEMIA	0.010724969	0.40235954825602993
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.01069518	0.4012419796567175
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.01063937	0.3991482033121734
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.010581805	0.3969885861239691
TYSHCHENKO SYNDROME	0.01057256	0.39664174931505825
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.01057256	0.39664174931505825
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01057256	0.39664174931505825
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.01055756	0.3960790070615524
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.01055756	0.3960790070615524
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.01050253	0.39401449331419064
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.01048499	0.3933564600390911
HYALINE FIBROMATOSIS SYNDROME; HFS	0.01048499	0.3933564600390911
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.01048499	0.3933564600390911
PITT-HOPKINS SYNDROME	0.010428139	0.3912236293821537
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.010417054	0.39080776285681285
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.010345339	0.3881172921428014
PULMONARY ARTERIOVENOUS MALFORMATION	0.010345339	0.3881172921428014
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.010345339	0.3881172921428014
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.010345339	0.3881172921428014
SNEDDON SYNDROME	0.010345339	0.3881172921428014
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.010345339	0.3881172921428014
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.010345339	0.3881172921428014
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.010345339	0.3881172921428014
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.010345339	0.3881172921428014
HARTNUP DISEASE	0.010345339	0.3881172921428014
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.010345339	0.3881172921428014
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.010345339	0.3881172921428014
PHACE ASSOCIATION	0.010345339	0.3881172921428014
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.010324029	0.3873178229813207
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.010309299999999999	0.38676524760452813
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	0.010309299999999999	0.38676524760452813
CHAND SYNDROME	0.010309299999999999	0.38676524760452813
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.010309299999999999	0.38676524760452813
EEC SYNDROME	0.010309299999999999	0.38676524760452813
DERMOODONTODYSPLASIA	0.010309299999999999	0.38676524760452813
ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12	0.010309299999999999	0.38676524760452813
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.010309299999999999	0.38676524760452813
LARON SYNDROME	0.010309299999999999	0.38676524760452813
KID SYNDROME	0.010309299999999999	0.38676524760452813
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.010309299999999999	0.38676524760452813
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.010309299999999999	0.38676524760452813
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.010309299999999999	0.38676524760452813
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	0.010309299999999999	0.38676524760452813
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.010309299999999999	0.38676524760452813
RECESSIVE X-LINKED ICHTHYOSIS	0.010309299999999999	0.38676524760452813
DAHLBERG-BORER-NEWCOMER SYNDROME	0.010309299999999999	0.38676524760452813
LELIS SYNDROME	0.010309299999999999	0.38676524760452813
HELIX SYNDROME; HELIX	0.010309299999999999	0.38676524760452813
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.010309299999999999	0.38676524760452813
JOHNSON NEUROECTODERMAL SYNDROME	0.010309299999999999	0.38676524760452813
FRONTONASAL DYSPLASIA 2; FND2	0.010309299999999999	0.38676524760452813
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.010309299999999999	0.38676524760452813
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.010309299999999999	0.38676524760452813
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010309299999999999	0.38676524760452813
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.010309299999999999	0.38676524760452813
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.010309299999999999	0.38676524760452813
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010309299999999999	0.38676524760452813
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.010309299999999999	0.38676524760452813
CYSTINOSIS, NEPHROPATHIC; CTNS	0.010309299999999999	0.38676524760452813
BATHING SUIT ICHTHYOSIS	0.010309299999999999	0.38676524760452813
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.010309299999999999	0.38676524760452813
ROSSELLI-GULIENETTI SYNDROME	0.010309299999999999	0.38676524760452813
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.010309299999999999	0.38676524760452813
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.01030853	0.3867363601688482
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.0102672	0.38518581767968846
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.0102672	0.38518581767968846
BURKITT LYMPHOMA	0.0102672	0.38518581767968846
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.01021964	0.3834015495745725
ACTH-INDEPENDENT CUSHING SYNDROME	0.01016862	0.3814874755896479
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.01016862	0.3814874755896479
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.01016862	0.3814874755896479
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.01016862	0.3814874755896479
EVANS SYNDROME	0.01016862	0.3814874755896479
ACTH-DEPENDENT CUSHING SYNDROME	0.01016862	0.3814874755896479
AREGENERATIVE ANEMIA	0.01016862	0.3814874755896479
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.010128199	0.3799710352810506
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.010128199	0.3799710352810506
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.010086685	0.37841358982024775
3Q29 MICRODELETION SYNDROME	0.01005733	0.3773123032301368
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.010020933999999999	0.3759468654262302
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.00998593	0.37463365010344896
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00998112	0.3744531974208247
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009975379	0.3742378172023329
CHROMOSOME 2Q37 DELETION SYNDROME	0.009975379	0.3742378172023329
PHENYLKETONURIA	0.009975379	0.3742378172023329
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.009975379	0.3742378172023329
SULFOCYSTEINURIA	0.009975379	0.3742378172023329
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.009975379	0.3742378172023329
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.009975379	0.3742378172023329
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009975379	0.3742378172023329
ECTODERMAL DYSPLASIA SYNDROME	0.009975379	0.3742378172023329
MICROFORM HOLOPROSENCEPHALY	0.009939804	0.3729031801577682
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.009937589	0.3728200818850005
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.009937589	0.3728200818850005
PAPILLOMA OF CHOROID PLEXUS	0.009933819	0.37267864599861933
OPTIC PATHWAY GLIOMA	0.009933819	0.37267864599861933
POSTENCEPHALITIC PARKINSONISM	0.009933819	0.37267864599861933
DRACUNCULIASIS	0.00990855	0.3717306503983634
NON-HISTAMINIC ANGIOEDEMA	0.00990855	0.3717306503983634
CHOLESTERYL ESTER STORAGE DISEASE	0.00990855	0.3717306503983634
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00990855	0.3717306503983634
INTESTINAL BOTULISM	0.00990855	0.3717306503983634
GAPO SYNDROME; GAPOS	0.009869774	0.3702759241569005
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.009869774	0.3702759241569005
ABETAL34V AMYLOIDOSIS	0.00980392	0.36780533559940887
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.36780533559940887
EPISODIC ATAXIA, TYPE 2	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.36780533559940887
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.36780533559940887
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.36780533559940887
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.36780533559940887
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.36780533559940887
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.36780533559940887
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.36780533559940887
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.36780533559940887
EPISODIC ATAXIA TYPE 7	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.36780533559940887
FAMILIAL CERVICAL ARTERY DISSECTION	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.36780533559940887
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.009800904	0.3676921868903039
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00978163	0.36696910061069915
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.009771904	0.366604218533526
CHST3-RELATED SKELETAL DYSPLASIA	0.00975288	0.3658905112914796
THORACIC OUTLET SYNDROME	0.00975288	0.3658905112914796
PYODERMA GANGRENOSUM	0.00975288	0.3658905112914796
LOCALIZED SCLERODERMA	0.00975288	0.3658905112914796
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00975288	0.3658905112914796
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00975288	0.3658905112914796
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00975288	0.3658905112914796
NEUROGENIC THORACIC OUTLET SYNDROME	0.00975288	0.3658905112914796
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00975288	0.3658905112914796
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00975288	0.3658905112914796
CUTANEOUS SMALL VESSEL VASCULITIS	0.00975288	0.3658905112914796
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00975288	0.3658905112914796
ERYTHEMA ELEVATUM DIUTINUM	0.00975288	0.3658905112914796
CONGENITAL PATELLA DISLOCATION	0.00975288	0.3658905112914796
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009746214	0.36564042863402163
PITUITARY APOPLEXY	0.00968107	0.3631964765431959
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.009675345	0.36298169658310786
CARTILAGE-HAIR HYPOPLASIA	0.009675345	0.36298169658310786
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.009675345	0.36298169658310786
MEIER-GORLIN SYNDROME 6; MGORS6	0.00961247	0.3606228686371624
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00958678	0.35965907873765807
INFANTILE DYSTONIA-PARKINSONISM	0.00958678	0.35965907873765807
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00958678	0.35965907873765807
CUTANEOUS MASTOCYTOMA	0.009508570000000001	0.3567249406278786
PREECLAMPSIA	0.009508570000000001	0.3567249406278786
PERINEURAL CYST	0.009508570000000001	0.3567249406278786
HEREDITARY SPHEROCYTOSIS	0.00947982	0.355646351308659
GLIOBLASTOMA	0.009463859	0.35504755603477856
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.009435109	0.35396896671555905
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00943396	0.35392586065894044
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.00943396	0.35392586065894044
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00943396	0.35392586065894044
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00943396	0.35392586065894044
CLASSIC MYCOSIS FUNGOIDES	0.00943396	0.35392586065894044
NEUTROPHIL CHEMOTACTIC RESPONSE	0.00943396	0.35392586065894044
ELASTODERMA	0.00943396	0.35392586065894044
PORPHYRIA CUTANEA TARDA, TYPE I	0.00943396	0.35392586065894044
8Q21.11 MICRODELETION SYNDROME	0.00943396	0.35392586065894044
DISTAL TRISOMY 5Q	0.00943396	0.35392586065894044
PITYRIASIS RUBRA PILARIS	0.00943396	0.35392586065894044
ACRAL PEELING SKIN SYNDROME	0.00943396	0.35392586065894044
IGE RESPONSIVENESS, ATOPIC	0.00943396	0.35392586065894044
BLAU SYNDROME	0.00943396	0.35392586065894044
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00943396	0.35392586065894044
PROTOPORPHYRIA, ERYTHROPOIETIC	0.00943396	0.35392586065894044
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00943396	0.35392586065894044
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00943396	0.35392586065894044
HELSMOORTEL-VAN DER AA SYNDROME	0.009422029	0.35347825547050193
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.009422029	0.35347825547050193
COFFIN-SIRIS SYNDROME 2; CSS2	0.009422029	0.35347825547050193
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.009422029	0.35347825547050193
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.009422029	0.35347825547050193
COFFIN-SIRIS SYNDROME 5	0.009422029	0.35347825547050193
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009398385	0.3525912236143757
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.009398385	0.3525912236143757
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009398385	0.3525912236143757
INCLUSION BODY MYOSITIS	0.00939617	0.352508125341608
NEMALINE MYOPATHY 4	0.00939617	0.352508125341608
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00939617	0.352508125341608
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0093924	0.3523666894552269
EPISODIC ATAXIA, TYPE 3	0.0093924	0.3523666894552269
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009353174	0.3508950809461589
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.009353174	0.3508950809461589
15Q26 OVERGROWTH SYNDROME	0.009328355	0.349963967613508
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.009328355	0.349963967613508
GIANT AXONAL NEUROPATHY	0.009328355	0.349963967613508
CARTILAGE-HAIR HYPOPLASIA; CHH	0.009328355	0.349963967613508
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00928673	0.34840235786002927
ATHYREOSIS	0.00928673	0.34840235786002927
PERIPHERAL HYPOTHYROIDISM	0.00928673	0.34840235786002927
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00928673	0.34840235786002927
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00928673	0.34840235786002927
COLE-CARPENTER SYNDROME 1; CLCRP1	0.009259485	0.34738023034691146
GNATHODIAPHYSEAL DYSPLASIA	0.009259485	0.34738023034691146
OSTEOGENESIS IMPERFECTA, TYPE IV	0.009259485	0.34738023034691146
OSTEOGENESIS IMPERFECTA, TYPE IX	0.009259485	0.34738023034691146
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.009259485	0.34738023034691146
BRUCK SYNDROME	0.009259485	0.34738023034691146
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.009259485	0.34738023034691146
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.009259485	0.34738023034691146
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.009259485	0.34738023034691146
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.009259485	0.34738023034691146
CAMPOMELIC DYSPLASIA	0.009259485	0.34738023034691146
PAINE SYNDROME	0.00925926	0.3473717892131089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00925926	0.3473717892131089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.3473717892131089
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.00925926	0.3473717892131089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
INCONTINENTIA PIGMENTI	0.009228754	0.346227321534079
KNOBLOCH SYNDROME	0.009221739	0.34596414574018935
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00921145	0.3455781420704346
AMISH LETHAL MICROCEPHALY	0.00921145	0.3455781420704346
X SMALL RINGS	0.00921145	0.3455781420704346
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.009180549999999999	0.3444188930282125
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.009180549999999999	0.3444188930282125
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00914992	0.34326977334655356
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00909166	0.3410840824339368
BOHRING-OPITZ SYNDROME	0.009025908999999999	0.3386173580399192
BOHRING-OPITZ SYNDROME	0.009025908999999999	0.3386173580399192
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.008997435	0.33754912317816416
MUCOPOLYSACCHARIDOSIS TYPE 1	0.008997435	0.33754912317816416
FOCAL DERMAL HYPOPLASIA	0.008973405	0.33664761008804783
RETT SYNDROME; RTT	0.008954024	0.33592050958036795
RETT SYNDROME, CONGENITAL VARIANT	0.008954024	0.33592050958036795
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.3355736727714572
INFANTILE SIALIC ACID STORAGE DISEASE	0.008944779	0.3355736727714572
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008944779	0.3355736727714572
ADAMS-OLIVER SYNDROME	0.008944779	0.3355736727714572
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.3355736727714572
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.008944779	0.3355736727714572
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
MELNICK-NEEDLES SYNDROME	0.00894471	0.3355710841570911
PITUICYTOMA	0.00892244	0.3347355994913861
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00892244	0.3347355994913861
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00892244	0.3347355994913861
FUNCTIONING GONADOTROPIC ADENOMA	0.00892244	0.3347355994913861
MONOSOMY 9Q22.3	0.008921799	0.3347115516390862
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00891902	0.33460729425758673
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00891902	0.33460729425758673
ASPARTYLGLUCOSAMINURIA; AGU	0.008907144	0.33416175245741103
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.00889369	0.3336570101721665
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00889369	0.3336570101721665
BECKER MUSCULAR DYSTROPHY	0.00889369	0.3336570101721665
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.00889369	0.3336570101721665
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.008889755000000001	0.33350938412099684
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.008889755000000001	0.33350938412099684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00888061	0.3331662989271094
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.008874749	0.33294641677058956
ZIMMERMANN-LABAND SYNDROME	0.008874749	0.33294641677058956
MENTAL RETARDATION, X-LINKED 21	0.008874749	0.33294641677058956
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.008874749	0.33294641677058956
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.008874749	0.33294641677058956
MAN1B1-CDG	0.008874749	0.33294641677058956
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008874749	0.33294641677058956
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.008805878999999999	0.33036267950399295
WOLCOTT-RALLISON SYNDROME	0.008805878999999999	0.33036267950399295
KALLMANN SYNDROME	0.008805878999999999	0.33036267950399295
PRADER-WILLI-LIKE SYNDROME	0.008751189	0.32831092124771066
DESANTO-SHINAWI SYNDROME	0.008751189	0.32831092124771066
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.008751189	0.32831092124771066
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.008689709	0.3260044283313413
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.008687335000000001	0.32591536499068646
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.008687335000000001	0.32591536499068646
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.008687335000000001	0.32591536499068646
SPONDYLO-OCULAR SYNDROME	0.00868032	0.3256521891967969
RENAL COLOBOMA SYNDROME	0.00868032	0.3256521891967969
GAPO SYNDROME	0.00868032	0.3256521891967969
CRANIOECTODERMAL DYSPLASIA	0.00868032	0.3256521891967969
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00868032	0.3256521891967969
ARGININOSUCCINIC ACIDURIA	0.008606059000000001	0.3228662023642903
MAPLE SYRUP URINE DISEASE; MSUD	0.008606059000000001	0.3228662023642903
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.008606059000000001	0.3228662023642903
METHYLMALONIC ACIDURIA, CBLA TYPE	0.008606059000000001	0.3228662023642903
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.008606059000000001	0.3228662023642903
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.008606059000000001	0.3228662023642903
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.008606059000000001	0.3228662023642903
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.008606059	0.3228662023642903
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00853752	0.3202948829434211
HEMOCHROMATOSIS TYPE 4	0.00853752	0.3202948829434211
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00853752	0.3202948829434211
XERODERMA PIGMENTOSUM	0.008492809	0.3186174983503211
CANAVAN DISEASE	0.008436149	0.31649183327807834
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
PEMPHIGOID GESTATIONIS	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31526171622806476
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.31526171622806476
HYDROLETHALUS	0.00840336	0.31526171622806476
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31526171622806476
SCHISIS ASSOCIATION	0.00840336	0.31526171622806476
ROBERTS SYNDROME	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.31526171622806476
NEMALINE MYOPATHY 10	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806476
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.31526171622806476
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31526171622806476
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.31526171622806476
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.31526171622806476
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31526171622806476
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.31526171622806476
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31526171622806476
RETINOPATHY OF PREMATURITY	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31526171622806476
HEC SYNDROME	0.00840336	0.31526171622806476
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31526171622806476
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.31526171622806476
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.31526171622806476
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31526171622806476
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806476
VACTERL/VATER ASSOCIATION	0.00840336	0.31526171622806476
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
DISTAL MONOSOMY 17Q	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.31526171622806476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806476
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.31526171622806476
CRANIOSYNOSTOSIS 2	0.008386899	0.31464416287906743
EAR-PATELLA-SHORT STATURE SYNDROME	0.00838038	0.31439959509569376
2Q32Q33 MICRODELETION SYNDROME	0.00838038	0.31439959509569376
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00838038	0.31439959509569376
LISSENCEPHALY, X-LINKED, 2	0.008363579	0.31376928625561695
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.008363579	0.31376928625561695
FLYNN-AIRD SYNDROME	0.008358149	0.31356557355984793
MEESTER-LOEYS SYNDROME; MRLS	0.00833333	0.31263446022719704
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00833333	0.31263446022719704
WILSON DISEASE	0.00833333	0.31263446022719704
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00833333	0.31263446022719704
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.00833333	0.31263446022719704
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00833333	0.31263446022719704
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00833333	0.31263446022719704
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00833333	0.31263446022719704
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.00833333	0.31263446022719704
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00833333	0.31263446022719704
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00833333	0.31263446022719704
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00833333	0.31263446022719704
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.00833333	0.31263446022719704
OCULO-PALATO-CEREBRAL SYNDROME	0.00833333	0.31263446022719704
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00833333	0.31263446022719704
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00833333	0.31263446022719704
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00833333	0.31263446022719704
NEMALINE MYOPATHY 7; NEM7	0.00833333	0.31263446022719704
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.008331059	0.3125492610500163
BETA-KETOTHIOLASE DEFICIENCY	0.008331059	0.3125492610500163
CITRULLINEMIA TYPE II	0.008331059	0.3125492610500163
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.008331059	0.3125492610500163
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.008331059	0.3125492610500163
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.008331059	0.3125492610500163
GALACTOSE EPIMERASE DEFICIENCY	0.00830417	0.31154048928638167
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00826446	0.3100507229606005
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00826446	0.3100507229606005
DYSOSTEOSCLEROSIS	0.00826446	0.3100507229606005
ANTLEY-BIXLER SYNDROME	0.00826446	0.3100507229606005
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00826446	0.3100507229606005
JUVENILE PAGET DISEASE	0.00826446	0.3100507229606005
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.00826446	0.3100507229606005
FAMILIAL PAPILLARY THYROID CARCINOMA WITH RENAL PAPILLARY NEOPLASIA	0.00826446	0.3100507229606005
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.00826446	0.3100507229606005
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00826446	0.3100507229606005
FAMILIAL PARATHYROID ADENOMA	0.00826446	0.3100507229606005
ACHONDROGENESIS TYPE 1A	0.00826446	0.3100507229606005
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00826446	0.3100507229606005
OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES	0.00826446	0.3100507229606005
HYPOPHOSPHATASIA, ADULT	0.00826446	0.3100507229606005
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00826446	0.3100507229606005
URBAN-ROGERS-MEYER SYNDROME	0.00826446	0.3100507229606005
GRANGE SYNDROME; GRNG	0.00826446	0.3100507229606005
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00826446	0.3100507229606005
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00826446	0.3100507229606005
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00826446	0.3100507229606005
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00826446	0.3100507229606005
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.008247854	0.3094277297698193
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.008247854	0.3094277297698193
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.008245078999999999	0.30932362245292067
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.008233729	0.308897814147768
TYROSINEMIA TYPE 2	0.008233729	0.308897814147768
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.008233729	0.308897814147768
VICI SYNDROME	0.008187119000000001	0.30714918638537414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008161429000000001	0.3061853964858698
SHORT STATURE DUE TO GHSR DEFICIENCY	0.008148289999999999	0.3056924717879488
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.008148289999999999	0.3056924717879488
CONGENITAL PANCREATIC CYST	0.008148289999999999	0.3056924717879488
PEUTZ-JEGHERS SYNDROME	0.008148289999999999	0.3056924717879488
MOWAT-WILSON SYNDROME; MOWS	0.008128909	0.304965371280269
METHYLMALONIC ACIDURIA, CBLB TYPE	0.008064640000000001	0.3025542458208979
LIVER FAILURE, INFANTILE, TRANSIENT	0.008064640000000001	0.3025542458208979
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.008058209	0.3023129794587448
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.008058209	0.3023129794587448
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.008058209	0.3023129794587448
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.008058209	0.3023129794587448
PETERS-PLUS SYNDROME; PTRPLS	0.008054163999999999	0.30216122663104933
OLIVER SYNDROME	0.008037275	0.301527616369752
1Q44 MICRODELETION SYNDROME	0.008037275	0.301527616369752
FARBER DISEASE	0.00800241	0.3002196157918532
KLEEFSTRA SYNDROME	0.007984689	0.2995547920935614
DDOST-CDG	0.007958999	0.298591002194057
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.007958999	0.298591002194057
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00795139	0.2983055418069286
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00795139	0.2983055418069286
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.00795139	0.2983055418069286
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00795139	0.2983055418069286
RARE HEREDITARY HEMOCHROMATOSIS	0.00795139	0.2983055418069286
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00795139	0.2983055418069286
TREHALASE DEFICIENCY	0.00790581	0.2965955556792755
LACTOSE INTOLERANCE, ADULT TYPE	0.00790581	0.2965955556792755
MEIER-GORLIN SYNDROME 1; MGORS1	0.00789473	0.2961798767346859
MUCOLIPIDOSIS III GAMMA	0.007869455000000001	0.29523165603752854
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00786221	0.29495985152908516
2Q23.1 MICRODUPLICATION SYNDROME	0.00786221	0.29495985152908516
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.007851733999999999	0.2945668323392366
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.007816730000000001	0.2932536170164554
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.007816730000000001	0.2932536170164554
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.007816730000000001	0.2932536170164554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.007816730000000001	0.2932536170164554
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.0077896400000000005	0.29223730450662383
GALACTOSEMIA	0.0077896400000000005	0.29223730450662383
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0077896400000000005	0.29223730450662383
CHYLOMICRON RETENTION DISEASE	0.0077896400000000005	0.29223730450662383
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0077896400000000005	0.29223730450662383
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0077896400000000005	0.29223730450662383
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.0077896400000000005	0.29223730450662383
COLCHICINE POISONING	0.0077896400000000005	0.29223730450662383
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0077896400000000005	0.29223730450662383
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.0077896400000000005	0.29223730450662383
ENTERIC ANENDOCRINOSIS	0.0077896400000000005	0.29223730450662383
CHYLOMICRON RETENTION DISEASE	0.0077896400000000005	0.29223730450662383
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.007747624	0.2906610259384037
HARROD SYNDROME	0.007747624	0.2906610259384037
15Q24 MICRODELETION SYNDROME	0.007747624	0.2906610259384037
1Q21.1 MICRODELETION SYNDROME	0.007747624	0.2906610259384037
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.007721703999999999	0.28968860732434554
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.007706435	0.28911577322642684
OGDEN SYNDROME; OGDNS	0.007706435	0.28911577322642684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.007706435	0.28911577322642684
PSEUDODIASTROPHIC DYSPLASIA	0.007706435	0.28911577322642684
CAP POLYPOSIS	0.007703659999999999	0.2890116659095282
INFANT BOTULISM	0.007703659999999999	0.2890116659095282
WAARDENBURG-SHAH SYNDROME	0.007703659999999999	0.2890116659095282
PERITONEAL CYSTIC MESOTHELIOMA	0.007703659999999999	0.2890116659095282
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.007703659999999999	0.2890116659095282
NEUROENDOCRINE TUMOR OF THE RECTUM	0.007703659999999999	0.2890116659095282
ISAAC SYNDROME	0.00769231	0.28858585760437544
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00769231	0.28858585760437544
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.00769231	0.28858585760437544
PHEOCHROMOCYTOMA	0.00769231	0.28858585760437544
PITUITARY GIGANTISM	0.00769231	0.28858585760437544
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00769231	0.28858585760437544
PACHYONYCHIA CONGENITA	0.00769231	0.28858585760437544
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00769231	0.28858585760437544
PARAGANGLIOMAS 1	0.00769231	0.28858585760437544
BÖÖK SYNDROME	0.00769231	0.28858585760437544
GRANULOSIS RUBRA NASI	0.00769231	0.28858585760437544
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.00769231	0.28858585760437544
X-LINKED ACROGIGANTISM	0.00769231	0.28858585760437544
DIENCEPHALIC SYNDROME	0.00769231	0.28858585760437544
TRANSGREDIENS ET PROGREDIENS PALMOPLANTAR KERATODERMA	0.00769231	0.28858585760437544
MAL DE MELEDA	0.00769231	0.28858585760437544
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.00769231	0.28858585760437544
PARAGANGLIOMAS 3	0.00769231	0.28858585760437544
ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS	0.00769231	0.28858585760437544
PERIPHERAL MOTOR NEUROPATHY-DYSAUTONOMIA SYNDROME	0.00769231	0.28858585760437544
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00769231	0.28858585760437544
STIFF-PERSON SYNDROME; SPS	0.00769231	0.28858585760437544
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00769231	0.28858585760437544
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE	0.00769231	0.28858585760437544
PARAGANGLIOMAS 4	0.00769231	0.28858585760437544
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00769231	0.28858585760437544
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.00769231	0.28858585760437544
NAXOS DISEASE	0.00769231	0.28858585760437544
KERATOLYTIC WINTER ERYTHEMA	0.00769231	0.28858585760437544
HYPERHIDROSIS, GUSTATORY	0.00769231	0.28858585760437544
MAL DE MELEDA	0.00769231	0.28858585760437544
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00769231	0.28858585760437544
PEELING SKIN SYNDROME	0.00769231	0.28858585760437544
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.00769231	0.28858585760437544
PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	0.00769231	0.28858585760437544
ACROKERATOELASTOIDOSIS OF COSTA	0.00769231	0.28858585760437544
PRIMARY SCLEROSING CHOLANGITIS	0.00767833	0.288061381824108
CHOLANGIOCARCINOMA	0.00767833	0.288061381824108
KLATSKIN TUMOR	0.00767833	0.288061381824108
DUBIN-JOHNSON SYNDROME	0.00767833	0.288061381824108
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00767833	0.288061381824108
HALL-RIGGS SYNDROME	0.007671414	0.28780192012909156
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007658949	0.2873342813164282
AORTIC ARCH DEFECTS	0.0076457	0.2868372298419816
MARTSOLF SYNDROME	0.0076457	0.2868372298419816
LEPRECHAUNISM	0.0076457	0.2868372298419816
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00762001	0.28587343994247727
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00762001	0.28587343994247727
CONGENITAL HYPOTHYROIDISM	0.00762001	0.28587343994247727
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.0075874900000000006	0.2846534147368766
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0075874900000000006	0.2846534147368766
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
CYSTINOSIS	0.00756216	0.28370313065145636
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00756216	0.28370313065145636
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007551794	0.28331423823813356
14Q12 MICRODELETION SYNDROME	0.007551794	0.28331423823813356
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.007551794	0.28331423823813356
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00751679	0.2820010229153523
ADULT-ONSET NEMALINE MYOPATHY	0.00751679	0.2820010229153523
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00751679	0.2820010229153523
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00741758	0.2782790456506646
IMMUNODEFICIENCY 57; IMD57	0.0073707	0.2765202885277076
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.0073707	0.2765202885277076
RETICULAR DYSGENESIS	0.0073707	0.2765202885277076
IMMUNODEFICIENCY 22; IMD22	0.0073707	0.2765202885277076
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00734501	0.27555649862820325
YOUNG-ONSET PARKINSON DISEASE	0.00734501	0.27555649862820325
ATTRV30M AMYLOIDOSIS	0.00734501	0.27555649862820325
SATOYOSHI SYNDROME	0.00731968	0.274606214542783
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.007277074	0.27300780144592496
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.007277074	0.27300780144592496
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.007277074	0.27300780144592496
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.007277074	0.27300780144592496
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.007252829000000001	0.27209822238350834
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.007252829000000001	0.27209822238350834
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.007252829000000001	0.27209822238350834
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.007252829000000001	0.27209822238350834
IMMUNODEFICIENCY 37; IMD37	0.007252829000000001	0.27209822238350834
SLC39A8-CDG	0.007252829000000001	0.27209822238350834
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.007252829000000001	0.27209822238350834
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.007252829000000001	0.27209822238350834
224250 DYSMYELINATION WITH JAUNDICE	0.007252829000000001	0.27209822238350834
DESBUQUOIS SYNDROME	0.007206205	0.2703490693950112
CRANIOLENTICULOSUTURAL DYSPLASIA	0.007206205	0.2703490693950112
CATEL-MANZKE SYNDROME	0.007206205	0.2703490693950112
HYPOCHONDROPLASIA	0.007206205	0.2703490693950112
SPONASTRIME DYSPLASIA	0.007206205	0.2703490693950112
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.007206205	0.2703490693950112
ODONTOCHONDRODYSPLASIA	0.007206205	0.2703490693950112
LATERAL MENINGOCELE SYNDROME	0.007206205	0.2703490693950112
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.007206205	0.2703490693950112
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.007206205	0.2703490693950112
FRYNS-SMEETS-THIRY SYNDROME	0.007206205	0.2703490693950112
ACROGERIA	0.007206205	0.2703490693950112
3M SYNDROME	0.007206205	0.2703490693950112
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.007206205	0.2703490693950112
CRANIOFRONTONASAL DYSPLASIA	0.007206205	0.2703490693950112
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.007206205	0.2703490693950112
TRISOMY 20P	0.007206205	0.2703490693950112
CODAS SYNDROME	0.007206205	0.2703490693950112
MULTIMINICORE MYOPATHY	0.007206205	0.2703490693950112
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.007206205	0.2703490693950112
MUCOPOLYSACCHARIDOSIS TYPE 4	0.007206205	0.2703490693950112
COOPER-JABS SYNDROME	0.007206205	0.2703490693950112
SECKEL SYNDROME	0.007206205	0.2703490693950112
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.007206205	0.2703490693950112
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.007163938999999999	0.26876341178923263
GAMMA-HEAVY CHAIN DISEASE	0.0071432200000000005	0.26798611467254013
FAMILIAL THYROID DYSHORMONOGENESIS	0.00711753	0.2670223247730358
IATROGENIC BOTULISM	0.00711753	0.2670223247730358
THYROID HYPOPLASIA	0.00711753	0.2670223247730358
THYROID HEMIAGENESIS	0.00711753	0.2670223247730358
LIDDLE SYNDROME	0.00711753	0.2670223247730358
PANHYPOPITUITARISM	0.00711753	0.2670223247730358
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00704225	0.26419810898344104
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
SARCOSINEMIA	0.00704225	0.26419810898344104
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
W SYNDROME	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.26419810898344104
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
BAKER-GORDON SYNDROME; BAGOS	0.007010374999999999	0.26300228169474105
POPOV-CHANG SYNDROME; POPCHAS	0.007010374999999999	0.26300228169474105
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007010374999999999	0.26300228169474105
AICARDI-GOUTIÈRES SYNDROME	0.006912784	0.2593410430772818
BRANCHIOOCULOFACIAL SYNDROME	0.006856709	0.25723732495292567
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.006761345	0.25365963480203685
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.006761345	0.25365963480203685
2P15P16.1 MICRODELETION SYNDROME	0.006761345	0.25365963480203685
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.006752599	0.25333151855209274
15Q11Q13 MICRODUPLICATION SYNDROME	0.006752599	0.25333151855209274
10Q22.3Q23.3 MICRODELETION SYNDROME	0.006752599	0.25333151855209274
TRISOMY X	0.006752599	0.25333151855209274
THANATOPHORIC DYSPLASIA TYPE 2	0.006752599	0.25333151855209274
THANATOPHORIC DYSPLASIA	0.006752599	0.25333151855209274
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.006752599	0.25333151855209274
DISTAL MONOSOMY 19P13.3	0.006752599	0.25333151855209274
AU-KLINE SYNDROME; AUKS	0.006735655	0.2526958449025325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.006726678999999999	0.25235909993803457
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.006726678999999999	0.25235909993803457
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.006726678999999999	0.25235909993803457
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00671141	0.2517862658401159
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00671141	0.2517862658401159
CYSTIC DISEASE OF LUNG	0.00671141	0.2517862658401159
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00671141	0.2517862658401159
LAZY LEUKOCYTE SYNDROME	0.00671141	0.2517862658401159
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00671141	0.2517862658401159
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00671141	0.2517862658401159
IMMUNODEFICIENCY 32A	0.00671141	0.2517862658401159
RABSON-MENDENHALL SYNDROME	0.00671141	0.2517862658401159
IMMUNODEFICIENCY 52; IMD52	0.00671141	0.2517862658401159
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.00671141	0.2517862658401159
MACROCEPHALY/AUTISM SYNDROME	0.00671141	0.2517862658401159
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00671141	0.2517862658401159
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.00671141	0.2517862658401159
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.00671141	0.2517862658401159
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00671141	0.2517862658401159
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00671141	0.2517862658401159
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00671141	0.2517862658401159
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00671141	0.2517862658401159
VELOCARDIOFACIAL SYNDROME	0.00671141	0.2517862658401159
TUFTSIN DEFICIENCY	0.00671141	0.2517862658401159
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00671141	0.2517862658401159
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00671141	0.2517862658401159
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.00671141	0.2517862658401159
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00671141	0.2517862658401159
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.00671141	0.2517862658401159
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00671141	0.2517862658401159
IDIOPATHIC APLASTIC ANEMIA	0.00671141	0.2517862658401159
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00671141	0.2517862658401159
IMMUNODEFICIENCY 9; IMD9	0.00671141	0.2517862658401159
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00671141	0.2517862658401159
SYNDROMIC DIARRHEA	0.00671141	0.2517862658401159
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00671141	0.2517862658401159
UROCANIC ACIDURIA	0.00671141	0.2517862658401159
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.00671141	0.2517862658401159
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.00671141	0.2517862658401159
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00671141	0.2517862658401159
GRISCELLI SYNDROME TYPE 2	0.006676389	0.2504724127427806
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.006676389	0.2504724127427806
MULTIPLE CARBOXYLASE DEFICIENCY	0.006676389	0.2504724127427806
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.006676389	0.2504724127427806
EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	0.00662252	0.24845145524584017
CONGENITAL FACTOR V DEFICIENCY	0.00662252	0.24845145524584017
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00662252	0.24845145524584017
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.00662252	0.24845145524584017
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION	0.00662252	0.24845145524584017
THROMBOCYTOPENIA 5; THC5	0.00662252	0.24845145524584017
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00662252	0.24845145524584017
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.00662252	0.24845145524584017
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00662252	0.24845145524584017
FANCONI ANEMIA	0.00662252	0.24845145524584017
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00662252	0.24845145524584017
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00662252	0.24845145524584017
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00662252	0.24845145524584017
FACTOR V DEFICIENCY	0.00662252	0.24845145524584017
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00662252	0.24845145524584017
FECHTNER SYNDROME	0.00662252	0.24845145524584017
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00662252	0.24845145524584017
IMMUNE THROMBOCYTOPENIC PURPURA	0.00662252	0.24845145524584017
ACQUIRED VON WILLEBRAND SYNDROME	0.00662252	0.24845145524584017
PLASMIN INHIBITOR DEFICIENCY	0.00662252	0.24845145524584017
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00662252	0.24845145524584017
EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTINABNORMALITY	0.00662252	0.24845145524584017
BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	0.00662252	0.24845145524584017
CONGENITAL FACTOR VII DEFICIENCY	0.00662252	0.24845145524584017
BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	0.00662252	0.24845145524584017
GRAY PLATELET SYNDROME	0.00662252	0.24845145524584017
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00662252	0.24845145524584017
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00662252	0.24845145524584017
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00662252	0.24845145524584017
THROMBOCYTOPENIA 2	0.00662252	0.24845145524584017
CONGENITAL PROTHROMBIN DEFICIENCY	0.00662252	0.24845145524584017
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00662252	0.24845145524584017
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00662252	0.24845145524584017
FACTOR XIII, B SUBUNIT, DEFICIENCY OF	0.00662252	0.24845145524584017
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.00662252	0.24845145524584017
HEMOPHILIA A WITH VASCULAR ABNORMALITY	0.00662252	0.24845145524584017
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00662252	0.24845145524584017
HEMOPHILIA A	0.00662252	0.24845145524584017
BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	0.00662252	0.24845145524584017
FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF	0.00662252	0.24845145524584017
EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	0.00662252	0.24845145524584017
ARTERIAL TORTUOSITY SYNDROME	0.00662252	0.24845145524584017
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00662252	0.24845145524584017
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.00662252	0.24845145524584017
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00662252	0.24845145524584017
GLANZMANN THROMBASTHENIA	0.00662252	0.24845145524584017
CONGENITAL FACTOR X DEFICIENCY	0.00662252	0.24845145524584017
176630 PRIMARY RELEASE DISORDER OF PLATELETS	0.00662252	0.24845145524584017
CONGENITAL FACTOR XIII DEFICIENCY	0.00662252	0.24845145524584017
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00662252	0.24845145524584017
MYH9-RELATED DISEASE	0.00662252	0.24845145524584017
%605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12;;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 DEFICIENCY, PLATELET;;PGHS1 DEFICIENCY;;PLATELET CYCLOOXYGENASE 1 DEFICIENCY;;PLATELET COX1 DEFICIENCY	0.00662252	0.24845145524584017
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00662252	0.24845145524584017
PURPURA SIMPLEX	0.00662252	0.24845145524584017
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00662252	0.24845145524584017
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.00662252	0.24845145524584017
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00662252	0.24845145524584017
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00662252	0.24845145524584017
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.006607679	0.24789467806022145
BETA-THALASSEMIA MAJOR	0.00657449	0.2466495545501144
GENITOPATELLAR SYNDROME	0.006556769	0.2459847308518226
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.006556769	0.2459847308518226
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.006556769	0.2459847308518226
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.006556769	0.2459847308518226
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.006556769	0.2459847308518226
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.006556769	0.2459847308518226
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.006556769	0.2459847308518226
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00651772	0.24451976270134596
LAING EARLY-ONSET DISTAL MYOPATHY	0.006342615	0.2379504972146697
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.006342615	0.2379504972146697
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.006342615	0.2379504972146697
PURE MITOCHONDRIAL MYOPATHY	0.006342615	0.2379504972146697
BASAL CELL NEVUS SYNDROME	0.006342615	0.2379504972146697
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.006342615	0.2379504972146697
MYOPATHY, DISTAL, 1; MPD1	0.006342615	0.2379504972146697
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.0063152899999999994	0.2369253684095332
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.006307739	0.23664208395911837
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.006282049	0.235678294059614
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006282049	0.235678294059614
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006282049	0.235678294059614
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006282049	0.235678294059614
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.006256718999999999	0.23472800997419377
COCKAYNE SYNDROME	0.006256718999999999	0.23472800997419377
BRACHYDACTYLY TYPE E	0.00621118	0.23301956200870022
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00621118	0.23301956200870022
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00621118	0.23301956200870022
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00621118	0.23301956200870022
16P13.11 MICRODUPLICATION SYNDROME	0.00621118	0.23301956200870022
TEMTAMY SYNDROME	0.00621118	0.23301956200870022
THORACOMELIC DYSPLASIA	0.00621118	0.23301956200870022
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00621118	0.23301956200870022
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00621118	0.23301956200870022
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00621118	0.23301956200870022
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.00621118	0.23301956200870022
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00621118	0.23301956200870022
NAIL-PATELLA SYNDROME	0.00621118	0.23301956200870022
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.00621118	0.23301956200870022
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00621118	0.23301956200870022
GRANT SYNDROME	0.00621118	0.23301956200870022
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00621118	0.23301956200870022
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00621118	0.23301956200870022
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00621118	0.23301956200870022
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00621118	0.23301956200870022
COENZYME Q10 DEFICIENCY	0.00621118	0.23301956200870022
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00621118	0.23301956200870022
ALDH18A1-RELATED DE BARSY SYNDROME	0.00621118	0.23301956200870022
AUTOSOMAL DOMINANT CUTIS LAXA	0.00621118	0.23301956200870022
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00621118	0.23301956200870022
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00621118	0.23301956200870022
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00621118	0.23301956200870022
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00621118	0.23301956200870022
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00621118	0.23301956200870022
SHORT SYNDROME	0.00621118	0.23301956200870022
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00621118	0.23301956200870022
SCARF SYNDROME	0.00621118	0.23301956200870022
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00621118	0.23301956200870022
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00618526	0.2320471433946421
LARYNGOTRACHEAL ANGIOMA	0.00618526	0.2320471433946421
ATRESIA OF SMALL INTESTINE	0.00618526	0.2320471433946421
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00618526	0.2320471433946421
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.00618526	0.2320471433946421
ISOLATED COMPLEX I DEFICIENCY	0.00618526	0.2320471433946421
17Q24.2 MICRODELETION SYNDROME	0.006174783999999999	0.23165412420479362
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.006174783999999999	0.23165412420479362
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.006174783999999999	0.23165412420479362
16Q24.3 MICRODELETION SYNDROME	0.006174783999999999	0.23165412420479362
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.006174783999999999	0.23165412420479362
HYDATIDIFORM MOLE	0.00613497	0.23016045619938816
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.23016045619938816
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00613497	0.23016045619938816
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00613497	0.23016045619938816
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.00613497	0.23016045619938816
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.23016045619938816
WOLMAN DISEASE	0.00613497	0.23016045619938816
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00606626	0.227582721516829
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.006015349999999999	0.22567277430843008
16P11.2P12.2 MICRODELETION SYNDROME	0.006015349999999999	0.22567277430843008
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.006015349999999999	0.22567277430843008
MEIER-GORLIN SYNDROME 5; MGORS5	0.006015349999999999	0.22567277430843008
ISOTRETINOIN-LIKE SYNDROME	0.006015349999999999	0.22567277430843008
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.006015349999999999	0.22567277430843008
SENGERS SYNDROME	0.00601524	0.2256686475319044
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.005917759	0.2220115356909708
PARIETAL FORAMINA	0.005917759	0.2220115356909708
ABETA AMYLOIDOSIS, DUTCH TYPE	0.005917759	0.2220115356909708
PINEOBLASTOMA	0.005917759	0.2220115356909708
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.005917759	0.2220115356909708
NEUROFIBROMATOSIS, TYPE II	0.005917759	0.2220115356909708
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.005917759	0.2220115356909708
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.005917759	0.2220115356909708
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.005917759	0.2220115356909708
SNEDDON SYNDROME	0.005917759	0.2220115356909708
ROSAÏ-DORFMAN DISEASE	0.005917759	0.2220115356909708
NARP SYNDROME	0.005917759	0.2220115356909708
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.005917759	0.2220115356909708
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.005917759	0.2220115356909708
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.005889009000000001	0.22093294637175126
MICROPHTHALMIA, SYNDROMIC 1	0.005889009000000001	0.22093294637175126
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.005889009000000001	0.22093294637175126
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.005889009000000001	0.22093294637175126
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.005889009000000001	0.22093294637175126
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.005889009000000001	0.22093294637175126
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.005889009000000001	0.22093294637175126
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.005889009000000001	0.22093294637175126
WARBURG MICRO SYNDROME 3; WARBM3	0.005889009000000001	0.22093294637175126
INCONTINENTIA PIGMENTI; IP	0.005889009000000001	0.22093294637175126
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005889009000000001	0.22093294637175126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.005889009000000001	0.22093294637175126
HYPEREKPLEXIA 4; HKPX4	0.005889009000000001	0.22093294637175126
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.005889009000000001	0.22093294637175126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.005889009000000001	0.22093294637175126
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00576632	0.21633012741572588
LOCKED-IN SYNDROME	0.00576632	0.21633012741572588
CHOANAL ATRESIA	0.00576632	0.21633012741572588
19Q13.11 MICRODELETION SYNDROME	0.00576632	0.21633012741572588
OROFACIODIGITAL SYNDROME TYPE 4	0.00576632	0.21633012741572588
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.21536633751622153
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00574063	0.21536633751622153
COFFIN-SIRIS SYNDROME 7; CSS7	0.00574063	0.21536633751622153
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00574063	0.21536633751622153
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.21536633751622153
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00574063	0.21536633751622153
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0057152999999999995	0.21441605343080128
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0057152999999999995	0.21441605343080128
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0056333649999999996	0.21134216766140113
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.005585024000000001	0.20952859944295277
SHASHI-PENA SYNDROME; SHAPNS	0.005585024000000001	0.20952859944295277
JOUBERT SYNDROME	0.005585024000000001	0.20952859944295277
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.005585024000000001	0.20952859944295277
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.005585024000000001	0.20952859944295277
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.005585024000000001	0.20952859944295277
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.005400315	0.20259902884943184
CZECH DYSPLASIA, METATARSAL TYPE	0.005400315	0.20259902884943184
PSEUDOACHONDROPLASIA	0.005400315	0.20259902884943184
PYLE DISEASE; PYL	0.005400315	0.20259902884943184
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.005400315	0.20259902884943184
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.005400315	0.20259902884943184
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.005400315	0.20259902884943184
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.005400315	0.20259902884943184
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005382594	0.20193420515114002
TEMPI SYNDROME	0.00537634	0.2016995791475783
SOLAR URTICARIA	0.00537634	0.2016995791475783
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.2016995791475783
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.2016995791475783
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.2016995791475783
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00537634	0.2016995791475783
HYDROXYKYNURENINURIA	0.00537634	0.2016995791475783
CROUZON DISEASE	0.00537634	0.2016995791475783
PITUITARY CARCINOMA	0.00537634	0.2016995791475783
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.2016995791475783
SCLEROSTEOSIS 1; SOST1	0.00537634	0.2016995791475783
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.2016995791475783
ADENOHYPOPHYSITIS	0.00537634	0.2016995791475783
PANHYPOPHYSITIS	0.00537634	0.2016995791475783
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.2016995791475783
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.2016995791475783
SECONDARY POLYCYTHEMIA	0.00537634	0.2016995791475783
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.2016995791475783
MANGANESE POISONING	0.00537634	0.2016995791475783
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.2016995791475783
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.2016995791475783
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.2016995791475783
INTERNAL CAROTID AGENESIS	0.00537634	0.2016995791475783
X-LINKED ADRENOLEUKODYSTROPHY	0.00537634	0.2016995791475783
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.2016995791475783
SYDENHAM CHOREA	0.00537634	0.2016995791475783
SCHOLTE SYNDROME; SHLTS	0.00534759	0.20062098982835874
MYOPATHY AND DIABETES MELLITUS	0.00534759	0.20062098982835874
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00534759	0.20062098982835874
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00534759	0.20062098982835874
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00534759	0.20062098982835874
CARPENTER SYNDROME	0.00534759	0.20062098982835874
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00534759	0.20062098982835874
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00534759	0.20062098982835874
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00534759	0.20062098982835874
CENTRAL CORE DISEASE	0.00534759	0.20062098982835874
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00534759	0.20062098982835874
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00534759	0.20062098982835874
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00534759	0.20062098982835874
PROTEUS SYNDROME	0.00534759	0.20062098982835874
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.00534759	0.20062098982835874
TUBULAR AGGREGATE MYOPATHY	0.00534759	0.20062098982835874
NEUROFIBROMA	0.00534759	0.20062098982835874
MENTAL RETARDATION, X-LINKED 19	0.00534759	0.20062098982835874
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00534759	0.20062098982835874
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00534759	0.20062098982835874
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00534759	0.20062098982835874
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00534759	0.20062098982835874
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00534759	0.20062098982835874
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00534759	0.20062098982835874
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00534759	0.20062098982835874
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00534759	0.20062098982835874
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00534759	0.20062098982835874
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00534759	0.20062098982835874
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00534759	0.20062098982835874
MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	0.00534759	0.20062098982835874
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00534759	0.20062098982835874
PRIMARY DYSTONIA, DYT4 TYPE	0.00534759	0.20062098982835874
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00534759	0.20062098982835874
PRIMARY ORTHOSTATIC TREMOR	0.00534759	0.20062098982835874
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.00534759	0.20062098982835874
PYOMYOSITIS	0.00534759	0.20062098982835874
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00534759	0.20062098982835874
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00534759	0.20062098982835874
RAHMAN SYNDROME	0.00534759	0.20062098982835874
COG1-CDG	0.00534759	0.20062098982835874
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00534759	0.20062098982835874
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00534759	0.20062098982835874
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00534759	0.20062098982835874
DYSSPONDYLOENCHONDROMATOSIS	0.00534759	0.20062098982835874
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00534759	0.20062098982835874
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00534759	0.20062098982835874
RICHIERI COSTA-DA SILVA SYNDROME	0.00534759	0.20062098982835874
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00534759	0.20062098982835874
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00534759	0.20062098982835874
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.00534759	0.20062098982835874
DK1-CDG	0.00534759	0.20062098982835874
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00534759	0.20062098982835874
SECKEL SYNDROME 8; SCKL8	0.00534759	0.20062098982835874
PRIMARY LIPODYSTROPHY	0.00534759	0.20062098982835874
OROFACIODIGITAL SYNDROME XI; OFD11	0.00534759	0.20062098982835874
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.00534759	0.20062098982835874
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00534759	0.20062098982835874
3Q27.3 MICRODELETION SYNDROME	0.00534759	0.20062098982835874
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00534759	0.20062098982835874
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00534759	0.20062098982835874
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00534759	0.20062098982835874
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00534759	0.20062098982835874
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.00534759	0.20062098982835874
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00534759	0.20062098982835874
ACROOTOOCULAR SYNDROME	0.00534759	0.20062098982835874
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00534759	0.20062098982835874
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00534759	0.20062098982835874
DISTAL MYOPATHY, TATEYAMA TYPE	0.00534759	0.20062098982835874
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.00534759	0.20062098982835874
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00534759	0.20062098982835874
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00534759	0.20062098982835874
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00534759	0.20062098982835874
DYSTROPHIA MYOTONICA 2	0.00534759	0.20062098982835874
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00534759	0.20062098982835874
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00534759	0.20062098982835874
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00534759	0.20062098982835874
FOCAL MYOSITIS	0.00534759	0.20062098982835874
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00534759	0.20062098982835874
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00534759	0.20062098982835874
DYSTONIA, JUVENILE-ONSET	0.00534759	0.20062098982835874
YOU-HOOVER-FONG SYNDROME; YHFS	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00534759	0.20062098982835874
MCDONOUGH SYNDROME	0.00534759	0.20062098982835874
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.00534759	0.20062098982835874
MYOTONIA, POTASSIUM-AGGRAVATED	0.00534759	0.20062098982835874
LARSEN-LIKE SYNDROME	0.00534759	0.20062098982835874
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00534759	0.20062098982835874
MYOTILINOPATHY	0.00534759	0.20062098982835874
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00534759	0.20062098982835874
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00534759	0.20062098982835874
NEUTRAL LIPID STORAGE MYOPATHY	0.00534759	0.20062098982835874
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00534759	0.20062098982835874
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00534759	0.20062098982835874
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.00534759	0.20062098982835874
MONOSOMY 18P	0.00534759	0.20062098982835874
CAMPOMELIC DYSPLASIA	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00534759	0.20062098982835874
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00534759	0.20062098982835874
ANE SYNDROME	0.00534759	0.20062098982835874
%109500 BASILAR IMPRESSION, PRIMARY	0.00534759	0.20062098982835874
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.005179758999999999	0.19432461681848262
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.005179758999999999	0.19432461681848262
11Q22.2Q22.3 MICRODELETION SYNDROME	0.005179758999999999	0.19432461681848262
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.005179758999999999	0.19432461681848262
WOLF-HIRSCHHORN SYNDROME	0.005133564	0.1925915582584358
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.005127255	0.1923548688666112
HOLOPROSENCEPHALY 2; HPE2	0.005107874	0.19162776835893144
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.005107874	0.19162776835893144
ATYPICAL JUVENILE PARKINSONISM	0.005082544	0.1906774842735112
OCULOFACIOCARDIODENTAL SYNDROME	0.0050436050000000005	0.18921664289956025
GOLDENHAR SYNDROME	0.0050436050000000005	0.18921664289956025
ALLAN-HERNDON-DUDLEY SYNDROME	0.0050436050000000005	0.18921664289956025
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0050436050000000005	0.18921664289956025
NEMALINE MYOPATHY 3; NEM3	0.0050436050000000005	0.18921664289956025
CAFFEY DISEASE	0.0050436050000000005	0.18921664289956025
FREEMAN-SHELDON SYNDROME	0.0050436050000000005	0.18921664289956025
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.005011085	0.18799661769395953
ACQUIRED PARTIAL LIPODYSTROPHY	0.0049467090000000005	0.18558147800651337
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.0049467090000000005	0.18558147800651337
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.004841175	0.18162224860774753
LYMPHEDEMA, HEREDITARY, III	0.004841175	0.18162224860774753
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.004841175	0.18162224860774753
CRANIOLENTICULOSUTURAL DYSPLASIA	0.004841175	0.18162224860774753
17P11.2 MICRODUPLICATION SYNDROME	0.004841175	0.18162224860774753
17Q23.1Q23.2 MICRODELETION SYNDROME	0.004841175	0.18162224860774753
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.004841175	0.18162224860774753
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0046383399999999995	0.1740126602750902
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0046383399999999995	0.1740126602750902
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.004592145000000001	0.17227960171504333
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.004592145000000001	0.17227960171504333
HURLER-SCHEIE SYNDROME	0.004592145000000001	0.17227960171504333
OPSISMODYSPLASIA; OPSMD	0.004592145000000001	0.17227960171504333
MUCOPOLYSACCHARIDOSIS TYPE 7	0.004592145000000001	0.17227960171504333
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.004592145000000001	0.17227960171504333
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.004592145000000001	0.17227960171504333
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004589999000000001	0.1721990920566418
BOWEN-CONRADI SYNDROME	0.004589999000000001	0.1721990920566418
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004589999000000001	0.1721990920566418
2Q33.1 DELETION SYNDROME	0.004589999000000001	0.1721990920566418
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.004589999000000001	0.1721990920566418
PEHO SYNDROME; PEHO	0.004589999000000001	0.1721990920566418
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.004589999000000001	0.1721990920566418
NON-DISTAL MONOSOMY 20Q	0.004589999000000001	0.1721990920566418
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.004589999000000001	0.1721990920566418
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004589999000000001	0.1721990920566418
21Q22.11Q22.12 MICRODELETION SYNDROME	0.004589999000000001	0.1721990920566418
OROFACIODIGITAL SYNDROME TYPE 6	0.004589999000000001	0.1721990920566418
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.004589999000000001	0.1721990920566418
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004589999000000001	0.1721990920566418
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004589999000000001	0.1721990920566418
OHDO SYNDROME	0.004589999000000001	0.1721990920566418
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004589999000000001	0.1721990920566418
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004589999000000001	0.1721990920566418
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004589999000000001	0.1721990920566418
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.004589999000000001	0.1721990920566418
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004589999000000001	0.1721990920566418
ACROCARDIOFACIAL SYNDROME	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.004589999000000001	0.1721990920566418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.004589999000000001	0.1721990920566418
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004589999000000001	0.1721990920566418
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.004589999000000001	0.1721990920566418
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.004589999000000001	0.1721990920566418
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004589999000000001	0.1721990920566418
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.0045664550000000005	0.17131581181553898
HISTIOCYTOID CARDIOMYOPATHY	0.004557479	0.17097906685104103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.004557479	0.17097906685104103
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.004557479	0.17097906685104103
INFANTILE LIVER FAILURE SYNDROME 2	0.004557479	0.17097906685104103
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004557479	0.17097906685104103
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.004557479	0.17097906685104103
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.004557479	0.17097906685104103
KRABBE DISEASE	0.004557479	0.17097906685104103
CITRULLINEMIA, CLASSIC	0.004557479	0.17097906685104103
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.004557479	0.17097906685104103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.004557479	0.17097906685104103
DEND SYNDROME	0.004557479	0.17097906685104103
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.004557479	0.17097906685104103
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004557479	0.17097906685104103
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004557479	0.17097906685104103
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.004557479	0.17097906685104103
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.004541125	0.17036552773011873
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00440529	0.16526952146312088
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00440529	0.16526952146312088
CHILBLAIN LUPUS 1	0.00440529	0.16526952146312088
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.16526952146312088
LOWRY-WOOD SYNDROME	0.00440529	0.16526952146312088
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	0.00440529	0.16526952146312088
LEDDERHOSE DISEASE	0.00440529	0.16526952146312088
EIKEN SYNDROME	0.00440529	0.16526952146312088
PANDAS	0.00440529	0.16526952146312088
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00440529	0.16526952146312088
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00440529	0.16526952146312088
ALKAPTONURIA	0.00440529	0.16526952146312088
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00440529	0.16526952146312088
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.16526952146312088
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00440529	0.16526952146312088
BLAU SYNDROME	0.00440529	0.16526952146312088
COMPLEMENT COMPONENT C1R DEFICIENCY	0.00440529	0.16526952146312088
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00440529	0.16526952146312088
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00440529	0.16526952146312088
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.00440529	0.16526952146312088
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00440529	0.16526952146312088
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00440529	0.16526952146312088
WELLS SYNDROME	0.00440529	0.16526952146312088
NEURALGIC AMYOTROPHY	0.00440529	0.16526952146312088
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00440529	0.16526952146312088
UPINGTON DISEASE	0.00440529	0.16526952146312088
RELAPSING POLYCHONDRITIS	0.00440529	0.16526952146312088
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.00440529	0.16526952146312088
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.16526952146312088
OSTEOCHONDRITIS DISSECANS	0.00440529	0.16526952146312088
HAND OSTEOARTHRITIS	0.00440529	0.16526952146312088
SAGLIKER SYNDROME	0.00440529	0.16526952146312088
LEGG-CALVÉ-PERTHES DISEASE	0.00440529	0.16526952146312088
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00440529	0.16526952146312088
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00440529	0.16526952146312088
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.16526952146312088
UPINGTON DISEASE	0.00440529	0.16526952146312088
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2	0.00440529	0.16526952146312088
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.00440529	0.16526952146312088
SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	0.00440529	0.16526952146312088
HEMOPHILIA A	0.00440529	0.16526952146312088
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00440529	0.16526952146312088
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.004387569	0.16460469776482906
ATYPICAL RETT SYNDROME	0.004387569	0.16460469776482906
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.004387569	0.16460469776482906
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.004387569	0.16460469776482906
HADDAD SYNDROME	0.004387569	0.16460469776482906
1Q21.1 MICRODUPLICATION SYNDROME	0.004387569	0.16460469776482906
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.004387569	0.16460469776482906
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004387569	0.16460469776482906
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.004387569	0.16460469776482906
SEVERE CANAVAN DISEASE	0.004387569	0.16460469776482906
WEBB-DATTANI SYNDROME; WEDAS	0.004387569	0.16460469776482906
FRYNS SYNDROME	0.004387569	0.16460469776482906
FRAGILE X SYNDROME	0.004387569	0.16460469776482906
HEREDITARY HYPEREKPLEXIA	0.004387569	0.16460469776482906
HEART AND BRAIN MALFORMATION SYNDROME	0.004387569	0.16460469776482906
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.004387569	0.16460469776482906
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004314999	0.16188215074236773
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.004314999	0.16188215074236773
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.004314999	0.16188215074236773
CEREBROTENDINOUS XANTHOMATOSIS	0.004314999	0.16188215074236773
ETHYLMALONIC ENCEPHALOPATHY	0.004314999	0.16188215074236773
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.004314999	0.16188215074236773
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.004314999	0.16188215074236773
BETA-MANNOSIDOSIS	0.004138539	0.15526205087212483
HENNEKAM SYNDROME	0.004138539	0.15526205087212483
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.004138539	0.15526205087212483
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004138539	0.15526205087212483
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.004138539	0.15526205087212483
ALSTRÖM SYNDROME	0.004138539	0.15526205087212483
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.004138539	0.15526205087212483
SANDHOFF DISEASE	0.004138539	0.15526205087212483
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.004138539	0.15526205087212483
LIPOID PROTEINOSIS	0.004138539	0.15526205087212483
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.004138539	0.15526205087212483
TETRASOMY 5P	0.004138539	0.15526205087212483
TAY-SACHS DISEASE	0.004138539	0.15526205087212483
ATAXIA-TELANGIECTASIA	0.004138539	0.15526205087212483
VICI SYNDROME; VICIS	0.004138539	0.15526205087212483
SANJAD-SAKATI SYNDROME	0.004138539	0.15526205087212483
FREE SIALIC ACID STORAGE DISEASE	0.004138539	0.15526205087212483
HEREDITARY ELLIPTOCYTOSIS	0.00413223	0.15502536148030024
GCGR-RELATED HYPERGLUCAGONEMIA	0.00413223	0.15502536148030024
KETAMINE-INDUCED BILIARY DILATATION	0.00413223	0.15502536148030024
HEREDITARY CHRONIC PANCREATITIS	0.00413223	0.15502536148030024
PLUMMER-VINSON SYNDROME	0.00413223	0.15502536148030024
OVARIAN FIBROMA	0.00413223	0.15502536148030024
OVARIAN FIBROTHECOMA	0.00413223	0.15502536148030024
PEUTZ-JEGHERS SYNDROME	0.00413223	0.15502536148030024
OVARIAN HYPERSTIMULATION SYNDROME	0.00413223	0.15502536148030024
EPIDERMOLYSIS BULLOSA ACQUISITA	0.00413223	0.15502536148030024
HEREDITARY ANGIOEDEMA	0.00413223	0.15502536148030024
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00413223	0.15502536148030024
INFUNDIBULOPELVIC DYSGENESIS	0.00413223	0.15502536148030024
MYXOID/ROUND CELL LIPOSARCOMA	0.00413223	0.15502536148030024
NEUROENDOCRINE TUMOR OF THE COLON	0.00413223	0.15502536148030024
ACQUIRED ANGIOEDEMA	0.00413223	0.15502536148030024
TROPICAL CALCIFIC PANCREATITIS	0.00413223	0.15502536148030024
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.00413223	0.15502536148030024
FAMILIAL PROGRESSIVE CARDIAC CONDUCTION DEFECT	0.00413223	0.15502536148030024
TANGIER DISEASE	0.00413223	0.15502536148030024
ROTOR SYNDROME	0.00413223	0.15502536148030024
JUVENILE POLYPOSIS OF INFANCY	0.00413223	0.15502536148030024
CARNEY-STRATAKIS SYNDROME	0.00413223	0.15502536148030024
HEPATIC VENO-OCCLUSIVE DISEASE	0.00413223	0.15502536148030024
INFLAMMATORY BOWEL DISEASE 11	0.00413223	0.15502536148030024
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00413223	0.15502536148030024
CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENTOF DIAPHRAGM	0.00413223	0.15502536148030024
SICKLE CELL ANEMIA	0.00413223	0.15502536148030024
ALPHA-HEAVY CHAIN DISEASE	0.00413223	0.15502536148030024
BUDD-CHIARI SYNDROME	0.00413223	0.15502536148030024
HEMOCHROMATOSIS, TYPE 1	0.00413223	0.15502536148030024
PRIMARY EFFUSION LYMPHOMA	0.00413223	0.15502536148030024
NEPHROBLASTOMA	0.00413223	0.15502536148030024
MALIGNANT PERITONEAL MESOTHELIOMA	0.00413223	0.15502536148030024
GONADOBLASTOMA	0.00413223	0.15502536148030024
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00413223	0.15502536148030024
TETANUS	0.00413223	0.15502536148030024
PANCREATITIS, HEREDITARY	0.00413223	0.15502536148030024
POLYEMBRYOMA	0.00413223	0.15502536148030024
TEMPLE-BARAITSER SYNDROME	0.004112849	0.15429826097262048
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262048
TRISOMY 8P	0.004112849	0.15429826097262048
9Q33.3Q34.11 MICRODELETION SYNDROME	0.004112849	0.15429826097262048
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004112849	0.15429826097262048
MOWAT-WILSON SYNDROME	0.004112849	0.15429826097262048
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262048
2Q23.1 MICRODELETION SYNDROME	0.004112849	0.15429826097262048
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0040875189999999995	0.15334797688720023
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0040875189999999995	0.15334797688720023
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0040875189999999995	0.15334797688720023
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0040875189999999995	0.15334797688720023
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.0040875189999999995	0.15334797688720023
RING CHROMOSOME 1 SYNDROME	0.00404858	0.15188713551324928
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.15188713551324928
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00404858	0.15188713551324928
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.15188713551324928
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.15188713551324928
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.15188713551324928
MOEBIUS SYNDROME	0.00404858	0.15188713551324928
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.15188713551324928
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00404858	0.15188713551324928
MYOTONIC DYSTROPHY 1	0.00404858	0.15188713551324928
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00404858	0.15188713551324928
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.15188713551324928
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.15188713551324928
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.00404858	0.15188713551324928
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.15188713551324928
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00404858	0.15188713551324928
AICARDI-GOUTIERES SYNDROME 5	0.00404858	0.15188713551324928
PEMPHIGUS VULGARIS	0.00404858	0.15188713551324928
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.15188713551324928
APERT SYNDROME	0.00404858	0.15188713551324928
PIERRE ROBIN SYNDROME	0.00404858	0.15188713551324928
JEUNE SYNDROME	0.00404858	0.15188713551324928
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00404858	0.15188713551324928
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.15188713551324928
MOEBIUS SYNDROME; MBS	0.00404858	0.15188713551324928
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.15188713551324928
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.15188713551324928
PETERS PLUS SYNDROME	0.00404858	0.15188713551324928
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.15188713551324928
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00404858	0.15188713551324928
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00404858	0.15188713551324928
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.15066711030764857
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.15066711030764857
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.15066711030764857
LESCH-NYHAN SYNDROME; LNS	0.00401606	0.15066711030764857
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00401606	0.15066711030764857
GALACTOSE EPIMERASE DEFICIENCY	0.00401606	0.15066711030764857
VALINEMIA	0.00401606	0.15066711030764857
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.15066711030764857
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00401606	0.15066711030764857
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00401606	0.15066711030764857
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.15066711030764857
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00401606	0.15066711030764857
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.15066711030764857
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.15066711030764857
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.15066711030764857
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.15066711030764857
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00401606	0.15066711030764857
MUCOPOLYSACCHARIDOSIS TYPE 3	0.0040055839999999995	0.15027409111780007
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0040055839999999995	0.15027409111780007
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.0040055839999999995	0.15027409111780007
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0040055839999999995	0.15027409111780007
FOUNTAIN SYNDROME	0.0040055839999999995	0.15027409111780007
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0040055839999999995	0.15027409111780007
SJÖGREN-LARSSON SYNDROME	0.0040055839999999995	0.15027409111780007
TARP SYNDROME	0.0040055839999999995	0.15027409111780007
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0040055839999999995	0.15027409111780007
19P13.12 MICRODELETION SYNDROME	0.0040055839999999995	0.15027409111780007
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.0040055839999999995	0.15027409111780007
SWEENEY-COX SYNDROME; SWCOS	0.00384615	0.1442927412214366
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00384615	0.1442927412214366
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.1442927412214366
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00384615	0.1442927412214366
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.1442927412214366
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00384615	0.1442927412214366
8Q12 MICRODUPLICATION SYNDROME	0.00384615	0.1442927412214366
GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00384615	0.1442927412214366
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00384615	0.1442927412214366
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.1442927412214366
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00384615	0.1442927412214366
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00384615	0.1442927412214366
TOWNES-BROCKS SYNDROME 1; TBS1	0.00384615	0.1442927412214366
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00384615	0.1442927412214366
DIARRHEA 9; DIAR9	0.00377358	0.14157019419897524
RAPADILINO SYNDROME	0.00377358	0.14157019419897524
INTESTINAL LYMPHANGIECTASIA	0.00377358	0.14157019419897524
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00377358	0.14157019419897524
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00377358	0.14157019419897524
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00377358	0.14157019419897524
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00377358	0.14157019419897524
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.00377358	0.14157019419897524
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.00377358	0.14157019419897524
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00377358	0.14157019419897524
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.00377358	0.14157019419897524
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00377358	0.14157019419897524
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00377358	0.14157019419897524
TRICHOHEPATOENTERIC SYNDROME 2	0.00377358	0.14157019419897524
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00377358	0.14157019419897524
MICROVILLUS INCLUSION DISEASE	0.00377358	0.14157019419897524
GLYCOGEN STORAGE DISEASE IXB	0.00377358	0.14157019419897524
ENTEROKINASE DEFICIENCY	0.00377358	0.14157019419897524
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00377358	0.14157019419897524
MITCHELL-RILEY SYNDROME; MTCHRS	0.00377358	0.14157019419897524
LACTASE DEFICIENCY, CONGENITAL	0.00377358	0.14157019419897524
ADULT INTESTINAL BOTULISM	0.00377358	0.14157019419897524
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00377358	0.14157019419897524
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00377358	0.14157019419897524
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00377358	0.14157019419897524
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00377358	0.14157019419897524
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00377358	0.14157019419897524
CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL	0.00377358	0.14157019419897524
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00377358	0.14157019419897524
PIERPONT SYNDROME	0.0037056439999999997	0.13902149701669697
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0037056439999999997	0.13902149701669697
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0037056439999999997	0.13902149701669697
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0037056439999999997	0.13902149701669697
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0037056439999999997	0.13902149701669697
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0037056439999999997	0.13902149701669697
KBG SYNDROME	0.0037056439999999997	0.13902149701669697
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0037056439999999997	0.13902149701669697
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0037056439999999997	0.13902149701669697
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0037056439999999997	0.13902149701669697
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0037056439999999997	0.13902149701669697
COFFIN-SIRIS SYNDROME 4; CSS4	0.0037056439999999997	0.13902149701669697
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0037056439999999997	0.13902149701669697
WIEACKER-WOLFF SYNDROME	0.0037056439999999997	0.13902149701669697
COFFIN-SIRIS SYNDROME 3; CSS3	0.0037056439999999997	0.13902149701669697
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0037056439999999997	0.13902149701669697
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0037056439999999997	0.13902149701669697
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0037056439999999997	0.13902149701669697
JOUBERT SYNDROME WITH RENAL DEFECT	0.0037056439999999997	0.13902149701669697
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.00359712	0.13495009432873234
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00359712	0.13495009432873234
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	0.00359712	0.13495009432873234
PRIMARY PULMONARY HYPOPLASIA	0.00359712	0.13495009432873234
PARTIAL ATRIOVENTRICULAR CANAL	0.00359712	0.13495009432873234
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00359712	0.13495009432873234
SPINAL MUSCULAR ATROPHY, TYPE II	0.00359712	0.13495009432873234
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00359712	0.13495009432873234
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00359712	0.13495009432873234
JUNG SYNDROME	0.00359712	0.13495009432873234
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00359712	0.13495009432873234
HARLEQUIN ICHTHYOSIS	0.00359712	0.13495009432873234
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00359712	0.13495009432873234
RETINITIS PIGMENTOSA 6	0.00359712	0.13495009432873234
HEREDITARY OROTIC ACIDURIA	0.00359712	0.13495009432873234
CILIARY DYSKINESIA, PRIMARY, 32; CILD32	0.00359712	0.13495009432873234
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.00359712	0.13495009432873234
GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	0.00359712	0.13495009432873234
CILIARY DYSKINESIA, PRIMARY, 29; CILD29	0.00359712	0.13495009432873234
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00359712	0.13495009432873234
MUCOLIPIDOSIS TYPE II	0.00359712	0.13495009432873234
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00359712	0.13495009432873234
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.00359712	0.13495009432873234
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.00359712	0.13495009432873234
LAMELLAR ICHTHYOSIS	0.00359712	0.13495009432873234
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00359712	0.13495009432873234
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00359712	0.13495009432873234
ALOPECIA ANTIBODY DEFICIENCY	0.00359712	0.13495009432873234
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00359712	0.13495009432873234
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00359712	0.13495009432873234
CD8 DEFICIENCY, FAMILIAL	0.00359712	0.13495009432873234
ICF SYNDROME	0.00359712	0.13495009432873234
CYSTIC FIBROSIS	0.00359712	0.13495009432873234
GLYCOGEN STORAGE DISEASE II	0.00359712	0.13495009432873234
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.13495009432873234
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00359712	0.13495009432873234
PRIMARY ERYTHROMELALGIA	0.00359712	0.13495009432873234
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00359712	0.13495009432873234
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00359712	0.13495009432873234
JACOBSEN SYNDROME	0.00359712	0.13495009432873234
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00359712	0.13495009432873234
OPSISMODYSPLASIA	0.00359712	0.13495009432873234
IMMUNODEFICIENCY 53; IMD53	0.00359712	0.13495009432873234
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00359712	0.13495009432873234
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00359712	0.13495009432873234
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.13495009432873234
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00359712	0.13495009432873234
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.00359712	0.13495009432873234
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00359712	0.13495009432873234
PAPILLON-LEFÈVRE SYNDROME	0.00359712	0.13495009432873234
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.00359712	0.13495009432873234
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00359712	0.13495009432873234
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.00359712	0.13495009432873234
SPASTIC PARAPLEGIA TYPE 2	0.00359712	0.13495009432873234
PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG	0.00359712	0.13495009432873234
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00359712	0.13495009432873234
LARYNX ATRESIA	0.00359712	0.13495009432873234
THORACIC DYSOSTOSIS, ISOLATED	0.00359712	0.13495009432873234
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00359712	0.13495009432873234
ATAXIA-PANCYTOPENIA SYNDROME	0.00359712	0.13495009432873234
CHITAYAT SYNDROME	0.00359712	0.13495009432873234
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00359712	0.13495009432873234
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00359712	0.13495009432873234
NIEMANN-PICK DISEASE, TYPE B	0.00359712	0.13495009432873234
IMMUNODEFICIENCY 43	0.00359712	0.13495009432873234
HURLER SYNDROME	0.00359712	0.13495009432873234
TOWNES-BROCKS SYNDROME	0.00357143	0.133986304429228
THYROID ECTOPIA	0.00357143	0.133986304429228
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00357143	0.133986304429228
NEUROFERRITINOPATHY	0.00357143	0.133986304429228
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.133986304429228
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.133986304429228
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00357143	0.133986304429228
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.133986304429228
WOUND BOTULISM	0.00357143	0.133986304429228
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.133986304429228
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY	0.00357143	0.133986304429228
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.133986304429228
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.133986304429228
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.133986304429228
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.133986304429228
KAPUR-TORIELLO SYNDROME	0.00357143	0.133986304429228
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.133986304429228
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.133986304429228
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00357143	0.133986304429228
FG SYNDROME 2; FGS2	0.00357143	0.133986304429228
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00357143	0.133986304429228
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.0035461	0.13303602034380776
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0035461	0.13303602034380776
X-LINKED SIDEROBLASTIC ANEMIA	0.0035461	0.13303602034380776
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.13303602034380776
ANISOCORIA	0.0035461	0.13303602034380776
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.0035461	0.13303602034380776
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.0035461	0.13303602034380776
KUFOR-RAKEB SYNDROME	0.0035461	0.13303602034380776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0035461	0.13303602034380776
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0035461	0.13303602034380776
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0035461	0.13303602034380776
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.13303602034380776
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0035461	0.13303602034380776
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0035461	0.13303602034380776
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.13303602034380776
FOLLICULAR LYMPHOMA	0.0035461	0.13303602034380776
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.13303602034380776
MAST CELL SARCOMA	0.0035461	0.13303602034380776
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.0035461	0.13303602034380776
CHRONIC MYELOID LEUKEMIA	0.0035461	0.13303602034380776
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.13303602034380776
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.13303602034380776
BARTH SYNDROME; BTHS	0.0035461	0.13303602034380776
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0035461	0.13303602034380776
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.13303602034380776
MUCOLIPIDOSIS TYPE III	0.0035461	0.13303602034380776
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380776
PRIMARY BILIARY CHOLANGITIS	0.0035461	0.13303602034380776
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.13303602034380776
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0035461	0.13303602034380776
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.003464165	0.1299621345744076
MONOSOMY X	0.003464165	0.1299621345744076
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.003464165	0.1299621345744076
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.003464165	0.1299621345744076
POLAND SYNDROME	0.003464165	0.1299621345744076
KNIEST DYSPLASIA	0.003464165	0.1299621345744076
DESBUQUOIS DYSPLASIA 1	0.003464165	0.1299621345744076
BRITTLE CORNEA SYNDROME	0.003464165	0.1299621345744076
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.003464165	0.1299621345744076
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.003464165	0.1299621345744076
COHEN-GIBSON SYNDROME; COGIS	0.003464165	0.1299621345744076
MEIER-GORLIN SYNDROME 7	0.003464165	0.1299621345744076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.003464165	0.1299621345744076
MOSAIC MONOSOMY X	0.003464165	0.1299621345744076
STICKLER SYNDROME, TYPE I	0.003464165	0.1299621345744076
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.003464165	0.1299621345744076
TURNER SYNDROME	0.003464165	0.1299621345744076
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.003464165	0.1299621345744076
HUNTER-MACDONALD SYNDROME	0.003464165	0.1299621345744076
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.003464165	0.1299621345744076
CHROMOSOME 9P DELETION SYNDROME	0.003464165	0.1299621345744076
LAMB-SHAFFER SYNDROME	0.003464165	0.1299621345744076
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.003464165	0.1299621345744076
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.003464165	0.1299621345744076
NEMALINE MYOPATHY 2; NEM2	0.0031642249999999997	0.11870954047330451
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0031642249999999997	0.11870954047330451
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0031642249999999997	0.11870954047330451
STUVE-WIEDEMANN SYNDROME	0.0031642249999999997	0.11870954047330451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0031642249999999997	0.11870954047330451
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0031642249999999997	0.11870954047330451
MARDEN-WALKER SYNDROME	0.0031642249999999997	0.11870954047330451
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0031642249999999997	0.11870954047330451
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0031642249999999997	0.11870954047330451
TYPICAL NEMALINE MYOPATHY	0.0031642249999999997	0.11870954047330451
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0031642249999999997	0.11870954047330451
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0031642249999999997	0.11870954047330451
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0031642249999999997	0.11870954047330451
CHARGE SYNDROME	0.0031642249999999997	0.11870954047330451
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0031642249999999997	0.11870954047330451
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0031642249999999997	0.11870954047330451
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0031642249999999997	0.11870954047330451
5Q35 MICRODUPLICATION SYNDROME	0.003010559	0.11294458373148912
ACROMELIC FRONTONASAL DYSPLASIA	0.003010559	0.11294458373148912
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.003010559	0.11294458373148912
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.003010559	0.11294458373148912
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.003010559	0.11294458373148912
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.003010559	0.11294458373148912
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.003010559	0.11294458373148912
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003010559	0.11294458373148912
OCULODENTODIGITAL DYSPLASIA	0.003010559	0.11294458373148912
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.003010559	0.11294458373148912
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.003010559	0.11294458373148912
MEHMO SYNDROME; MEHMO	0.003010559	0.11294458373148912
GYRATE ATROPHY OF CHOROID AND RETINA	0.003010559	0.11294458373148912
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.003010559	0.11294458373148912
TEMTAMY SYNDROME; TEMTYS	0.003010559	0.11294458373148912
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.003010559	0.11294458373148912
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.003010559	0.11294458373148912
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.003010559	0.11294458373148912
MUSCLE-EYE-BRAIN DISEASE	0.003010559	0.11294458373148912
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.003010559	0.11294458373148912
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.003010559	0.11294458373148912
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.003010559	0.11294458373148912
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.003010559	0.11294458373148912
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.003010559	0.11294458373148912
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.003010559	0.11294458373148912
DONNAI-BARROW SYNDROME	0.003010559	0.11294458373148912
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.003010559	0.11294458373148912
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0027106189999999996	0.10169198963038599
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0027106189999999996	0.10169198963038599
8P11.2 DELETION SYNDROME	0.0027106189999999996	0.10169198963038599
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0027106189999999996	0.10169198963038599
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0027106189999999996	0.10169198963038599
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0027106189999999996	0.10169198963038599
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0027106189999999996	0.10169198963038599
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0027106189999999996	0.10169198963038599
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0027106189999999996	0.10169198963038599
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027106189999999996	0.10169198963038599
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0027106189999999996	0.10169198963038599
5Q14.3 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0027106189999999996	0.10169198963038599
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027106189999999996	0.10169198963038599
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027106189999999996	0.10169198963038599
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027106189999999996	0.10169198963038599
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0027106189999999996	0.10169198963038599
STT3B-CDG	0.0027106189999999996	0.10169198963038599
STT3A-CDG	0.0027106189999999996	0.10169198963038599
RETINITIS PIGMENTOSA 59; RP59	0.0027106189999999996	0.10169198963038599
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0027106189999999996	0.10169198963038599
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.10169198963038599
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0027106189999999996	0.10169198963038599
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0027106189999999996	0.10169198963038599
17Q12 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0027106189999999996	0.10169198963038599
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0027106189999999996	0.10169198963038599
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.10169198963038599
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00246914	0.09263262718809664
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00246914	0.09263262718809664
HYPEREKPLEXIA 2; HKPX2	0.00246914	0.09263262718809664
XYLT1-CDG	0.00246914	0.09263262718809664
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00246914	0.09263262718809664
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00246914	0.09263262718809664
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00246914	0.09263262718809664
NOONAN SYNDROME 6; NS6	0.00246914	0.09263262718809664
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00246914	0.09263262718809664
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00246914	0.09263262718809664
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00246914	0.09263262718809664
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00246914	0.09263262718809664
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00246914	0.09263262718809664
%609256 MYOPIA 7; MYP7	0.00246914	0.09263262718809664
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00246914	0.09263262718809664
RETINAL CONE DYSTROPHY 3B	0.00246914	0.09263262718809664
%609257 MYOPIA 8; MYP8	0.00246914	0.09263262718809664
MYOPIA 15; MYP15	0.00246914	0.09263262718809664
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00246914	0.09263262718809664
CHAR SYNDROME	0.00246914	0.09263262718809664
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00246914	0.09263262718809664
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00246914	0.09263262718809664
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00246914	0.09263262718809664
WEILL-MARCHESANI SYNDROME 3	0.00246914	0.09263262718809664
SVEINSSON CHORIORETINAL ATROPHY	0.00246914	0.09263262718809664
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00246914	0.09263262718809664
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00246914	0.09263262718809664
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00246914	0.09263262718809664
USHER SYNDROME	0.00246914	0.09263262718809664
CHOROIDEREMIA	0.00246914	0.09263262718809664
%609258 MYOPIA 9; MYP9	0.00246914	0.09263262718809664
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00246914	0.09263262718809664
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00246914	0.09263262718809664
%609259 MYOPIA 10; MYP10	0.00246914	0.09263262718809664
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00246914	0.09263262718809664
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00246914	0.09263262718809664
FRONTOOCULAR SYNDROME	0.00246914	0.09263262718809664
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00246914	0.09263262718809664
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00246914	0.09263262718809664
ALAND ISLAND EYE DISEASE	0.00246914	0.09263262718809664
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00246914	0.09263262718809664
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00246914	0.09263262718809664
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00246914	0.09263262718809664
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00246914	0.09263262718809664
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00246914	0.09263262718809664
OPTIC ATROPHY 11; OPA11	0.00246914	0.09263262718809664
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00246914	0.09263262718809664
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00246914	0.09263262718809664
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00246914	0.09263262718809664
RETINITIS PIGMENTOSA 1	0.00246914	0.09263262718809664
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00246914	0.09263262718809664
ABLEPHARON MACROSTOMIA SYNDROME	0.00246914	0.09263262718809664
BARDET-BIEDL SYNDROME 21; BBS21	0.00246914	0.09263262718809664
BARDET-BIEDL SYNDROME 1; BBS1	0.00246914	0.09263262718809664
OCULOCUTANEOUS ALBINISM	0.00246914	0.09263262718809664
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00246914	0.09263262718809664
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00246914	0.09263262718809664
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00246914	0.09263262718809664
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00246914	0.09263262718809664
HYPERTRYPTOPHANEMIA; HYPTRP	0.00246914	0.09263262718809664
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00246914	0.09263262718809664
ALAGILLE SYNDROME 1; ALGS1	0.00246914	0.09263262718809664
ACROCRANIOFACIAL DYSOSTOSIS	0.00246914	0.09263262718809664
MYOPIA, INFANTILE SEVERE	0.00246914	0.09263262718809664
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00246914	0.09263262718809664
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00246914	0.09263262718809664
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00246914	0.09263262718809664
XP22.3 MICRODELETION SYNDROME	0.00246914	0.09263262718809664
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00246914	0.09263262718809664
BLUE CONE MONOCHROMACY; BCM	0.00246914	0.09263262718809664
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00246914	0.09263262718809664
POLYDACTYLY-MYOPIA SYNDROME	0.00246914	0.09263262718809664
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00246914	0.09263262718809664
%310460 MYOPIA 1, X-LINKED; MYP1	0.00246914	0.09263262718809664
ALPORT SYNDROME, X-LINKED; ATS	0.00246914	0.09263262718809664
PROTEUS-LIKE SYNDROME	0.00246914	0.09263262718809664
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00246914	0.09263262718809664
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00246914	0.09263262718809664
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00246914	0.09263262718809664
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00246914	0.09263262718809664
RETINITIS PIGMENTOSA 75; RP75	0.00246914	0.09263262718809664
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00246914	0.09263262718809664
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00246914	0.09263262718809664
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00246914	0.09263262718809664
ÅLAND ISLANDS EYE DISEASE	0.00246914	0.09263262718809664
X-LINKED RECESSIVE OCULAR ALBINISM	0.00246914	0.09263262718809664
GASTROCUTANEOUS SYNDROME	0.00246914	0.09263262718809664
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00246914	0.09263262718809664
6Q16 MICRODELETION SYNDROME	0.00246914	0.09263262718809664
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.00246914	0.09263262718809664
GASTROCUTANEOUS SYNDROME	0.00246914	0.09263262718809664
MESOMELIA-SYNOSTOSES SYNDROME	0.00246914	0.09263262718809664
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00246914	0.09263262718809664
MICROSPHEROPHAKIA WITH HERNIA	0.00246914	0.09263262718809664
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00246914	0.09263262718809664
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00246914	0.09263262718809664
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00246914	0.09263262718809664
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00246914	0.09263262718809664
GLAUCOMA 1, OPEN ANGLE, A	0.00246914	0.09263262718809664
MICROCORIA, CONGENITAL	0.00246914	0.09263262718809664
STICKLER SYNDROME TYPE 2	0.00246914	0.09263262718809664
GLAUCOMA, PRIMARY OPEN ANGLE	0.00246914	0.09263262718809664
USHER SYNDROME TYPE 2	0.00246914	0.09263262718809664
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00246914	0.09263262718809664
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00246914	0.09263262718809664
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00246914	0.09263262718809664
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00246914	0.09263262718809664
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00246914	0.09263262718809664
VAN BOGAERT-HOZAY SYNDROME	0.00246914	0.09263262718809664
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00246914	0.09263262718809664
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00246914	0.09263262718809664
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00246914	0.09263262718809664
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00246914	0.09263262718809664
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00246914	0.09263262718809664
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00246914	0.09263262718809664
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00246914	0.09263262718809664
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00246914	0.09263262718809664
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00246914	0.09263262718809664
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00246914	0.09263262718809664
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00246914	0.09263262718809664
CATARACT-MICROCORNEA SYNDROME	0.00246914	0.09263262718809664
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00246914	0.09263262718809664
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00246914	0.09263262718809664
CRANIOECTODERMAL DYSPLASIA 1	0.00246914	0.09263262718809664
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00246914	0.09263262718809664
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00246914	0.09263262718809664
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00246914	0.09263262718809664
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021691999999999996	0.08138003308699353
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0021691999999999996	0.08138003308699353
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0021691999999999996	0.08138003308699353
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021691999999999996	0.08138003308699353
48,XYYY SYNDROME	0.0021691999999999996	0.08138003308699353
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.08138003308699353
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021691999999999996	0.08138003308699353
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0021691999999999996	0.08138003308699353
SPINOCEREBELLAR ATAXIA TYPE 7	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.08138003308699353
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021691999999999996	0.08138003308699353
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699353
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699353
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0021691999999999996	0.08138003308699353
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0021691999999999996	0.08138003308699353
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.0021691999999999996	0.08138003308699353
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0021691999999999996	0.08138003308699353
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0021691999999999996	0.08138003308699353
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0021691999999999996	0.08138003308699353
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.08138003308699353
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021691999999999996	0.08138003308699353
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.08138003308699353
CRISS-CROSS HEART	0.0021691999999999996	0.08138003308699353
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0021691999999999996	0.08138003308699353
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.08138003308699353
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021691999999999996	0.08138003308699353
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.08138003308699353
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0021691999999999996	0.08138003308699353
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.08138003308699353
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.08138003308699353
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0021691999999999996	0.08138003308699353
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699353
AURICULOCONDYLAR SYNDROME	0.0021691999999999996	0.08138003308699353
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.08138003308699353
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021691999999999996	0.08138003308699353
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.08138003308699353
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.08138003308699353
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.08138003308699353
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0021691999999999996	0.08138003308699353
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.08138003308699353
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0021691999999999996	0.08138003308699353
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.08138003308699353
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.08138003308699353
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.08138003308699353
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.08138003308699353
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0021691999999999996	0.08138003308699353
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.08138003308699353
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.08138003308699353
CONO-SPONDYLAR DYSPLASIA	0.001536444	0.05764146392970345
RECOMBINANT 8 SYNDROME	0.001536444	0.05764146392970345
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.001536444	0.05764146392970345
MENTAL RETARDATION, X-LINKED 82	0.001536444	0.05764146392970345
KLEEFSTRA SYNDROME 2; KLEFS2	0.001536444	0.05764146392970345
C SYNDROME	0.001536444	0.05764146392970345
LINEAR VERRUCOUS NEVUS SYNDROME	0.001536444	0.05764146392970345
8P INVERTED DUPLICATION/DELETION SYNDROME	0.001536444	0.05764146392970345
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001536444	0.05764146392970345
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.001536444	0.05764146392970345
MONOSOMY 9P	0.001536444	0.05764146392970345
15Q14 MICRODELETION SYNDROME	0.001536444	0.05764146392970345
CLARK-BARAITSER SYNDROME	0.001536444	0.05764146392970345
FRAGILE X MENTAL RETARDATION SYNDROME	0.001536444	0.05764146392970345
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.001536444	0.05764146392970345
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001536444	0.05764146392970345
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001536444	0.05764146392970345
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001536444	0.05764146392970345
ISOLATED SPINA BIFIDA	0.001536444	0.05764146392970345
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.001536444	0.05764146392970345
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001536444	0.05764146392970345
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001536444	0.05764146392970345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.001536444	0.05764146392970345
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001536444	0.05764146392970345
NEUROFIBROMATOSIS, TYPE I	0.001536444	0.05764146392970345
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001536444	0.05764146392970345
4Q21 MICRODELETION SYNDROME	0.001536444	0.05764146392970345
WEAVER SYNDROME	0.001536444	0.05764146392970345
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001536444	0.05764146392970345
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001536444	0.05764146392970345
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001536444	0.05764146392970345
RAMON SYNDROME	0.001536444	0.05764146392970345
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001536444	0.05764146392970345
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001536444	0.05764146392970345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001536444	0.05764146392970345
6Q TERMINAL DELETION SYNDROME	0.001536444	0.05764146392970345
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.001536444	0.05764146392970345
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001536444	0.05764146392970345
RETT SYNDROME	0.001536444	0.05764146392970345
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001536444	0.05764146392970345
MARDEN-WALKER SYNDROME	0.001536444	0.05764146392970345
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.001536444	0.05764146392970345
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.001536444	0.05764146392970345
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001536444	0.05764146392970345
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001536444	0.05764146392970345
SECKEL SYNDROME 1; SCKL1	0.001536444	0.05764146392970345
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.001536444	0.05764146392970345
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001536444	0.05764146392970345
2Q31.1 MICRODELETION SYNDROME	0.001536444	0.05764146392970345
MICRO SYNDROME	0.001536444	0.05764146392970345
ATKIN-FLAITZ SYNDROME	0.001536444	0.05764146392970345
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001536444	0.05764146392970345
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.001536444	0.05764146392970345
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001536444	0.05764146392970345
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.001536444	0.05764146392970345
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.001536444	0.05764146392970345
TRISOMY 13	0.001536444	0.05764146392970345
9Q21.13 MICRODELETION SYNDROME	0.001536444	0.05764146392970345
RUVALCABA SYNDROME	0.001536444	0.05764146392970345
X-LINKED CENTRONUCLEAR MYOPATHY	0.001536444	0.05764146392970345
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001536444	0.05764146392970345
FAMILIAL MULTIPLE NEVI FLAMMEI	0.001536444	0.05764146392970345
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001536444	0.05764146392970345
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.001536444	0.05764146392970345
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001536444	0.05764146392970345
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.001536444	0.05764146392970345
XP22.13P22.2 DUPLICATION SYNDROME	0.001536444	0.05764146392970345
CENTRONUCLEAR MYOPATHY	0.001536444	0.05764146392970345
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001536444	0.05764146392970345
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001536444	0.05764146392970345
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001536444	0.05764146392970345
MENTAL RETARDATION, X-LINKED 102	0.001536444	0.05764146392970345
TETRASOMY 18P	0.001536444	0.05764146392970345
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.001536444	0.05764146392970345
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001536444	0.05764146392970345
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001536444	0.05764146392970345
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001536444	0.05764146392970345
INTELLECTUAL DISABILITY, WOLFF TYPE	0.001536444	0.05764146392970345
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001536444	0.05764146392970345
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001536444	0.05764146392970345
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001536444	0.05764146392970345
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.001536444	0.05764146392970345
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.001536444	0.05764146392970345
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001536444	0.05764146392970345
NEVUS COMEDONICUS SYNDROME	0.001536444	0.05764146392970345
MICROPHTHALMIA, LENZ TYPE	0.001536444	0.05764146392970345
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001536444	0.05764146392970345
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001536444	0.05764146392970345
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.001536444	0.05764146392970345
PETTIGREW SYNDROME	0.001536444	0.05764146392970345
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.000995025	0.03732950738631097
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.000995025	0.03732950738631097
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.000995025	0.03732950738631097
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.000995025	0.03732950738631097
ALLAN-HERNDON-DUDLEY SYNDROME	0.000995025	0.03732950738631097
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.000995025	0.03732950738631097
ATELOSTEOGENESIS, TYPE II	0.000995025	0.03732950738631097
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.000995025	0.03732950738631097
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.000995025	0.03732950738631097
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000995025	0.03732950738631097
FRONTOMETAPHYSEAL DYSPLASIA	0.000995025	0.03732950738631097
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000995025	0.03732950738631097
MORQUIO SYNDROME A	0.000995025	0.03732950738631097
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000995025	0.03732950738631097
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.000995025	0.03732950738631097
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.000995025	0.03732950738631097
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000995025	0.03732950738631097
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000995025	0.03732950738631097
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.000995025	0.03732950738631097
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.000995025	0.03732950738631097
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.000995025	0.03732950738631097
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000995025	0.03732950738631097
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.000995025	0.03732950738631097
FOCAL DERMAL HYPOPLASIA; FDH	0.000995025	0.03732950738631097
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.000995025	0.03732950738631097
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000995025	0.03732950738631097
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.000995025	0.03732950738631097
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.000995025	0.03732950738631097
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.000995025	0.03732950738631097
BRADDOCK SYNDROME	0.000995025	0.03732950738631097
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.000995025	0.03732950738631097
PYCNODYSOSTOSIS	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.000995025	0.03732950738631097
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.000995025	0.03732950738631097
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.000995025	0.03732950738631097
FRONTOMETAPHYSEAL DYSPLASIA	0.000995025	0.03732950738631097
TRISOMY 5P	0.000995025	0.03732950738631097
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.000995025	0.03732950738631097
LEBER OPTIC ATROPHY AND DYSTONIA	0.000995025	0.03732950738631097
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000995025	0.03732950738631097
MARINESCO-SJÖGREN SYNDROME	0.000995025	0.03732950738631097
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.000995025	0.03732950738631097
SPONDYLOCAMPTODACTYLY	0.000995025	0.03732950738631097
DYSOSTOSIS, STANESCU TYPE	0.000995025	0.03732950738631097
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.000995025	0.03732950738631097
45,X/46,XY MIXED GONADAL DYSGENESIS	0.000995025	0.03732950738631097
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.000995025	0.03732950738631097
DUANE-RADIAL RAY SYNDROME; DRRS	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.000995025	0.03732950738631097
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000995025	0.03732950738631097
TRISOMY 4P	0.000995025	0.03732950738631097
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.000995025	0.03732950738631097
RIGID SPINE MUSCULAR DYSTROPHY 1	0.000995025	0.03732950738631097
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.000995025	0.03732950738631097
MUCOLIPIDOSIS III ALPHA/BETA	0.000995025	0.03732950738631097
BECKER NEVUS SYNDROME	0.000995025	0.03732950738631097
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.000995025	0.03732950738631097
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000995025	0.03732950738631097
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.000995025	0.03732950738631097
TERMINAL TRANSVERSE LIMB DEFECT	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.000995025	0.03732950738631097
ACROCAPITOFEMORAL DYSPLASIA	0.000995025	0.03732950738631097
12Q14 MICRODELETION SYNDROME	0.000995025	0.03732950738631097
MARINESCO-SJOGREN SYNDROME; MSS	0.000995025	0.03732950738631097
DIASTEMATOMYELIA	0.000995025	0.03732950738631097
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.000995025	0.03732950738631097
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.03732950738631097
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.000995025	0.03732950738631097
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.000995025	0.03732950738631097
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000995025	0.03732950738631097
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.000995025	0.03732950738631097
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000995025	0.03732950738631097
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.000995025	0.03732950738631097
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.000995025	0.03732950738631097
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.000995025	0.03732950738631097
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000995025	0.03732950738631097
CRANIOSYNOSTOSIS 6; CRS6	0.000995025	0.03732950738631097
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000995025	0.03732950738631097
THORACOLARYNGOPELVIC DYSPLASIA	0.000995025	0.03732950738631097
TIBIAL TORSION, BILATERAL MEDIAL	0.000995025	0.03732950738631097
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.000995025	0.03732950738631097
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.000995025	0.03732950738631097
MYOPATHY, SCAPULOHUMEROPERONEAL	0.000995025	0.03732950738631097
BRACHYDACTYLY TYPE A1	0.000995025	0.03732950738631097
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000995025	0.03732950738631097
MAXILLONASAL DYSPLASIA	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000995025	0.03732950738631097
MICROTRIPLICATION 11Q24.1	0.000995025	0.03732950738631097
FETAL AKINESIA DEFORMATION SEQUENCE	0.000995025	0.03732950738631097
LERI PLEONOSTEOSIS	0.000995025	0.03732950738631097
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.000995025	0.03732950738631097
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.000995025	0.03732950738631097
49,XYYYY SYNDROME	0.000995025	0.03732950738631097
GENITOPALATOCARDIAC SYNDROME	0.000995025	0.03732950738631097
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000995025	0.03732950738631097
OGDEN SYNDROME	0.000995025	0.03732950738631097
RUVALCABA SYNDROME	0.000995025	0.03732950738631097
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.000995025	0.03732950738631097
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.000995025	0.03732950738631097
SHPRINTZEN OMPHALOCELE SYNDROME	0.000995025	0.03732950738631097
ATELOSTEOGENESIS TYPE I	0.000995025	0.03732950738631097
FRIEDREICH ATAXIA	0.000995025	0.03732950738631097
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.000995025	0.03732950738631097
SPRENGEL DEFORMITY	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.000995025	0.03732950738631097
OSTEOMESOPYKNOSIS	0.000995025	0.03732950738631097
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000995025	0.03732950738631097
BALLER-GEROLD SYNDROME	0.000995025	0.03732950738631097
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.000995025	0.03732950738631097
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000995025	0.03732950738631097
OROFACIODIGITAL SYNDROME TYPE 5	0.000995025	0.03732950738631097
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.000995025	0.03732950738631097
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.000995025	0.03732950738631097
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.000995025	0.03732950738631097
PENTALOGY OF CANTRELL	0.000995025	0.03732950738631097
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000995025	0.03732950738631097
CAREY-FINEMAN-ZITER SYNDROME	0.000995025	0.03732950738631097
NEU-LAXOVA SYNDROME 2; NLS2	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.000995025	0.03732950738631097
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000995025	0.03732950738631097
SHOX-RELATED SHORT STATURE	0.000995025	0.03732950738631097
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.000995025	0.03732950738631097
SPONDYLOCAMPTODACTYLY SYNDROME	0.000995025	0.03732950738631097
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.000995025	0.03732950738631097
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.000995025	0.03732950738631097
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.000995025	0.03732950738631097
FRANK-TER HAAR SYNDROME	0.000995025	0.03732950738631097
FEMORAL-FACIAL SYNDROME	0.000995025	0.03732950738631097
AASE-SMITH SYNDROME	0.000995025	0.03732950738631097
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.000995025	0.03732950738631097
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.000995025	0.03732950738631097
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.000995025	0.03732950738631097
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.000995025	0.03732950738631097
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000995025	0.03732950738631097
3MC SYNDROME	0.000995025	0.03732950738631097
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.000995025	0.03732950738631097
ACRODYSPLASIA SCOLIOSIS	0.000995025	0.03732950738631097
BRACHYOLMIA, MAROTEAUX TYPE	0.000995025	0.03732950738631097
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.000995025	0.03732950738631097
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.000995025	0.03732950738631097
CAUDAL REGRESSION SEQUENCE	0.000995025	0.03732950738631097
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.000995025	0.03732950738631097
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.000995025	0.03732950738631097
CEREBELLOFACIODENTAL SYNDROME	0.000995025	0.03732950738631097
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.000995025	0.03732950738631097
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.000995025	0.03732950738631097
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.000995025	0.03732950738631097
9P13 MICRODELETION SYNDROME	0.000995025	0.03732950738631097
METATROPIC DYSPLASIA	0.000995025	0.03732950738631097
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.000995025	0.03732950738631097
ISOLATED KLIPPEL-FEIL SYNDROME	0.000995025	0.03732950738631097
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.000995025	0.03732950738631097
TRISOMY 9P	0.000995025	0.03732950738631097
DUCHENNE MUSCULAR DYSTROPHY	0.000995025	0.03732950738631097
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000995025	0.03732950738631097
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000995025	0.03732950738631097
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000995025	0.03732950738631097
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.000995025	0.03732950738631097
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000995025	0.03732950738631097
IVIC SYNDROME	0.000995025	0.03732950738631097
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.000995025	0.03732950738631097
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.000995025	0.03732950738631097
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.000995025	0.03732950738631097
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000995025	0.03732950738631097
JUBERG-HAYWARD SYNDROME	0.000995025	0.03732950738631097
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.000995025	0.03732950738631097
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.000995025	0.03732950738631097
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.000995025	0.03732950738631097
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000995025	0.03732950738631097
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.000995025	0.03732950738631097
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000995025	0.03732950738631097
DYSTONIA, DOPA-RESPONSIVE; DRD	0.000995025	0.03732950738631097
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.000995025	0.03732950738631097
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.000995025	0.03732950738631097
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.000995025	0.03732950738631097
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.000995025	0.03732950738631097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.000995025	0.03732950738631097
DIPHALLIA	0.000995025	0.03732950738631097
LERI-WEILL DYSCHONDROSTEOSIS	0.000995025	0.03732950738631097
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.000995025	0.03732950738631097
IVIC SYNDROME	0.000995025	0.03732950738631097
MCDONOUGH SYNDROME	0.000995025	0.03732950738631097
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.000995025	0.03732950738631097
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.000995025	0.03732950738631097
TRISOMY 17P	0.000995025	0.03732950738631097
POSTERIOR COLUMN ATAXIA	0.000995025	0.03732950738631097
AREDYLD SYNDROME	0.000995025	0.03732950738631097
HIP DYSPLASIA, BEUKES TYPE	0.000995025	0.03732950738631097
SHELDON-HALL SYNDROME	0.000995025	0.03732950738631097
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.000995025	0.03732950738631097
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000995025	0.03732950738631097
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000995025	0.03732950738631097
KUSKOKWIM SYNDROME	0.000995025	0.03732950738631097
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.000995025	0.03732950738631097
METATROPIC DYSPLASIA	0.000995025	0.03732950738631097
TOWNES-BROCKS SYNDROME 2; TBS2	0.000995025	0.03732950738631097
OSTEOGLOSPHONIC DYSPLASIA	0.000995025	0.03732950738631097
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.000995025	0.03732950738631097
NEU-LAXOVA SYNDROME	0.000995025	0.03732950738631097
ACRO-RENAL-MANDIBULAR SYNDROME	0.000995025	0.03732950738631097
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.000995025	0.03732950738631097
ATAXIA WITH VITAMIN E DEFICIENCY	0.000995025	0.03732950738631097
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000995025	0.03732950738631097
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.000995025	0.03732950738631097
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.000995025	0.03732950738631097
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.000995025	0.03732950738631097
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000995025	0.03732950738631097
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.03732950738631097
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.000995025	0.03732950738631097
MOSAIC TRISOMY 8	0.000995025	0.03732950738631097
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.000995025	0.03732950738631097
OROFACIODIGITAL SYNDROME V; OFD5	0.000995025	0.03732950738631097
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.000995025	0.03732950738631097
DISTAL MONOSOMY 6P	0.000995025	0.03732950738631097
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.000995025	0.03732950738631097
ISOLATED HEMIHYPERPLASIA	0.000995025	0.03732950738631097
OTOPALATODIGITAL SYNDROME TYPE 2	0.000995025	0.03732950738631097
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.000995025	0.03732950738631097
MOSAIC TRISOMY 9	0.000995025	0.03732950738631097
CEREBROFACIOTHORACIC DYSPLASIA	0.000995025	0.03732950738631097
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.000995025	0.03732950738631097
HOLT-ORAM SYNDROME	0.000995025	0.03732950738631097
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.000995025	0.03732950738631097
FRONTORHINY	0.000995025	0.03732950738631097
FETAL TRIMETHADIONE SYNDROME	0.000995025	0.03732950738631097
GORLIN SYNDROME	0.000995025	0.03732950738631097
GORDON SYNDROME	0.000995025	0.03732950738631097
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000995025	0.03732950738631097
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.03732950738631097
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.000995025	0.03732950738631097
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000995025	0.03732950738631097
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.000995025	0.03732950738631097
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.000995025	0.03732950738631097
OSTEOGENESIS IMPERFECTA, TYPE X	0.000995025	0.03732950738631097
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.000995025	0.03732950738631097
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.000995025	0.03732950738631097
231970 GLUTEAL MUSCLES, ABSENCE OF	0.000995025	0.03732950738631097
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.000995025	0.03732950738631097
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.000995025	0.03732950738631097
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.000995025	0.03732950738631097
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.000995025	0.03732950738631097
FACIOCARDIORENAL SYNDROME	0.000995025	0.03732950738631097
ENG-STROM SYNDROME	0.000995025	0.03732950738631097
WAGR SYNDROME	0.000995025	0.03732950738631097
OCULOAURICULOFRONTONASAL SYNDROME	0.000995025	0.03732950738631097
FRIED SYNDROME	0.000995025	0.03732950738631097
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.000995025	0.03732950738631097
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000995025	0.03732950738631097
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.000995025	0.03732950738631097
SYMBRACHYDACTYLY OF HANDS AND FEET	0.000995025	0.03732950738631097
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.000995025	0.03732950738631097
NEMALINE MYOPATHY 1; NEM1	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.000995025	0.03732950738631097
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.000995025	0.03732950738631097
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.000995025	0.03732950738631097
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.000995025	0.03732950738631097
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.000995025	0.03732950738631097
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.03732950738631097
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.000995025	0.03732950738631097
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000995025	0.03732950738631097
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.000995025	0.03732950738631097
HYPOPHOSPHATEMIC RICKETS	0.000995025	0.03732950738631097
NOONAN SYNDROME 4; NS4	0.000995025	0.03732950738631097
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000995025	0.03732950738631097
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.000995025	0.03732950738631097
XFE PROGEROID SYNDROME; XFEPS	0.000995025	0.03732950738631097
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.000995025	0.03732950738631097
JOUBERT SYNDROME 7	0.000995025	0.03732950738631097
SALIH MYOPATHY; SALMY	0.000995025	0.03732950738631097
BRESEK SYNDROME	0.000995025	0.03732950738631097
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.000995025	0.03732950738631097
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.000995025	0.03732950738631097
WAARDENBURG SYNDROME TYPE 1	0.000995025	0.03732950738631097
HEMIHYPERPLASIA, ISOLATED	0.000995025	0.03732950738631097
STEEL SYNDROME; STLS	0.000995025	0.03732950738631097
ALAZAMI SYNDROME; ALAZS	0.000995025	0.03732950738631097
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.000995025	0.03732950738631097
MYASTHENIC SYNDROME, CONGENITAL, 13	0.000995025	0.03732950738631097
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000995025	0.03732950738631097
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.000995025	0.03732950738631097
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.000995025	0.03732950738631097
WEISMANN-NETTER SYNDROME	0.000995025	0.03732950738631097
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.000995025	0.03732950738631097
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.000995025	0.03732950738631097
CENANI-LENZ SYNDROME	0.000995025	0.03732950738631097
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.000995025	0.03732950738631097
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000995025	0.03732950738631097
SOTOS SYNDROME 2	0.000995025	0.03732950738631097
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.000995025	0.03732950738631097
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.000995025	0.03732950738631097
CLASSIC MULTIMINICORE MYOPATHY	0.000995025	0.03732950738631097
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000995025	0.03732950738631097
BANGSTAD SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
KBG SYNDROME	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020311956543392476
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.020311956543392476
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
WALKER-WARBURG SYNDROME	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000541419	0.020311956543392476
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392476
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
COACH SYNDROME	0.000541419	0.020311956543392476
MYHRE SYNDROME	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
KEUTEL SYNDROME	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392476
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392476
MACDERMOT-WINTER SYNDROME	0.000541419	0.020311956543392476
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
PALLISTER-HALL SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392476
ARGININEMIA	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
ELEJALDE DISEASE	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
SIALIDOSIS TYPE 2	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
ALG3-CDG	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
DPM1-CDG	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
SCHIZENCEPHALY	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392476
LEIGH SYNDROME; LS	0.000541419	0.020311956543392476
47,XYY SYNDROME	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
TRIPLE A SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392476
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 1	0.000541419	0.020311956543392476
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020311956543392476
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000541419	0.020311956543392476
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.020311956543392476
KETOADIPICACIDURIA	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 1; HPE1	0.000541419	0.020311956543392476
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
HARTNUP DISORDER	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020311956543392476
COG8-CDG	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
DPAGT1-CDG	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020311956543392476
PITUITARY STALK INTERRUPTION SYNDROME	0.000541419	0.020311956543392476
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
MOSAIC TRISOMY 14	0.000541419	0.020311956543392476
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000541419	0.020311956543392476
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.020311956543392476
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
LISSENCEPHALY 8; LIS8	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392476
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392476
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.020311956543392476
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020311956543392476
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020311956543392476
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.020311956543392476
MOMO SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.020311956543392476
AL KAISSI SYNDROME; ALKAS	0.000541419	0.020311956543392476
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.020311956543392476
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392476
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000541419	0.020311956543392476
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000541419	0.020311956543392476
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020311956543392476
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.020311956543392476
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000541419	0.020311956543392476
20P13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392476
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020311956543392476
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392476
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.020311956543392476
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.020311956543392476
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020311956543392476
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
MEVALONIC ACIDURIA	0.000541419	0.020311956543392476
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020311956543392476
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020311956543392476
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392476
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.020311956543392476
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000541419	0.020311956543392476
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.020311956543392476
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.020311956543392476
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
EAST SYNDROME	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.020311956543392476
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
HYDRANENCEPHALY	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
2P21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
DISTAL MONOSOMY 3P	0.000541419	0.020311956543392476
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
DISTAL MONOSOMY 15Q	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
RING CHROMOSOME 22 SYNDROME	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392476
XQ21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392476
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020311956543392476
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.020311956543392476
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
6Q25 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
8P23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.020311956543392476
LOWRY-MACLEAN SYNDROME	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MATERNAL PHENYLKETONURIA	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000541419	0.020311956543392476
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.020311956543392476
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392476
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.020311956543392476
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020311956543392476
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020311956543392476
DUANE RETRACTION SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020311956543392476
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
MUENKE SYNDROME	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE	0.000541419	0.020311956543392476
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.020311956543392476
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392476
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392476
LEIGH SYNDROME	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392476
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.020311956543392476
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392476
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
SALLA DISEASE	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000541419	0.020311956543392476
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.020311956543392476
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000541419	0.020311956543392476
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.020311956543392476
LISSENCEPHALY 1; LIS1	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
LATHOSTEROLOSIS	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000541419	0.020311956543392476
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.020311956543392476
WAISMAN SYNDROME; WSMN	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.020311956543392476
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
ANGELMAN SYNDROME	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.020311956543392476
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392476
XYLOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.020311956543392476
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392476
INFANTILE REFSUM DISEASE	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020311956543392476
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392476
MENKES DISEASE	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020311956543392476
XQ25 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
LEBER CONGENITAL AMAUROSIS	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
MEND SYNDROME; MEND	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392476
CEDNIK SYNDROME	0.000541419	0.020311956543392476
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
LATHOSTEROLOSIS	0.000541419	0.020311956543392476
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
RENPENNING SYNDROME	0.000541419	0.020311956543392476
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392476
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392476
SCHINDLER DISEASE, TYPE I	0.000541419	0.020311956543392476
CHIME SYNDROME	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
WILSON-TURNER SYNDROME	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.020311956543392476
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.020311956543392476
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392476
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392476
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
SRD5A3-CDG	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 1	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020311956543392476
FILIPPI SYNDROME	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
ISOVALERIC ACIDEMIA	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020311956543392476
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000541419	0.020311956543392476
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.020311956543392476
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 7	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020311956543392476
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392476
PHACE SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.020311956543392476
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392476
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020311956543392476
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392476
NEONATAL ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.020311956543392476
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392476
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.020311956543392476
CHROMOSOME 10Q26 DELETION SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
GLASS SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY 4	0.000541419	0.020311956543392476
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020311956543392476
DISTAL MONOSOMY 1Q	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.020311956543392476
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392476
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.020311956543392476
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.020311956543392476
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020311956543392476
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000541419	0.020311956543392476
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020311956543392476
MEND SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
